Â© 2000-2023 QIAGEN. All rights reserved.

Categories	Functions	Diseases or Functions Annotation	p-value	B-H p-value	Predicted Activation State	Activation z-score	Molecules	# Molecules
Cellular Function and Maintenance	engulfment	Engulfment of cells	3,59E-06	3,33E-02	Decreased	-4,979	ACTR2,ACTR3,AP2S1,ARPC2,ARPC3,ARPC4,ATP6V0D1,ATP6V1F,BRK1,CD47,CNN2,CORO1A,CSK,CXCR4,CYBA,EFHD2,FCMR,FGR,FLNA,GLRX,GNAI2,GRB2,GRN,GSN,HCK,HMOX1,HSH2D,ILK,ITGB2,JAK1,MYO1G,NCKAP1L,NME1,NME2,OGT,PARK7,PFN1,PKM,PLD4,PLEK,PSMD4,PTPN1,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RHOA,RHOG,S100A10,SIGLEC10,SNX3,SPI1,SRA1,SYK,TLN1,TNF,UBE2L3,UCP2,VIM,WASF2,WIPF1	62
Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Inflammatory Response	phagocytosis	Phagocytosis of cells	5,93E-06	3,33E-02	Decreased	-4,314	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD47,CNN2,CORO1A,CSK,CYBA,FCMR,FGR,FLNA,GLRX,GNAI2,GRB2,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,JAK1,MYO1G,NCKAP1L,PFN1,PKM,PLD4,PLEK,PSMD4,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RHOA,RHOG,SIGLEC10,SNX3,SPI1,SYK,TLN1,TNF,UBE2L3,UCP2,VIM,WASF2	48
Organismal Injury and Abnormalities,Renal and Urological Disease	damage	Damage of kidney	2,13E-05	5,29E-02	 	-1,660	CXCR3,CXCR4,DUSP1,FGR,FKBP1A,GRN,HCK,PARP1,PKM,POU2F2,PREX1,RAC1,TLN1,TNF,TXNIP,YBX1	16
Cellular Function and Maintenance	internalization	Internalization of cells	2,89E-05	5,29E-02	Decreased	-4,490	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD47,CNN2,CSK,FCMR,FGR,GLRX,GNAI2,GRB2,GRN,GSN,HCK,HMOX1,HSH2D,ILK,ITGB2,JAK1,MYO1G,NCKAP1L,PFN1,PKM,PLEK,PSMD4,PTPN6,PTPRC,RAC1,RAC2,RHOA,RHOG,SIGLEC10,SPI1,SYK,TLN1,TNF,UBE2L3,UCP2,VIM,WASF2	43
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Inflammatory Response	binding	Binding of professional phagocytic cells	3,45E-05	5,29E-02	Decreased	-3,065	CD99,CORO1A,CXCR4,FGR,FLNA,GLRX,HCK,ITGAX,ITGB2,ITGB7,LCP1,LSP1,NCKAP1L,PAK2,PKM,PREX1,PTPN22,PTPN6,PTPRC,RAC1,RAC2,RASGRP2,RHOA,SLC44A2,SPI1,TLN1,TNF	27
Cellular Development,Cellular Growth and Proliferation,Connective Tissue Development and Function,Tissue Development	cell proliferation	Cell proliferation of fibroblasts	3,45E-05	5,29E-02	Decreased	-3,211	ACTB,ARID3A,BRK1,CIB1,CKS2,DUSP1,GPI,GRB2,GRN,HMOX1,IFI30,ILK,NCOA4,OGT,PKM,PRDX1,PTPN6,RAC1,RAP1B,RHOA,SEPTIN6,TNF,TXNIP,VCP,VIM,WASF2,YBX1	27
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	interaction	Interaction of phagocytes	4,01E-05	5,29E-02	Decreased	-3,186	CD47,CD99,CORO1A,CXCR4,FGR,FLNA,GLRX,HCK,ITGAX,ITGB2,ITGB7,LCP1,LSP1,NCKAP1L,PAK2,PKM,PREX1,PTPN22,PTPN6,PTPRC,RAC1,RAC2,RASGRP2,RHOA,SLC44A2,SPI1,TLN1,TNF	28
Cell-To-Cell Signaling and Interaction	binding	Binding of myeloid cells	4,56E-05	5,29E-02	Decreased	-3,190	CD99,CIB1,CORO1A,CSK,FGR,FLNA,GLRX,HCK,ITGAX,ITGB2,ITGB7,LCP1,LSP1,NCKAP1L,PAK2,PKM,PREX1,PTPN22,PTPN6,PTPRC,RAC1,RAC2,RAP1B,RASGRP2,RHOA,SLC44A2,SPI1,TLN1,TNF	29
Cellular Function and Maintenance	endocytosis	Endocytosis by eukaryotic cells	4,73E-05	5,29E-02	Decreased	-4,697	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,ATP6V0D1,ATP6V1F,BRK1,CD47,CNN2,CSK,CXCR4,EFHD2,FCMR,FGR,FLNA,GLRX,GNAI2,GRB2,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,JAK1,MYO1G,NCKAP1L,NME1,NME2,OGT,PARK7,PFN1,PKM,PLEK,PSMD4,PTPN6,PTPRC,RAC1,RAC2,RHOA,RHOG,SIGLEC10,SPI1,SYK,TLN1,TNF,UBE2L3,UCP2,VIM,WASF2	51
Cellular Function and Maintenance,Inflammatory Response	phagocytosis	Phagocytosis	4,73E-05	5,29E-02	Decreased	-4,367	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD47,CNN2,CORO1A,CSK,CYBA,FCMR,FGR,FLNA,GABARAPL2,GLRX,GNAI2,GRB2,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,JAK1,MYO1G,NCKAP1L,PFN1,PIKFYVE,PKM,PLD4,PLEK,PSMD4,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RHOA,RHOG,SIGLEC10,SNX3,SPI1,SYK,TLN1,TNF,UBE2L3,UCP2,VCP,VIM,WASF2	51
Cellular Function and Maintenance	endocytosis	Endocytosis	5,18E-05	5,29E-02	Decreased	-4,776	ACTB,ACTG1,ACTR2,ACTR3,AP2S1,ARPC2,ARPC3,ARPC4,ATP6V0D1,ATP6V1F,BRK1,CAP1,CD47,CD82,CNN2,CSK,CXCR4,EEA1,EFHD2,FCMR,FGR,FLNA,GLRX,GNAI2,GRB2,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,JAK1,MYO1G,NCKAP1L,NME1,NME2,OGT,PARK7,PFN1,PKM,PLEK,PSMD4,PTPN1,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RHOA,RHOG,S100A10,SIGLEC10,SPI1,SYK,TLN1,TNF,UBE2L3,UCP2,VCP,VIM,WASF2,WIPF1	62
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of blood cells	8,32E-05	7,78E-02	Decreased	-2,858	ATP2A3,CD47,CD99,CIB1,CORO1A,CSK,CXCR3,CXCR4,FGR,FLNA,GLRX,GNAI2,HCK,ILK,ITGAX,ITGB2,ITGB7,JAK1,LCP1,LSP1,MAP4K1,MS4A1,MYO1G,NCKAP1L,PAK2,PKM,PREX1,PTPN22,PTPN6,PTPRC,RAC1,RAC2,RAP1B,RASGRP1,RASGRP2,RHOA,SLC44A2,SPI1,SYK,TLN1,TNF,VASP,VIM	43
Inflammatory Response	immune response	Immune response of cells	1,08E-04	9,31E-02	Decreased	-4,915	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD19,CD47,CD68,CD79A,CNN2,CORO1A,CSK,CYBA,FCMR,FGR,FLNA,GAPDH,GLRX,GNAI2,GRB2,GRN,GSN,HCK,HLA-DQB1,HMOX1,HSH2D,ITGAX,ITGB2,JAK1,LITAF,MALT1,MAP4K1,MS4A1,MYO1G,NCKAP1L,PARP1,PFN1,PKM,PLD4,PLEK,PSMB8,PSMD4,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RHOA,RHOG,SIGLEC10,SNX3,SPI1,SYK,TCIRG1,TLN1,TNF,TNFRSF1B,UBE2L3,UCP2,VASP,VIM,WASF2	63
Cellular Movement	cell movement	Cell movement of lymphoma cell lines	1,23E-04	9,34E-02	 	-1,221	BTG1,CD47,CXCR3,CXCR4,HVCN1,ITGB7,MS4A1,MTSS1,NME1,PARVG,RAC2,TNF	12
Cellular Assembly and Organization,Cellular Function and Maintenance	organization	Organization of actin cytoskeleton	1,25E-04	9,34E-02	Decreased	-2,395	ACTR2,ARHGDIB,ARPC5,BRK1,CAP1,CD47,CD82,CD99,CFL1,CORO1A,CSK,CSRP1,CXCR3,FGR,FLNA,GRB2,GSN,HCK,ILK,LCP1,MTSS1,NCKAP1L,PLEK,PTPN1,RAC1,RAC2,RHOA,RHOG,TLN1,TNF,TWF2,VASP,WASF2,WDR1	34
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking	adhesion	Adhesion of immune cells	1,38E-04	9,67E-02	Decreased	-2,838	CD47,CD99,CORO1A,CSK,CXCR3,CXCR4,FGR,FLNA,GLRX,GNAI2,HCK,ILK,ITGAX,ITGB2,ITGB7,JAK1,LCP1,LSP1,MAP4K1,MS4A1,MYO1G,NCKAP1L,PAK2,PKM,PREX1,PTPN22,PTPN6,PTPRC,RAC1,RAC2,RAP1B,RASGRP1,RASGRP2,RHOA,SLC44A2,SPI1,SYK,TLN1,TNF,VASP,VIM	41
Post-Translational Modification	phosphorylation	Phosphorylation of protein	2,21E-04	1,30E-01	 	-1,190	CALM1 (includes others),CD19,CD47,CD79A,CDK2AP1,CFL1,CIB1,CSK,CXCR4,DUSP1,DYNLL1,FCRL5,FGR,FLNA,HCK,HCST,ILK,ITGB2,JAK1,LAT2,MAP4K1,NCKAP1L,NME1,NOP53,PAK2,PARK7,PIKFYVE,PPIA,PRDX1,PSAP,PTPN1,PTPN22,PTPN6,PTPRC,RAC1,RASGRP1,SPI1,SRPK2,SYK,TAF10,TERF2IP,TNF	42
Cellular Function and Maintenance	ion homeostasis	Ion homeostasis of cells	2,26E-04	1,30E-01	 	-1,844	ANXA2,ATP2A3,ATP2B1,ATP6V0D1,CD19,CD52,CD79A,CXCR3,CXCR4,CYB561A3,EFHD2,FGR,FTL,HCK,HMOX1,IRAG2,ITGB2,LAT2,MS4A1,MT2A,MTMR14,NCOA4,NEAT1,NME2,PAK2,PARP1,PPIA,PTPRC,RAC1,RAC2,SYK,TCIRG1,TESC,TNF,UCP2,UNC93B1	36
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of myeloid cells	2,31E-04	1,30E-01	Decreased	-3,020	CD99,CIB1,CORO1A,CSK,FGR,FLNA,GLRX,HCK,ITGAX,ITGB2,ITGB7,LCP1,NCKAP1L,PAK2,PREX1,PTPN22,PTPN6,RAC1,RAC2,RASGRP2,SLC44A2,SPI1,TLN1,TNF	24
Cellular Function and Maintenance	engulfment	Engulfment of leukocytes	2,31E-04	1,30E-01	Decreased	-2,662	CD47,CNN2,FCMR,FGR,GLRX,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,MYO1G,NCKAP1L,PTPN6,PTPRC,RAC1,RAC2,RHOA,RHOG,SPI1,SRA1,SYK,TNF,UCP2	24
Cardiovascular Disease,Organismal Injury and Abnormalities	formation	Formation of blood clot	2,48E-04	1,33E-01	 	-0,850	ANXA2,ATP2A3,CSK,ITGB2,PTPN22,RAP1B,RHOA,RHOG,SYK,TNF,TNFRSF1B,TWF2,VIM	13
Cellular Movement,Hematological System Development and Function,Humoral Immune Response,Immune Cell Trafficking	cell movement	Cell movement of B lymphocytes	2,72E-04	1,39E-01	Decreased	-2,785	CD19,CD47,COMMD8,CXCR3,CXCR4,GNAI2,ITGB7,LCP1,MALT1,MYO1G,RAC1,RAC2,RAP1B,TNF,TNFRSF1B,WIPF1	16
Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Inflammatory Response	phagocytosis	Phagocytosis of tumor cell lines	3,46E-04	1,44E-01	Decreased	-3,635	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD47,CSK,GNAI2,GRB2,HCK,HMOX1,ITGB2,JAK1,NCKAP1L,PFN1,PKM,PLEK,PSMD4,PTPN6,RAC1,RHOA,RHOG,SIGLEC10,SPI1,TLN1,TNF,UBE2L3,VIM,WASF2	30
Cellular Function and Maintenance,Hematological System Development and Function	engulfment	Engulfment of myeloid cells	3,74E-04	1,44E-01	Decreased	-4,197	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD47,CNN2,FCMR,FGR,GLRX,GNAI2,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,JAK1,NCKAP1L,PLEK,PTPN6,PTPRC,RAC1,RAC2,RHOA,RHOG,SPI1,SYK,TLN1,TNF,UBE2L3,UCP2,WASF2	34
Cellular Function and Maintenance	engulfment	Engulfment of blood cells	3,76E-04	1,44E-01	Decreased	-3,955	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD47,CNN2,FCMR,FGR,GLRX,GNAI2,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,JAK1,MYO1G,NCKAP1L,PLEK,PTPN6,PTPRC,RAC1,RAC2,RHOA,RHOG,SPI1,SRA1,SYK,TLN1,TNF,UBE2L3,UCP2,WASF2	36
Cell Signaling,Post-Translational Modification	tyrosine phosphorylation	Tyrosine phosphorylation of protein	3,81E-04	1,44E-01	 	-0,227	CD19,CD47,CD79A,CSK,DUSP1,FCRL5,FLNA,HCK,ILK,ITGB2,LAT2,PPIA,PRDX1,PSAP,PTPN1,PTPN22,PTPN6,PTPRC,RAC1,SPI1,SYK,TNF	22
Cellular Function and Maintenance	engulfment	Engulfment of phagocytes	3,81E-04	1,44E-01	Decreased	-2,714	CD47,CNN2,FGR,GLRX,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,NCKAP1L,PTPN6,PTPRC,RAC1,RAC2,RHOA,RHOG,SPI1,SRA1,SYK,TNF,UCP2	22
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	chemotaxis	Chemotaxis of granulocytes	3,81E-04	1,44E-01	Decreased	-2,176	CD47,CORO1A,CXCR3,FGR,GRN,GSN,HCK,ITGB2,LSP1,NCKAP1L,PIKFYVE,PNOC,PPIA,PREX1,PTPN6,RAC1,RAC2,SERPINB1,SPI1,SYK,TMSB10/TMSB4X,TNF	22
Cellular Movement	cell movement	Cell movement	3,82E-04	1,44E-01	Decreased	-6,436	ACTB,ACTG1,ACTR2,ANXA2,AP1S2,ARHGDIB,ARID3A,ARPC1B,ARPC2,ARPC3,ATP5F1A,ATP5F1B,BRK1,BTG1,CAP1,CAPNS1,CD19,CD47,CD53,CD82,CD99,CDCA7L,CFL1,CHD4,CIB1,CKS2,CLIC1,CNN2,COMMD8,CORO1A,CSK,CTSH,CUX1,CXCR3,CXCR4,CYBA,CYTOR,DBNL,DDX17,DUSP1,EFHD2,FABP5,FGR,FLNA,FUT8,GAPDH,GLRX,GLUL,GNAI2,GOLPH3,GPI,GRB2,GRN,GSN,HCK,HHEX,HLA-DQB1,HMGA1,HMOX1,HSBP1,HVCN1,IGF2BP3,ILK,ITGAX,ITGB2,ITGB7,JAK1,LCP1,LITAF,LSP1,MAD1L1,MALT1,MAP4K1,MAZ,MEF2C,MIEN1,MRPL52,MS4A1,MTCH2,MTSS1,MYL12A,MYO1G,NCKAP1L,NCOA3,NDUFB2,NEAT1,NME1,NME2,OGT,PAK2,PARK7,PARP1,PARVG,PDLIM1,PFN1,PIKFYVE,PKM,PNOC,PPIA,PPP1CA,PRDX1,PREX1,PSMB8,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RABEP1,RAC1,RAC2,RAP1B,RASGRP1,RASGRP2,RHOA,RHOG,RNF141,S100A10,S100A11,SEPTIN7,SERPINB1,SLC38A1,SMARCC1,SPI1,SUMO1,SYK,TAGLN2,TCIRG1,TESC,TKT,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,TPI1,TPM3,TPT1,TRAPPC1,TSC22D3,TWF2,UCP2,VASP,VCP,VDAC1,VIM,VSIR,WASF2,WIPF1,YBX1,YWHAE,ZDHHC12,ZEB2,ZYX	153
Free Radical Scavenging	synthesis	Synthesis of reactive oxygen species	3,93E-04	1,44E-01	 	-1,813	ACTB,ANXA2,ARHGDIB,CAPNS1,CD47,CD52,CLIC1,COX5B,CYBA,CYTOR,DBI,DECR1,DUSP1,FCMR,FGR,FLNA,FTL,GRN,GSN,HCK,HMOX1,HVCN1,ILK,ITGAX,ITGB2,MS4A1,NDUFA11,NDUFV2,PARK7,PARP1,PIKFYVE,PPIA,PRDX1,PREX1,PSMB8,PTPN1,PTPN22,PTPN6,PYCARD,RAC1,RAC2,RHOA,ROMO1,SAT1,SIGLEC10,SPI1,SYK,TNF,TXNIP,UCP2,VDAC1	51
Cellular Movement	migration	Migration of cells	3,98E-04	1,44E-01	Decreased	-6,409	ACTB,ACTG1,ANXA2,AP1S2,ARHGDIB,ARID3A,ARPC2,ATP5F1A,ATP5F1B,BRK1,CAP1,CAPNS1,CD19,CD47,CD53,CD82,CD99,CDCA7L,CFL1,CIB1,CKS2,CNN2,COMMD8,CORO1A,CSK,CTSH,CUX1,CXCR3,CXCR4,CYBA,CYTOR,DBNL,DDX17,DUSP1,EFHD2,FABP5,FGR,FLNA,FUT8,GAPDH,GLRX,GLUL,GNAI2,GOLPH3,GPI,GRB2,GRN,GSN,HCK,HHEX,HLA-DQB1,HMGA1,HMOX1,HSBP1,HVCN1,IGF2BP3,ILK,ITGAX,ITGB2,ITGB7,JAK1,LCP1,LITAF,LSP1,MAD1L1,MALT1,MAP4K1,MAZ,MEF2C,MIEN1,MRPL52,MS4A1,MTCH2,MTSS1,MYL12A,MYO1G,NCKAP1L,NCOA3,NDUFB2,NEAT1,NME1,NME2,OGT,PAK2,PARK7,PARP1,PDLIM1,PFN1,PIKFYVE,PKM,PNOC,PPIA,PPP1CA,PRDX1,PREX1,PSMB8,PTPN1,PTPN6,PTPRC,PYCARD,RABEP1,RAC1,RAC2,RAP1B,RASGRP1,RASGRP2,RHOA,RHOG,RNF141,S100A10,S100A11,SEPTIN7,SERPINB1,SLC38A1,SMARCC1,SPI1,SUMO1,SYK,TAGLN2,TCIRG1,TESC,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,TPM3,TPT1,TRAPPC1,TSC22D3,UCP2,VASP,VCP,VDAC1,VIM,VSIR,WASF2,WIPF1,YBX1,YWHAE,ZDHHC12,ZEB2,ZYX	142
Cellular Movement	migration	Migration of myeloid cells	4,64E-04	1,57E-01	Decreased	-2,808	CD47,CD99,CNN2,CORO1A,CXCR4,FGR,GNAI2,HCK,HMOX1,ITGAX,ITGB2,LSP1,NCKAP1L,PARP1,PKM,PREX1,PTPN6,RAC1,RAP1B,RASGRP2,RHOA,TLN1,TNF,VASP	24
Cell-To-Cell Signaling and Interaction	activation	Activation of cells	4,78E-04	1,57E-01	 	-1,261	ANXA2,ATP2A3,CD19,CD47,CD79A,CFL1,CLEC2D,CLIC1,CORO1A,CSK,CTSH,CXCR3,CXCR4,DUSP1,FKBP1A,FUT8,GNAI2,GRB2,GRN,GSN,HCK,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,HSH2D,HSPA4,HVCN1,IGF2BP3,ITGAX,ITGB2,JAK1,LAPTM5,LAT2,LSP1,MALT1,MAP4K1,MEF2C,MS4A1,OGT,PAK2,PARK7,PARP1,PKM,PLEK,PPIA,PPP1R18,PRDX1,PREX1,PSAP,PSMB8,PTPN22,PTPN6,PTPRC,PYCARD,RAC1,RASGRP1,RHOA,SELENOW,SIGLEC10,SPI1,SYK,TCF4,TCIRG1,TLN1,TNF,TNFRSF1B,TPT1,TRAPPC1,TXNIP,UNC93B1,VASP,VIM,VSIR	77
Developmental Disorder,Neurological Disease,Organismal Injury and Abnormalities	dysmyelination	Dysmyelination	4,99E-04	1,57E-01	 	1,136	CD19,CD47,CD52,CD68,CXCR3,DECR1,FDFT1,FDPS,HLA-DMB,HLA-DQA1,HLA-DQB1,HLA-DRA,LITAF,LY6E,MEF2C,MS4A1,NCOA3,OAS1,OGT,PSAP,PSMB8,PTPRC,TNF,TNFRSF1B,TSPO	25
Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities	immune mediated inflammatory disease	Immune mediated inflammatory disease	5,07E-04	1,57E-01	Decreased	-2,110	ACTB,ARHGDIB,ARPC1B,ARPC3,ATP2B1,BCAS4,CAPZB,CD19,CD47,CD52,CD68,CD79A,CFL1,CHD4,CIB1,CKS2,CRIP1,CSK,CUX1,CXCR4,DHRS9,DUSP1,DYNLL1,EEF1A1,FABP5,FCRL5,FDPS,FGR,FIBP,FKBP1A,FLNA,GAPDH,GLUL,GOLPH3,GRN,GSN,H3-3A/H3-3B,HCK,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HMGA1,HMOX1,IFI30,IKZF3,ILK,ITGAX,ITGB2,ITGB7,JAK1,JPT1,LAPTM5,LBH,LCP1,LY6E,MALT1,MAZ,MRPS36,MS4A1,MT2A,MYL12A,OAS1,OSTF1,PARP1,PDLIM1,PEA15,PFN1,PIKFYVE,PKM,PLD4,POLR2L,PPIA,PPP1CA,PPP1R7,PRDX1,PRDX5,PREX1,PSAP,PSMB2,PSMB8,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAB1B,RAC2,RASGRP1,RNPEPL1,RTF2,S100A10,S100A11,SAMHD1,SF3B6,SIGLEC10,SPI1,SUMO1,SYK,TAGLN2,TALDO1,TCF4,TCIRG1,TKT,TNF,TNFRSF1B,TPI1,TPM3,TSPO,UBE2L3,UGCG,UNC93B1,VCP,VIM,WIPF1,ZEB2,ZYX	119
Cell-To-Cell Signaling and Interaction	binding	Binding of blood cells	5,08E-04	1,57E-01	Decreased	-2,709	ATP2A3,CD47,CD99,CIB1,CORO1A,CSK,CXCR3,CXCR4,FGR,FLNA,GLRX,GNAI2,HCK,ILK,ITGAX,ITGB2,ITGB7,JAK1,LCP1,LSP1,MAP4K1,MS4A1,MYO1G,NCKAP1L,PAK2,PKM,PREX1,PTPN22,PTPN6,PTPRC,RAC1,RAC2,RAP1B,RASGRP1,RASGRP2,RHOA,SLC44A2,SPI1,SYK,TLN1,TNF,VASP,VIM,WIPF1	44
Connective Tissue Development and Function,Tissue Development	growth	Growth of connective tissue	5,38E-04	1,57E-01	Decreased	-2,759	ACTB,ARID3A,BRK1,CAPNS1,CIB1,CKS2,CSK,CXCR3,DUSP1,FTL,GNAI2,GOLPH3,GPI,GRB2,GRN,HMGA1,HMOX1,IFI30,IGF2BP3,ILK,JAK1,NCOA4,NEAT1,OGT,PKM,PRDX1,PTPN1,PTPN6,PTPRC,RAC1,RAP1B,RHOA,S100A11,SEPTIN6,TALDO1,TCIRG1,TNF,TXNIP,VCP,VIM,WASF2,YBX1	42
Cardiovascular Disease,Hematological Disease,Organismal Injury and Abnormalities	formation	Formation of thrombus	5,52E-04	1,57E-01	 	-0,494	ANXA2,ATP2A3,CSK,ITGB2,PTPN22,RAP1B,RHOA,RHOG,SYK,TNF,TNFRSF1B,TWF2	12
Cancer,Organismal Injury and Abnormalities	carcinoma	Invasive carcinoma	5,53E-04	1,57E-01	 	 	ACP5,ANXA2,CALM1 (includes others),CD47,CUX1,CXCR3,EEF1A1,EIF4A1,FDFT1,FDPS,FGR,FKBP1A,FTL,GABARAPL2,HLA-DQA1,IFI30,JAK1,LIMD2,LY6E,MEF2C,MYL12A,NAA50,OAS1,PAK2,PARP1,PKM,PPIA,PREX1,PSAP,PTPN1,PTPRC,RAC1,RHOA,S100A11,TERF2IP,TMSB10/TMSB4X,TNF,TPT1,VIM,WDR1,YWHAE	41
Cellular Assembly and Organization,Cellular Function and Maintenance	organization	Organization of cytoskeleton	5,65E-04	1,57E-01	Decreased	-3,697	ACTG1,ACTR2,ACTR3,ARHGDIB,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,BRK1,CAP1,CAPNS1,CAPZB,CD47,CD82,CD99,CFL1,CIB1,CNN2,CORO1A,CRIP1,CSK,CSRP1,CXCR3,CXCR4,DBNL,DYNLL1,FGR,FKBP1A,FLNA,FUT8,GDI2,GOLPH3,GRB2,GSN,HCK,ILK,LCP1,LSP1,MEF2C,MIEN1,MTSS1,NCKAP1L,NME1,OGT,PAK2,PARP1,PFDN5,PFN1,PKM,PLEK,PREX1,PSMF1,PTPN1,PTPN22,RAC1,RAC2,RAP1B,RHOA,RHOG,S100A11,SEPTIN7,SH3BGRL3,SMARCE1,SNX3,SPI1,SPTAN1,SSNA1,SYK,TLN1,TNF,TNFRSF1B,TWF2,UGCG,VASP,VDAC1,VIM,WASF2,WDR1,WIPF1,YBX1,YWHAH,ZEB2	83
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	cell movement	Cell movement of neutrophils	5,90E-04	1,57E-01	Decreased	-2,921	ANXA2,CD47,CD99,CNN2,CORO1A,DUSP1,FGR,GNAI2,GRN,GSN,HCK,HMOX1,ILK,ITGB2,LSP1,MALT1,NCKAP1L,PARP1,PIKFYVE,PKM,PNOC,PPIA,PREX1,PTPN6,RAC1,RAC2,RAP1B,RASGRP2,SERPINB1,SPI1,SYK,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,VASP,YBX1,ZDHHC12	38
Cellular Assembly and Organization,Cellular Function and Maintenance	organization	Organization of cytoplasm	6,05E-04	1,57E-01	Decreased	-3,803	ACTG1,ACTR2,ACTR3,ARHGDIB,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,BRK1,CAP1,CAPNS1,CAPZB,CD47,CD82,CD99,CFL1,CIB1,CNN2,CORO1A,CRIP1,CSK,CSRP1,CXCR3,CXCR4,DBNL,DYNLL1,FGR,FKBP1A,FLNA,FUT8,GDI2,GOLPH3,GRB2,GRN,GSN,HCK,ILK,LCP1,LSP1,MEF2C,MIEN1,MTSS1,NCKAP1L,NME1,OGT,PAK2,PARK7,PARP1,PFDN5,PFN1,PKM,PLEK,PREX1,PSMF1,PTPN1,PTPN22,RAB1B,RAC1,RAC2,RAP1B,RHOA,RHOG,S100A11,SEPTIN7,SH3BGRL3,SMARCE1,SNX3,SPI1,SPTAN1,SSNA1,SYK,TLN1,TNF,TNFRSF1B,TWF2,UGCG,VASP,VDAC1,VIM,WASF2,WDR1,WIPF1,YBX1,YWHAH,ZEB2	86
Cell Morphology,Cellular Assembly and Organization,Cellular Function and Maintenance	formation	Formation of cellular protrusions	6,11E-04	1,57E-01	Decreased	-3,842	ACTR2,ACTR3,ARPC1B,ARPC2,ARPC3,ARPC4,BRK1,CAP1,CAPNS1,CAPZB,CD47,CD82,CFL1,CIB1,CRIP1,CSRP1,CXCR3,CXCR4,DBNL,DYNLL1,FGR,FKBP1A,FLNA,FUT8,GDI2,GOLPH3,GRB2,GSN,HCK,ILK,LCP1,MEF2C,MIEN1,MTSS1,NCKAP1L,NME1,OGT,PAK2,PFN1,PREX1,PSMF1,PTPN22,RAC1,RAC2,RAP1B,RHOA,RHOG,S100A11,SEPTIN7,SNX3,SSNA1,SYK,TNF,TNFRSF1B,TWF2,UGCG,VASP,VDAC1,VIM,WASF2,WIPF1,YWHAH,ZEB2	63
Cell-To-Cell Signaling and Interaction,Inflammatory Response	immune response	Immune response of tumor cell lines	6,17E-04	1,57E-01	Decreased	-3,463	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD47,CSK,GAPDH,GNAI2,GRB2,HCK,HMOX1,ITGB2,JAK1,MS4A1,NCKAP1L,PFN1,PKM,PLEK,PSMD4,PTPN6,RAC1,RHOA,RHOG,SIGLEC10,SPI1,TLN1,TNF,UBE2L3,VIM,WASF2	32
Cellular Assembly and Organization,Cellular Function and Maintenance	organization	Microtubule dynamics	6,56E-04	1,61E-01	Decreased	-3,332	ACTG1,ACTR2,ACTR3,ARPC1B,ARPC2,ARPC3,ARPC4,BRK1,CAP1,CAPNS1,CAPZB,CD47,CD82,CFL1,CIB1,CORO1A,CRIP1,CSRP1,CXCR3,CXCR4,DBNL,DYNLL1,FGR,FKBP1A,FLNA,FUT8,GDI2,GOLPH3,GRB2,GSN,HCK,ILK,LCP1,MEF2C,MIEN1,MTSS1,NCKAP1L,NME1,OGT,PAK2,PARP1,PFDN5,PFN1,PKM,PREX1,PSMF1,PTPN22,RAC1,RAC2,RAP1B,RHOA,RHOG,S100A11,SEPTIN7,SMARCE1,SNX3,SPTAN1,SSNA1,SYK,TLN1,TNF,TNFRSF1B,TWF2,UGCG,VASP,VDAC1,VIM,WASF2,WIPF1,YBX1,YWHAH,ZEB2	72
Cellular Movement	movement	Movement of blood platelets	6,81E-04	1,61E-01	 	-0,853	FGR,FLNA,GSN,HCK,PTPN22,RAC1,RASGRP2,SYK,TLN1,TWF2	10
Cellular Movement	cell movement	Cell movement of blood cells	6,90E-04	1,61E-01	Decreased	-3,508	ACTB,ANXA2,CD19,CD47,CD53,CD99,CIB1,CNN2,COMMD8,CORO1A,CSK,CUX1,CXCR3,CXCR4,DBNL,DUSP1,FABP5,FGR,FLNA,FUT8,GLRX,GNAI2,GRN,GSN,HCK,HLA-DQB1,HMOX1,IGF2BP3,ILK,ITGAX,ITGB2,ITGB7,JAK1,LCP1,LITAF,LSP1,MALT1,MAP4K1,MS4A1,MTCH2,MYO1G,NCKAP1L,PARP1,PFN1,PIKFYVE,PKM,PNOC,PPIA,PRDX1,PREX1,PSMB8,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RAP1B,RASGRP1,RASGRP2,RHOA,S100A10,SERPINB1,SPI1,SUMO1,SYK,TCIRG1,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,TPT1,TRAPPC1,TWF2,UCP2,VASP,WIPF1,YBX1,ZDHHC12	80
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	chemotaxis	Chemotaxis of neutrophils	7,03E-04	1,61E-01	Decreased	-2,175	CD47,CORO1A,FGR,GRN,GSN,HCK,ITGB2,LSP1,NCKAP1L,PIKFYVE,PNOC,PPIA,PREX1,PTPN6,RAC1,RAC2,SERPINB1,SPI1,SYK,TMSB10/TMSB4X,TNF	21
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	adhesion	Adhesion of phagocytes	7,03E-04	1,61E-01	Decreased	-2,776	CD99,CORO1A,FLNA,GLRX,HCK,ITGAX,ITGB2,ITGB7,LCP1,NCKAP1L,PAK2,PREX1,PTPN22,PTPN6,RAC1,RAC2,RASGRP2,SLC44A2,SPI1,TLN1,TNF	21
Free Radical Scavenging	production	Production of reactive oxygen species	8,15E-04	1,76E-01	 	-1,519	ACTB,ANXA2,ARHGDIB,CAPNS1,CD52,CYBA,CYTOR,DBI,DECR1,FCMR,FGR,FLNA,FTL,GRN,GSN,HCK,HMOX1,HVCN1,ILK,ITGAX,ITGB2,MS4A1,NDUFA11,NDUFV2,PARK7,PARP1,PPIA,PRDX1,PSMB8,PTPN22,PTPN6,RAC1,RAC2,RHOA,ROMO1,SIGLEC10,SPI1,SYK,TNF,TXNIP,UCP2,VDAC1	42
Hematological System Development and Function,Tissue Morphology	quantity	Quantity of myeloid cells	8,21E-04	1,76E-01	 	-0,032	ADD3,ARHGDIB,ARID3A,CAPNS1,CD19,CD47,CD82,CIB1,CNN2,CSK,CXCR4,DBI,DUSP1,FABP5,FLNA,GNAI2,GRN,GSN,HCK,HMOX1,ITGB2,ITGB7,LITAF,LSP1,NCKAP1L,NEDD8,PAK2,PARP1,PCLAF,PIKFYVE,PLAC8,PLD4,PRDX1,PREX1,PTPN6,RAC1,RAC2,SERPINB1,SPI1,TCF4,TCIRG1,TNF,TNFRSF1B,TPM3,TRAPPC1,TSC22D3,UNC93B1,VASP,WIPF1,YBX1,ZEB2	51
Developmental Disorder,Neurological Disease,Organismal Injury and Abnormalities	demyelination	Demyelination	8,30E-04	1,76E-01	 	0,885	CD19,CD47,CD52,CD68,CXCR3,FDFT1,FDPS,HLA-DMB,HLA-DQA1,HLA-DQB1,HLA-DRA,LITAF,LY6E,MS4A1,NCOA3,OAS1,OGT,PSAP,PSMB8,PTPRC,TNF,TNFRSF1B,TSPO	23
Cancer,Organismal Injury and Abnormalities	metastatic carcinoma	Metastatic carcinoma	8,30E-04	1,76E-01	 	 	ANXA2,CD47,CXCR3,EEF1A1,EIF4A1,FDFT1,FDPS,FGR,FKBP1A,FTL,IFI30,JAK1,LIMD2,MYL12A,PARP1,PPIA,PTPRC,RAC1,S100A11,TMSB10/TMSB4X,TNF,TPT1,YWHAE	23
Cellular Movement	cell tethering or rolling	Cell tethering or rolling of leukocytes	8,45E-04	1,76E-01	 	-1,597	CD53,CD82,FGR,GNAI2,GOLPH3,HCK,ITGB2,ITGB7,PRDX1,PREX1,RAC2,TLN1,TNF	13
Cellular Movement	homing	Homing of cells	8,61E-04	1,76E-01	Decreased	-3,331	ACTR2,ANXA2,ARPC2,CD47,CD82,CORO1A,CSK,CUX1,CXCR3,CXCR4,DUSP1,FGR,GLRX,GNAI2,GRB2,GRN,GSN,HCK,ILK,ITGB2,ITGB7,JAK1,LCP1,LITAF,LSP1,MEF2C,MS4A1,MTSS1,NCKAP1L,PFN1,PIKFYVE,PNOC,PPIA,PREX1,PTPN1,PTPN6,PTPRC,RAC1,RAC2,RAP1B,RHOA,RHOG,SERPINB1,SPI1,SUMO1,SYK,TCIRG1,TMSB10/TMSB4X,TNF,WIPF1	50
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	binding	Binding of neutrophils	8,84E-04	1,77E-01	Decreased	-2,367	CD99,CORO1A,FGR,FLNA,GLRX,HCK,ITGAX,ITGB2,LCP1,LSP1,PREX1,PTPN22,PTPN6,RASGRP2,SLC44A2,TLN1,TNF	17
Cellular Function and Maintenance	homeostasis	Cellular homeostasis	9,16E-04	1,80E-01	Decreased	-2,636	ANXA2,ATP2A3,ATP2B1,ATP5MF,ATP6V0D1,BLOC1S1,CAPNS1,CD19,CD47,CD52,CD79A,CHD4,CHMP2A,CHMP4A,CLIC1,CORO1A,COX5A,CSK,CXCR3,CXCR4,CYB561A3,DYNLL1,EFHD2,EMP3,FABP5,FGR,FKBP1A,FTL,GABARAPL2,GAPDH,GPI,GRB2,GRN,GSN,HCK,HLA-DQA1,HLA-DQB1,HLA-DRA,HMGA1,HMOX1,HSPA4,IKZF3,IRAG2,ITGB2,JAK1,LAPTM5,LAT2,MAD1L1,MALT1,MEF2C,MRPL52,MS4A1,MT2A,MTCH2,MTMR14,MTSS1,NCKAP1L,NCOA4,NDUFAB1,NDUFB2,NEAT1,NME2,OAS1,OGT,PAK2,PARK7,PARP1,PFDN5,PIKFYVE,PKM,PLAC8,PLD4,PPIA,PPP1CA,PRDX1,PREX1,PSAP,PSMA5,PSMB8,PTPN22,PTPN6,PTPRC,PYCARD,RAB1B,RAC1,RAC2,RAP1B,RASGRP1,RFTN1,RHOA,SERPINB1,SLC25A5,SMARCE1,SPI1,SYK,TCF4,TCIRG1,TESC,TNF,TNFRSF1B,TSC22D3,TSPO,TXNIP,UCP2,UNC93B1,VASP,VCP,VDAC1,VIM,VPS25,YWHAE	111
Cellular Function and Maintenance	engulfment	Engulfment of tumor cell lines	9,58E-04	1,81E-01	Decreased	-4,092	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,ATP6V0D1,ATP6V1F,BRK1,CD47,CSK,EFHD2,GNAI2,GRB2,HCK,HMOX1,ITGB2,JAK1,NCKAP1L,NME1,NME2,OGT,PFN1,PKM,PLEK,PSMD4,PTPN6,RAC1,RHOA,RHOG,SIGLEC10,SPI1,TLN1,TNF,UBE2L3,VIM,WASF2	36
Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	neuromuscular disease with neuropathy	Neuromuscular disease with neuropathy	9,58E-04	1,81E-01	 	 	ANXA2,AP1S2,ARHGDIB,ARL6IP5,CAPZB,CD47,CD52,CD68,CXCR3,DBNL,EEF1A1,FDFT1,FDPS,FTL,H3-3A/H3-3B,HLA-DMB,HLA-DQA1,HLA-DQB1,HLA-DRA,LY6E,MS4A1,NCOA3,NDUFV2,NEAT1,OAS1,PARK7,PSAP,PSMB8,PTPRC,S100A10,SPTAN1,TNF,TPT1,TSPO,VCP,VIM	36
Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	progressive neuromuscular disease	Progressive neuromuscular disease	9,76E-04	1,81E-01	 	 	ANXA2,AP1S2,ARHGDIB,ARL6IP5,CAPZB,CD47,CD52,CD68,CXCR3,DBNL,EEF1A1,FDFT1,FDPS,FTL,H3-3A/H3-3B,HLA-DMB,HLA-DQA1,HLA-DQB1,HLA-DRA,LY6E,MS4A1,NCOA3,NDUFV2,NEAT1,OAS1,PARK7,PSAP,PSMB8,PTPRC,S100A10,TNF,TPT1,TSPO,VCP,VIM	35
Cell-To-Cell Signaling and Interaction	response	Response of myeloid cells	9,92E-04	1,81E-01	Decreased	-4,283	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD47,CNN2,FCMR,FGR,GLRX,GNAI2,GRN,GSN,HCK,HMOX1,HSH2D,ITGAX,ITGB2,JAK1,NCKAP1L,PARK7,PLEK,PTPRC,RAC1,RAC2,SPI1,SYK,TLN1,TNF,UBE2L3,UCP2,WASF2,ZEB2	34
Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Inflammatory Response	phagocytosis	Phagocytosis of blood cells	1,01E-03	1,81E-01	Decreased	-4,089	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD47,CNN2,FCMR,FGR,GLRX,GNAI2,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,JAK1,MYO1G,NCKAP1L,PLEK,PTPRC,RAC1,RAC2,SPI1,SYK,TLN1,TNF,UBE2L3,UCP2,WASF2	32
Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Inflammatory Response	phagocytosis	Phagocytosis of leukocytes	1,03E-03	1,81E-01	Decreased	-2,807	CD47,CNN2,FCMR,FGR,GLRX,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,MYO1G,NCKAP1L,PTPRC,SPI1,SYK,TNF,UCP2	18
Cell Morphology,Cellular Movement	cell spreading	Cell spreading of blood cells	1,03E-03	1,81E-01	Decreased	-2,079	CD19,CD47,CNN2,CORO1A,FGR,FLNA,HCK,ITGB2,MAP4K1,PTPN22,RAC1,RAP1B,RASGRP2,RHOA,SYK,TLN1,TNF,TWF2	18
Cellular Movement	cell movement	Cell movement of myeloid cells	1,05E-03	1,81E-01	Decreased	-3,661	ANXA2,CD47,CD99,CIB1,CNN2,CORO1A,CSK,CXCR3,CXCR4,DUSP1,FGR,FLNA,GNAI2,GRN,GSN,HCK,HMOX1,ILK,ITGAX,ITGB2,JAK1,LCP1,LITAF,LSP1,MALT1,NCKAP1L,PARP1,PFN1,PIKFYVE,PKM,PNOC,PPIA,PREX1,PSMB8,PTPN1,PTPN6,PTPRC,RAC1,RAC2,RAP1B,RASGRP2,RHOA,S100A10,SERPINB1,SPI1,SYK,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,VASP,YBX1,ZDHHC12	53
Neurological Disease,Organismal Injury and Abnormalities	progressive motor neuropathy	Progressive motor neuropathy	1,07E-03	1,83E-01	 	 	ACTB,ANXA2,AP1S2,ARHGDIB,ARL6IP5,CALM1 (includes others),CAPZB,CD47,CD52,CD68,CXCR3,DBI,DBNL,EEF1A1,EIF4A1,FDFT1,FDPS,FTL,GRN,GSN,H3-3A/H3-3B,HLA-DMB,HLA-DQA1,HLA-DQB1,HLA-DRA,JPT1,LY6E,MS4A1,NCOA3,NDUFV2,NEAT1,OAS1,PARK7,PFN1,PPIA,PSAP,PSMB8,PTPRC,RHOA,S100A10,TNF,TPT1,TSPO,VCP,VIM	45
Free Radical Scavenging	metabolism	Metabolism of reactive oxygen species	1,11E-03	1,85E-01	Decreased	-2,071	ACTB,ANXA2,ARHGDIB,CAPNS1,CD47,CD52,CLIC1,COX5B,CYBA,CYTOR,DBI,DECR1,DUSP1,FCMR,FGR,FLNA,FTL,GRN,GSN,HCK,HMOX1,HVCN1,ILK,ITGAX,ITGB2,MS4A1,NDUFA11,NDUFV2,PARK7,PARP1,PIKFYVE,PPIA,PRDX1,PRDX5,PREX1,PSMB8,PTPN1,PTPN22,PTPN6,PYCARD,RAC1,RAC2,RHOA,ROMO1,SAT1,SIGLEC10,SPI1,SYK,TNF,TXNIP,UCP2,VDAC1	52
Cell Signaling	cell surface receptor linked signal transduction	Cell surface receptor linked signal transduction	1,16E-03	1,89E-01	 	 	CD47,FGR,FKBP1A,FUT8,HCK,ILK,ITGB2,ITGB7,JAK1,MTSS1,NME2,PLEK,PTPN6,PTPRC,RHOA,SYK,TLN1,VCP,ZYX	19
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	migration	Migration of granulocytes	1,16E-03	1,89E-01	Decreased	-2,663	CD47,CD99,CNN2,CORO1A,FGR,GNAI2,HCK,ITGB2,LSP1,NCKAP1L,PKM,PREX1,PTPN6,RAC1,RAP1B,RASGRP2,TLN1,TNF,VASP	19
Cellular Movement	migration	Migration of blood cells	1,34E-03	2,15E-01	Decreased	-3,768	ACTB,ANXA2,CD19,CD47,CD53,CD99,CIB1,CNN2,COMMD8,CORO1A,CSK,CUX1,CXCR3,CXCR4,DBNL,DUSP1,FABP5,FGR,FLNA,FUT8,GLRX,GNAI2,GRN,GSN,HCK,HLA-DQB1,HMOX1,IGF2BP3,ILK,ITGAX,ITGB2,ITGB7,JAK1,LCP1,LITAF,LSP1,MALT1,MAP4K1,MS4A1,MTCH2,MYO1G,NCKAP1L,PARP1,PFN1,PIKFYVE,PKM,PNOC,PPIA,PRDX1,PREX1,PSMB8,PTPN1,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RAP1B,RASGRP1,RASGRP2,RHOA,S100A10,SERPINB1,SPI1,SUMO1,SYK,TCIRG1,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,TPT1,TRAPPC1,UCP2,VASP,WIPF1,YBX1,ZDHHC12	78
Cellular Growth and Proliferation,Connective Tissue Development and Function,Tissue Development	proliferation	Proliferation of connective tissue cells	1,43E-03	2,24E-01	Decreased	-2,993	ACTB,ARID3A,BRK1,CAPNS1,CIB1,CKS2,CSK,CXCR3,DUSP1,GNAI2,GOLPH3,GPI,GRB2,GRN,HMOX1,IFI30,ILK,JAK1,NCOA4,NEAT1,OGT,PKM,PRDX1,PTPN1,PTPN6,RAC1,RAP1B,RHOA,S100A11,SEPTIN6,TCIRG1,TNF,TXNIP,VCP,VIM,WASF2,YBX1	37
Organismal Development	morphology	Morphology of body cavity	1,44E-03	2,24E-01	 	 	ARHGDIB,ARID3A,ATP2A3,CAPNS1,CAPZB,CD19,CD47,CIB1,CUX1,CXCR4,DBNL,DECR1,DUSP1,EHD3,EIF6,FABP5,FDFT1,FKBP1A,FLNA,FUT8,GNAI2,GNG5,GRB2,GRN,GSN,H1-2,HCK,HCST,HHEX,HLA-DQA1,HLA-DQB1,HMGA1,HMOX1,HOPX,HSH2D,HVCN1,IDS,IKZF3,ILK,ITGB2,ITGB7,JAK1,LITAF,LY6E,MAD1L1,MALT1,MEF2A,MEF2C,MFSD1,MTMR14,MTPN,MTSS1,NDUFS6,OGT,PARK7,PARP1,PFN1,PLD4,PPIA,PPP1CA,PRDX1,PRDX5,PREX1,PSAP,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAC1,RASGRP1,RHOA,S100A10,SCP2,SPI1,SPTAN1,SYK,SYTL1,TCIRG1,TKT,TLN1,TNF,TNFRSF1B,TPI1,TPT1,TSC22D3,TXNIP,UGCG,UNC93B1,VDAC1,WASF2,WIPF1,YBX1,YWHAE,ZEB2	95
Connective Tissue Disorders,Hematological Disease,Organismal Injury and Abnormalities	erythrocytosis	Erythrocytosis	1,57E-03	2,33E-01	 	1,231	HMGA1,JAK1,PRDX1,PTPN6,RAC1,RAC2,RHOA	7
Developmental Disorder,Hereditary Disorder,Lipid Metabolism,Metabolic Disease,Organismal Injury and Abnormalities,Small Molecule Biochemistry	sphingolipidosis	Sphingolipidosis	1,57E-03	2,33E-01	 	 	CD47,CD68,GRN,ITGAX,PSAP,TNF,UGCG	7
Cell Death and Survival	removal	Removal of cells	1,58E-03	2,33E-01	 	-0,808	ANXA2,CD47,CD68,FABP5,FLNA,PAK2,SYK,TNF,UCP2	9
Cell Morphology,Cellular Movement,Hematological System Development and Function,Inflammatory Response	cell spreading	Cell spreading of blood platelets	1,58E-03	2,33E-01	 	-1,238	FGR,FLNA,HCK,PTPN22,RAC1,RASGRP2,SYK,TLN1,TWF2	9
Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Hematological System Development and Function	phagocytosis	Phagocytosis of myeloid cells	1,64E-03	2,38E-01	Decreased	-4,280	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD47,CNN2,FCMR,FGR,GLRX,GNAI2,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,JAK1,NCKAP1L,PLEK,PTPRC,RAC1,RAC2,SPI1,SYK,TLN1,TNF,UBE2L3,UCP2,WASF2	31
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	migration	Migration of phagocytes	1,65E-03	2,38E-01	Decreased	-3,615	ANXA2,CD47,CD99,CNN2,CORO1A,CXCR3,CXCR4,FGR,FLNA,HCK,HLA-DQB1,HMOX1,ITGAX,ITGB2,JAK1,LSP1,NCKAP1L,PARP1,PKM,PREX1,PTPN6,RAC1,RAC2,RAP1B,RASGRP2,RHOA,S100A10,SPI1,TLN1,TNF	30
Cardiovascular System Development and Function,Organ Development	heart rate	Heart rate	1,69E-03	2,41E-01	 	0,426	ANXA4,CALM1 (includes others),CAPNS1,CD47,EHD3,GNAI2,GSN,HMOX1,HOPX,MEF2A,NDUFS6,PARP1,PPP1CA,RHOA,SUMO1,TNF	16
Cardiovascular System Development and Function,Organ Development,Organ Morphology	contraction	Contraction of heart	1,77E-03	2,48E-01	 	0,128	ANXA4,CALM1 (includes others),CAPNS1,EHD3,GNAI2,GSN,HMOX1,HOPX,NDUFS6,PPP1CA,RHOA,SUMO1	12
Cellular Movement,Immune Cell Trafficking	migration	Leukocyte migration	1,85E-03	2,54E-01	Decreased	-3,637	ACTB,ANXA2,CD19,CD47,CD53,CD99,CIB1,CNN2,COMMD8,CORO1A,CSK,CUX1,CXCR3,CXCR4,DBNL,DUSP1,FABP5,FGR,FLNA,FUT8,GLRX,GNAI2,GRN,GSN,HCK,HLA-DQB1,HMOX1,IGF2BP3,ILK,ITGAX,ITGB2,ITGB7,JAK1,LCP1,LITAF,LSP1,MALT1,MAP4K1,MS4A1,MYO1G,NCKAP1L,PARP1,PFN1,PIKFYVE,PKM,PNOC,PPIA,PRDX1,PREX1,PSMB8,PTPN1,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RAP1B,RASGRP1,RASGRP2,RHOA,S100A10,SERPINB1,SPI1,SUMO1,SYK,TCIRG1,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,TPT1,TRAPPC1,UCP2,VASP,WIPF1,YBX1,ZDHHC12	77
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cell movement	Cell movement of granulocytes	1,91E-03	2,54E-01	Decreased	-2,681	ANXA2,CD47,CD99,CNN2,CORO1A,CSK,CXCR3,DUSP1,FGR,GNAI2,GRN,GSN,HCK,HMOX1,ILK,ITGB2,LSP1,MALT1,NCKAP1L,PARP1,PIKFYVE,PKM,PNOC,PPIA,PREX1,PTPN6,RAC1,RAC2,RAP1B,RASGRP2,SERPINB1,SPI1,SYK,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,VASP,YBX1,ZDHHC12	40
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	migration	Migration of neutrophils	1,93E-03	2,54E-01	Decreased	-2,922	CD47,CD99,CNN2,CORO1A,FGR,HCK,ITGB2,LSP1,NCKAP1L,PKM,PREX1,PTPN6,RAC1,RAP1B,RASGRP2,TLN1,TNF	17
Cancer,Organismal Injury and Abnormalities,Respiratory Disease	lung carcinoma	Advanced lung carcinoma	1,93E-03	2,54E-01	 	 	ANXA2,EEF1A1,EIF4A1,FDFT1,FDPS,FGR,FKBP1A,FTL,IFI30,JAK1,MYL12A,PARP1,PPIA,TMSB10/TMSB4X,TNF,TPT1,YWHAE	17
Cancer,Organismal Injury and Abnormalities,Respiratory Disease	metastatic lung carcinoma	Metastatic lung carcinoma	1,93E-03	2,54E-01	 	 	ANXA2,EEF1A1,EIF4A1,FDFT1,FDPS,FGR,FKBP1A,FTL,IFI30,JAK1,MYL12A,PARP1,PPIA,TMSB10/TMSB4X,TNF,TPT1,YWHAE	17
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cell movement	Cell movement of leukocytes	2,10E-03	2,75E-01	Decreased	-3,907	ACTB,ANXA2,CD19,CD47,CD53,CD99,CNN2,COMMD8,CORO1A,CSK,CUX1,CXCR3,CXCR4,DBNL,DUSP1,FABP5,FGR,FLNA,GNAI2,GRN,GSN,HCK,HLA-DQB1,HMOX1,IGF2BP3,ILK,ITGAX,ITGB2,ITGB7,JAK1,LCP1,LITAF,LSP1,MALT1,MAP4K1,MYO1G,NCKAP1L,PARP1,PFN1,PIKFYVE,PKM,PNOC,PPIA,PRDX1,PREX1,PSMB8,PTPN1,PTPN6,PYCARD,RAC1,RAC2,RAP1B,RASGRP1,RASGRP2,RHOA,S100A10,SERPINB1,SPI1,SUMO1,SYK,TCIRG1,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,TRAPPC1,UCP2,VASP,WIPF1,YBX1,ZDHHC12	71
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking	binding	Binding of granulocytes	2,13E-03	2,75E-01	Decreased	-2,233	CD99,CORO1A,CSK,FGR,FLNA,GLRX,HCK,ITGAX,ITGB2,LCP1,LSP1,PREX1,PTPN22,PTPN6,RASGRP2,SLC44A2,TLN1,TNF	18
Infectious Diseases,Organismal Injury and Abnormalities	infection	Viral Infection	2,27E-03	2,89E-01	Decreased	-5,590	ACTB,ACTR2,ACTR3,ADK,ANXA2,AP1S2,ARF5,ARHGDIB,ARPC1B,ARPC3,ARPC5,ATP5F1A,ATP5F1B,ATP6V0D1,BLOC1S1,CALM1 (includes others),CARD16,CD19,CD79A,CFL1,CHI3L2,CHMP2A,CHMP4A,CIB1,CLTA,CXCR3,CXCR4,DDX17,DECR1,DUSP1,EEA1,EEF1A1,EIF4E2,ELOB,FDFT1,FDPS,FKBP1A,FLNA,FTL,GABARAPL2,GAPDH,GLUL,GOLPH3,GRB2,H1-2,H3-3A/H3-3B,HCK,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HMGA1,HMOX1,HSPA4,ITGB2,ITGB7,JAK1,LAMTOR5,LAPTM5,LSP1,LY6E,MS4A1,MT2A,MYL6,NCOA3,NDUFS6,NEDD8,NOP53,OAS1,OGT,PAK2,PARP1,PFN1,PIKFYVE,PKM,PLAC8,PLEK,PNRC1,POLR2G,POLR2L,POU2F2,PPIA,PPM1M,PRDX1,PSMA2,PSMA5,PSMB8,PSMD4,PTPN1,PTPN6,PTPRC,PYCARD,RAB1B,RABEP1,RAC1,RAP1B,RHOA,SAMHD1,SAMM50,SAT1,SF3B6,SFT2D1,SNRPD1,SPI1,SPTAN1,SRPK2,SUB1,SUMO1,SUMO2,SYK,TAGLN2,TALDO1,TCIRG1,TKT,TLE5,TNF,TNFRSF1B,TPM3,TPT1,TRAPPC1,TSPO,TXNIP,UBE2L3,UGCG,UNC93B1,VCP,VIM,WASF2,WIPF1,YBX1,YWHAE,ZEB2,ZYX	135
Inflammatory Disease,Neurological Disease,Organismal Injury and Abnormalities	inflammatory demyelinating disease	Inflammatory demyelinating disease	2,30E-03	2,90E-01	 	 	CD19,CD47,CD52,CD68,CXCR3,FDFT1,FDPS,HLA-DMB,HLA-DQA1,HLA-DQB1,HLA-DRA,LY6E,MS4A1,NCOA3,OAS1,PSMB8,PTPRC,TNF,TSPO	19
Cell-To-Cell Signaling and Interaction	response	Response of tumor cell lines	2,43E-03	2,97E-01	Decreased	-3,347	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,CD47,CSK,GAPDH,GNAI2,GRB2,HCK,HMOX1,ITGB2,JAK1,MS4A1,NCKAP1L,PFN1,PKM,PLEK,PSMD4,PTPN6,RAC1,RHOA,RHOG,SIGLEC10,SPI1,TLN1,TNF,UBE2L3,VCP,VIM,WASF2	33
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	aggregation	Aggregation of blood cells	2,44E-03	2,97E-01	Decreased	-2,013	ATP2A3,CD47,CLIC1,CXCR3,GNAI2,GSN,ITGB2,PLEK,PPIA,PTPN1,PTPN22,PTPN6,RAP1B,RASGRP1,RASGRP2,RHOG,SYK,TLN1,TNF,VASP	20
Infectious Diseases,Organismal Injury and Abnormalities	severe COVID-19	Severe COVID-19	2,44E-03	2,97E-01	 	 	ACTB,AP1S2,DUSP1,EEF1A1,FLNA,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQB1,HLA-DRA,JAK1,PFN1,PKM,PLAC8,PLEK,PPIA,TAGLN2,TNF,TPT1,TXNIP	20
Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities	benign neuroendocrine neoplasm	Benign neuroendocrine neoplasm	2,63E-03	2,99E-01	 	 	ANXA2,CXCR4,GNAI2,H1-2,HMGA1,HMOX1,OGT,PRDX1,RAC2,RALY	10
Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities	head and neck neuroendocrine tumor	Head and neck neuroendocrine tumor	2,63E-03	2,99E-01	 	 	ANXA2,CXCR4,GNAI2,H1-2,HMGA1,HMOX1,JAK1,OGT,RAC2,RALY	10
Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities	lysosomal storage disease	Lysosomal storage disease	2,63E-03	2,99E-01	 	 	ATP5F1A,CD47,CD68,GRN,IDS,ITGAX,MS4A1,PSAP,TNF,UGCG	10
Cellular Assembly and Organization,Cellular Compromise	disassembly	Disassembly of filaments	2,63E-03	2,99E-01	Decreased	-2,537	CAP1,CFL1,CIB1,GSN,ILK,PLEK,PPP1CA,RAC1,VIM,WDR1	10
Cell Morphology,Hematological System Development and Function,Inflammatory Response	shape change	Shape change of blood platelets	2,63E-03	2,99E-01	 	-1,556	FGR,FLNA,HCK,PTPN22,RAC1,RASGRP2,RHOA,SYK,TLN1,TWF2	10
Cellular Assembly and Organization	development	Development of cytoplasm	2,64E-03	2,99E-01	Decreased	-3,075	ACTB,ACTG1,ARPC2,BLOC1S1,BRK1,CFL1,CORO1A,DBNL,DYNLL1,FLNA,GLUL,GNAI2,GNG5,GPI,GRB2,GSN,HCK,MS4A1,MTSS1,NCKAP1L,NCOA3,NDUFS6,PAK2,PARK7,PFDN5,PFN1,PIKFYVE,PREX1,PYCARD,RAC1,RHOA,S100A10,TCIRG1,TNF,TPM3,TWF2,VASP,VCP,WASF2,WIPF1,ZYX	41
Cellular Movement	chemotaxis	Chemotaxis of myeloid cells	2,66E-03	2,99E-01	Decreased	-2,273	CD47,CORO1A,CXCR3,CXCR4,DUSP1,FGR,GNAI2,GRN,GSN,HCK,ITGB2,LITAF,LSP1,NCKAP1L,PFN1,PIKFYVE,PNOC,PPIA,PREX1,PTPN6,PTPRC,RAC1,RAC2,RHOA,SERPINB1,SPI1,SYK,TMSB10/TMSB4X,TNF	29
Cellular Function and Maintenance,Molecular Transport	flux	Flux of inorganic cation	2,72E-03	2,99E-01	 	-1,853	ANXA2,CD19,CD79A,CXCR3,CXCR4,EFHD2,FGR,HCK,IRAG2,ITGB2,LAT2,MS4A1,NEAT1,NME2,PAK2,PARP1,PPIA,PTPRC,RAC1,RAC2,SYK,TNF,UCP2,UNC93B1	24
Cancer,Organismal Injury and Abnormalities	carcinoma	Advanced stage carcinoma	2,73E-03	2,99E-01	 	 	ANXA2,CARD16,CD47,CXCR3,EEF1A1,EIF4A1,FDFT1,FDPS,FGR,FKBP1A,FTL,IFI30,JAK1,LIMD2,MYL12A,PARP1,PPIA,PSMB2,PTPRC,S100A11,TMSB10/TMSB4X,TNF,TPT1,TXNIP,YWHAE	25
Digestive System Development and Function,Hepatic System Development and Function,Organ Morphology,Organismal Development	mass	Mass of liver	2,77E-03	2,99E-01	 	 	DECR1,DUSP1,EIF6,FABP5,FDFT1,GRN,IDS,PARP1,PRDX5,PSAP,SPI1,TKT,TNF,TNFRSF1B	14
Cell Morphology,Cellular Assembly and Organization,Cellular Function and Maintenance	reorganization	Reorganization of actin cytoskeleton	2,77E-03	2,99E-01	Decreased	-2,606	ARHGDIB,CD47,CD99,CFL1,CXCR3,FLNA,GRB2,HCK,ILK,LCP1,PLEK,PTPN1,RAC1,RHOA	14
Cardiovascular System Development and Function,Cellular Movement	migration	Migration of vascular endothelial cells	2,77E-03	2,99E-01	 	-0,997	ANXA2,CD82,CNN2,CYTOR,GLUL,HHEX,PKM,PTPN1,PTPN6,RAC1,RHOA,TAGLN2,TMSB10/TMSB4X,TNF	14
Connective Tissue Disorders,Inflammatory Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	rheumatic disease	Rheumatic Disease	2,83E-03	3,03E-01	 	-1,585	ACTB,ACTR3,ARHGAP30,ARHGDIB,ARPC3,ARPC5,ATP2B1,CD19,CD68,CD79A,CFL1,CIB1,CKS2,CSK,CXCR3,CXCR4,DHRS9,DUSP1,DYNLL1,FDFT1,FDPS,FGR,FIBP,FKBP1A,FTL,GLUL,GNAI2,GOLPH3,GPI,GRN,GSN,H3-3A/H3-3B,HCK,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,ILK,ITGB2,ITGB7,JAK1,LBH,LCP1,LY6E,MAP4K1,MAZ,MRPS36,MS4A1,MYL12A,PARP1,PKM,POLR2L,PPIA,PPP1R7,PRDX1,PRDX5,PSMB8,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAB1B,RAC1,RAC2,RHOA,RTF2,S100A10,SF3B6,SLC44A2,SPI1,SUMO1,SYK,TALDO1,TCF4,TCIRG1,TNF,TNFRSF1B,TPI1,TSPO,VIM,WIPF1	85
Immunological Disease,Organismal Injury and Abnormalities	hypersensitive reaction	Hypersensitive reaction	2,91E-03	3,09E-01	Decreased	-2,005	ACTB,CAPZB,CD47,CFL1,CHD4,CORO1A,CXCR4,DUSP1,EEF1A1,FABP5,FGR,FKBP1A,FLNA,GAPDH,GSN,H3-3A/H3-3B,HCK,HLA-DQA1,HLA-DQB1,HLA-DRA,IFI30,IKZF3,ITGB2,ITGB7,JAK1,JPT1,LAPTM5,MALT1,PPIA,PRDX1,PREX1,PSAP,PTPRC,PYCARD,S100A11,SPI1,SRM,SYK,TCIRG1,TKT,TNF,TPI1,TPM3,TSC22D3,VCP,ZYX	46
Cardiovascular System Development and Function,Cellular Movement	movement	Movement of vascular endothelial cells	3,19E-03	3,13E-01	 	-0,747	ANXA2,CD82,CNN2,CYTOR,GLUL,HHEX,MTSS1,PKM,PTPN1,PTPN6,RAC1,RHOA,TAGLN2,TMSB10/TMSB4X,TNF	15
Cellular Development	epithelial-mesenchymal transition	Epithelial-mesenchymal transition of tumor cell lines	3,19E-03	3,13E-01	Decreased	-2,354	CKS2,IGF2BP3,ILK,MEF2A,MRPL52,PDLIM1,PTPN18,PTPN6,RAC1,RHOA,SYK,TLN1,TNF,VIM,ZEB2	15
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology	quantity	Quantity of regulatory T lymphocytes	3,19E-03	3,13E-01	 	-1,221	CD19,CXCR3,CXCR4,FABP5,FKBP1A,ITGB2,MALT1,PARP1,PIKFYVE,PTPN22,RHOA,TLN1,TNF,TNFRSF1B,TXNIP	15
Cancer,Organismal Injury and Abnormalities,Respiratory Disease	metastatic non-small cell lung cancer	Metastatic non-small cell lung carcinoma	3,54E-03	3,13E-01	 	 	ANXA2,EEF1A1,EIF4A1,FDFT1,FDPS,FGR,FKBP1A,FTL,IFI30,JAK1,MYL12A,PARP1,PPIA,TMSB10/TMSB4X,TNF,TPT1	16
Cellular Movement	homing	Homing of tumor cell lines	3,54E-03	3,13E-01	 	-0,824	ANXA2,CD82,CSK,CXCR3,CXCR4,GRB2,HCK,ILK,ITGB7,MS4A1,MTSS1,PPIA,PTPN1,RHOA,SYK,TNF	16
Gastrointestinal Disease,Organismal Injury and Abnormalities	chronic bowel disorder	Chronic bowel disorder	3,54E-03	3,13E-01	 	 	ARHGDIB,CD19,CD53,CD79A,DHRS9,GNAI2,HLA-DMB,HLA-DQA1,HLA-DQB1,IKZF3,ITGB7,LAPTM5,MS4A1,PSMB8,PTPRC,TNF	16
Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Inflammatory Response	phagocytosis	Phagocytosis of phagocytes	3,54E-03	3,13E-01	Decreased	-2,901	CD47,CNN2,FGR,GLRX,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,NCKAP1L,PTPRC,SPI1,SYK,TNF,UCP2	16
Cell Death and Survival,Cellular Function and Maintenance	clearance	Clearance of cells	3,62E-03	3,13E-01	 	-0,808	ANXA2,CD47,FABP5,FLNA,PAK2,SYK,TNF,UCP2	8
Hematological System Development and Function	bleeding time	Bleeding time	3,62E-03	3,13E-01	 	1,134	ATP2A3,CLIC1,FLNA,GSN,PTPN22,RASGRP2,TLN1,TXNIP	8
Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Tissue Development	accumulation	Accumulation of macrophages	3,62E-03	3,13E-01	 	-1,178	GRN,HCK,HMOX1,ITGAX,PFN1,PIKFYVE,TNF,TNFRSF1B	8
Cell Death and Survival	cell death	Cell death of stem cells	3,62E-03	3,13E-01	 	-0,211	H3-3A/H3-3B,HMGA1,MTCH2,NOP53,PCLAF,PFN1,TNF,TPM3	8
Nervous System Development and Function	myelination	Myelination of nervous system	3,62E-03	3,13E-01	 	-1,083	CHD4,CXCR4,ILK,MEF2C,OGT,RAC1,TNF,TNFRSF1B	8
Cellular Assembly and Organization	disassembly	Disassembly of organelle	3,63E-03	3,13E-01	Decreased	-2,537	CAP1,CFL1,CIB1,DENR,GSN,ILK,PLEK,PPP1CA,RAC1,VIM,WDR1	11
Cellular Movement,Embryonic Development	cell movement	Cell movement of embryonic cells	3,63E-03	3,13E-01	 	-0,894	ARPC3,CAPNS1,CFL1,CXCR4,GRB2,PFN1,RAC1,RHOA,TLN1,TNF,ZEB2	11
Behavior	emotional behavior	Emotional behavior	3,63E-03	3,13E-01	 	0,461	ATP2A3,CD47,DBI,GNAI2,GRN,HMOX1,MEF2C,PREX1,TCF4,TNF,VDAC1	11
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	migration	Migration of macrophages	3,63E-03	3,13E-01	Decreased	-2,434	CNN2,CXCR4,FLNA,HCK,HMOX1,NCKAP1L,PARP1,RAC1,RAC2,S100A10,TNF	11
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cell rolling	Cell rolling of leukocytes	3,63E-03	3,13E-01	 	-1,263	CD53,FGR,GNAI2,HCK,ITGB2,ITGB7,PRDX1,PREX1,RAC2,TLN1,TNF	11
Cellular Assembly and Organization	formation	Formation of cytoskeleton	3,64E-03	3,13E-01	Decreased	-2,908	ACTB,ACTG1,ARPC2,BRK1,CFL1,CORO1A,DBNL,DYNLL1,FLNA,GNAI2,GNG5,GPI,GRB2,GSN,HCK,MS4A1,MTSS1,NCKAP1L,PAK2,PFDN5,PFN1,PREX1,PYCARD,RAC1,RHOA,S100A10,TNF,TPM3,TWF2,VASP,WASF2,WIPF1,ZYX	33
Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	dextran sodium sulfate-induced colitis	Dextran sodium sulfate-induced colitis	3,83E-03	3,13E-01	 	-0,689	ARHGDIB,CD19,CD47,CD53,CD79A,DHRS9,HLA-DMB,HLA-DQA1,HLA-DQB1,IKZF3,LAPTM5,MS4A1,PARP1,PSMB8,PTPRC,PYCARD,UNC93B1	17
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking	adhesion	Adhesion of granulocytes	3,83E-03	3,13E-01	Decreased	-2,617	CD99,CORO1A,CSK,FGR,FLNA,GLRX,HCK,ITGAX,ITGB2,LCP1,PREX1,PTPN22,PTPN6,RASGRP2,SLC44A2,TLN1,TNF	17
Cell Morphology,Cellular Movement	cell spreading	Cell spreading	3,89E-03	3,13E-01	Decreased	-2,154	ARPC3,CAP1,CD19,CD47,CIB1,CNN2,CORO1A,CSK,FGR,FLNA,HCK,ILK,ITGB2,MAP4K1,OGT,PARVG,PFN1,PREX1,PTPN22,RAC1,RAP1B,RASGRP2,RHOA,RHOG,SYK,TLN1,TNF,TWF2,VASP,VIM,ZYX	31
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	activation	Activation of blood cells	3,93E-03	3,13E-01	 	-0,617	ANXA2,CD19,CD47,CD79A,CLEC2D,CLIC1,CORO1A,CSK,CTSH,CXCR3,DUSP1,FKBP1A,FUT8,GNAI2,GRN,GSN,HCK,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,HSH2D,HSPA4,HVCN1,IGF2BP3,ITGB2,LAPTM5,LAT2,MALT1,MEF2C,MS4A1,PAK2,PARK7,PARP1,PLEK,PPIA,PRDX1,PREX1,PSAP,PSMB8,PTPN22,PTPN6,PTPRC,PYCARD,RASGRP1,RHOA,SIGLEC10,SYK,TCIRG1,TLN1,TNF,TNFRSF1B,TPT1,TRAPPC1,TXNIP,UNC93B1,VASP,VSIR	61
Cellular Function and Maintenance,Molecular Transport	transcytosis	Transcytosis	3,97E-03	3,13E-01	 	-0,447	CD79A,CXCR4,FLNA,RAC1,RHOA,TNF	6
Cell Death and Survival	quantity	Quantity of apoptotic cells	3,97E-03	3,13E-01	 	0,246	CAPNS1,GRN,ILK,TNF,TNFRSF1B,TPT1	6
Cellular Function and Maintenance,Molecular Transport,Small Molecule Biochemistry	homeostasis	Homeostasis of transition metal ion	3,97E-03	3,13E-01	 	 	ATP6V0D1,CYB561A3,FTL,HMOX1,MT2A,NCOA4	6
Cell-To-Cell Signaling and Interaction,Connective Tissue Development and Function,Embryonic Development,Organismal Development,Skeletal and Muscular System Development and Function,Tissue Development	activation	Activation of osteoclasts	3,97E-03	3,13E-01	 	-0,028	CXCR4,JAK1,PPP1R18,PTPN6,SELENOW,TNF	6
Cellular Assembly and Organization,Cellular Compromise	disassembly	Disassembly of actin filaments	3,97E-03	3,13E-01	Decreased	-2,393	CAP1,CFL1,GSN,PLEK,RAC1,WDR1	6
Cellular Movement	movement	Arrest in movement of cells	3,97E-03	3,13E-01	 	 	FLNA,GNAI2,ITGB2,ITGB7,TLN1,TNF	6
Cardiovascular System Development and Function,Embryonic Development,Organ Development,Organismal Development,Tissue Development	formation	Formation of heart ventricle	3,97E-03	3,13E-01	 	 	CXCR4,FKBP1A,HHEX,MEF2C,RHOA,TNFRSF1B	6
Nervous System Development and Function,Tissue Morphology	quantity	Quantity of central nervous system cells	3,97E-03	3,13E-01	 	-0,686	CXCR4,OGT,PSAP,RAC1,SPTAN1,UCP2	6
Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities	papillary thyroid carcinoma	Invasive papillary thyroid carcinoma	3,97E-03	3,13E-01	 	 	FGR,JAK1,LIMD2,PTPRC,S100A11,VIM	6
Neurological Disease,Organismal Injury and Abnormalities	neurological disorder	Severe neurological disorder	3,97E-03	3,13E-01	 	 	CD52,GRN,SPTAN1,TCF4,TSPO,UGCG	6
Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	inflammation	Inflammation of limb	3,97E-03	3,13E-01	 	 	CSK,ITGB2,LITAF,PPIA,PTPN6,TNF	6
Connective Tissue Disorders,Inflammatory Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	osteitis	Osteitis	3,97E-03	3,13E-01	 	 	FGR,JAK1,MS4A1,SYK,TNF,TNFRSF1B	6
Cancer,Organismal Injury and Abnormalities	papillary adenocarcinoma	Metastatic papillary adenocarcinoma	3,97E-03	3,13E-01	 	 	FGR,FKBP1A,JAK1,LIMD2,PTPRC,S100A11	6
Developmental Disorder,Hereditary Disorder,Lipid Metabolism,Metabolic Disease,Organismal Injury and Abnormalities,Small Molecule Biochemistry	Niemann-Pick disease	Niemann-Pick disease	3,97E-03	3,13E-01	 	 	CD47,CD68,GRN,ITGAX,PSAP,UGCG	6
Developmental Disorder,Immunological Disease,Inflammatory Disease,Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	multiple sclerosis	Multiple Sclerosis	4,06E-03	3,14E-01	 	 	CD47,CD52,CD68,CXCR3,FDFT1,FDPS,HLA-DMB,HLA-DQA1,HLA-DQB1,HLA-DRA,LY6E,MS4A1,NCOA3,OAS1,PSMB8,PTPRC,TNF,TSPO	18
Cellular Function and Maintenance	engulfment	Engulfment of antigen presenting cells	4,06E-03	3,14E-01	Decreased	-2,269	CD47,CNN2,FGR,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,NCKAP1L,PTPN6,PTPRC,RAC1,RHOA,RHOG,SPI1,TNF,UCP2	18
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Inflammatory Response	aggregation	Aggregation of blood platelets	4,06E-03	3,14E-01	 	-1,792	ATP2A3,CD47,CLIC1,GNAI2,GSN,PLEK,PPIA,PTPN1,PTPN22,PTPN6,RAP1B,RASGRP1,RASGRP2,RHOG,SYK,TLN1,TNF,VASP	18
Neurological Disease,Organismal Injury and Abnormalities	neurological disorder	Progressive neurological disorder	4,21E-03	3,23E-01	 	0,739	ACTB,ACTG1,ANXA2,AP1S2,ARHGDIB,ARL6IP5,ATP5F1A,ATP5PB,CALM1 (includes others),CAPZB,CD47,CD52,CD68,CFL1,CHI3L2,CIB1,CXCR3,CXCR4,DBI,DBNL,DECR1,EEF1A1,EIF4A1,FDFT1,FDPS,FGR,FTL,GAPDH,GLRX,GOLPH3,GRN,GSN,H3-3A/H3-3B,HLA-DMB,HLA-DQA1,HLA-DQB1,HLA-DRA,HMGA1,HMOX1,JPT1,LY6E,MEF2C,MS4A1,NCOA3,NDUFV2,NEAT1,OAS1,OAZ1,OGT,PARK7,PARP15,PFN1,PPIA,PRDX1,PREX1,PSAP,PSMB8,PTPRC,RHOA,S100A10,SCP2,SRPK2,TNF,TPT1,TSPO,VCP,VDAC1,VIM	68
Cell Morphology	shape change	Shape change of blood cells	4,23E-03	3,23E-01	Decreased	-2,139	CD19,CD47,CNN2,CORO1A,FGR,FLNA,HCK,ITGB2,MAP4K1,PTPN22,RAC1,RAP1B,RASGRP2,RHOA,SYK,TLN1,TNF,TWF2,WIPF1	19
Cardiovascular System Development and Function,Cellular Movement	migration	Migration of endothelial cells	4,47E-03	3,28E-01	Decreased	-2,356	ANXA2,ATP5F1A,ATP5F1B,CD82,CNN2,CYTOR,FLNA,GLUL,GPI,GRN,HHEX,MEF2C,PKM,PTPN1,PTPN6,RAC1,RAP1B,RHOA,SEPTIN7,TAGLN2,TMSB10/TMSB4X,TNF,VASP,VIM	24
Cell Morphology,Cellular Assembly and Organization,Cellular Function and Maintenance	formation	Formation of lamellipodia	4,47E-03	3,28E-01	Decreased	-3,160	ACTR2,ACTR3,ARPC1B,ARPC2,ARPC4,BRK1,CAP1,CAPZB,CD82,CFL1,CXCR3,GOLPH3,LCP1,PFN1,PREX1,PTPN22,RAC1,RAC2,RHOA,RHOG,SYK,TWF2,VIM,WASF2	24
Neurological Disease,Organismal Injury and Abnormalities	motor dysfunction or movement disorder	Motor dysfunction or movement disorder	4,48E-03	3,28E-01	Increased	2,079	ACTB,ADD3,ANXA2,AP1S2,ARF5,ARHGDIB,ARL6IP5,ATP2A3,ATP2B1,ATP5F1A,ATP5F1B,ATP5F1C,ATP5F1E,ATP5MF,ATP5MK,ATP5PB,ATP5PF,CAPNS1,CAPZB,CD68,CLTA,COX5A,COX5B,CXCR3,DBNL,DECR1,EEF1A1,FDFT1,FDPS,FKBP1A,FTL,GAPDH,GPI,GRN,H3-3A/H3-3B,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,HSBP1,IDS,ITGAX,LY6E,MALT1,MEF2C,MT2A,MYL12A,NDUFA7,NDUFAB1,NDUFB2,NDUFS6,NDUFV2,NEAT1,NME1,OGT,PARK7,PARP1,PDLIM1,PFN1,PKM,PLEK,PPIA,PSAP,PSMB8,PSMF1,RASGRP2,RHOG,S100A10,SAT1,SCP2,SEPTIN6,SPTAN1,SRM,SUB1,TCF4,TESC,TNF,TPI1,TPM3,TPT1,TSC22D3,TSPO,UCP2,UGCG,UQCR11,UQCRH,VCP,VIM	88
Cell Signaling,Cellular Function and Maintenance,Molecular Transport,Vitamin and Mineral Metabolism	flux	Flux of Ca2+	4,49E-03	3,28E-01	 	-1,704	ANXA2,CD19,CD79A,CXCR3,CXCR4,EFHD2,FGR,HCK,IRAG2,ITGB2,LAT2,MS4A1,NEAT1,NME2,PAK2,PARP1,PPIA,PTPRC,RAC1,RAC2,SYK,TNF,UNC93B1	23
Cellular Movement	homing	Homing of blood cells	4,50E-03	3,28E-01	Decreased	-2,883	CD47,CORO1A,CUX1,CXCR3,CXCR4,DUSP1,FGR,GNAI2,GRN,GSN,HCK,ITGB2,ITGB7,JAK1,LCP1,LITAF,LSP1,NCKAP1L,PFN1,PIKFYVE,PNOC,PPIA,PREX1,PTPN6,PTPRC,RAC1,RAC2,RAP1B,RHOA,SERPINB1,SPI1,SUMO1,SYK,TCIRG1,TMSB10/TMSB4X,TNF,WIPF1	37
Cell Cycle	ploidy	Ploidy of cells	4,53E-03	3,28E-01	 	1,311	CIB1,CKS2,JAK1,MAD1L1,NME1,PARP1,PTPN6,RHOA,TCIRG1,TNF,UGCG,YWHAH	12
Nervous System Development and Function	myelination	Myelination	4,53E-03	3,28E-01	 	-1,134	CHD4,CXCR4,ILK,ITGAX,MEF2C,OGT,PIKFYVE,PSAP,RAC1,TNF,TNFRSF1B,UGCG	12
Neurological Disease,Organismal Injury and Abnormalities	injury	Injury of central nervous system	4,53E-03	3,28E-01	 	-0,781	ADD3,CD47,FDPS,GSN,HMOX1,PARK7,PARP1,PYCARD,TNF,TNFRSF1B,TSPO,UCP2	12
Cellular Assembly and Organization,Organismal Development,Tissue Development	fibrogenesis	Fibrogenesis	4,70E-03	3,36E-01	Decreased	-3,468	ACTB,ACTG1,ARPC2,BRK1,CFL1,CHD4,CORO1A,DYNLL1,GNAI2,GNG5,GPI,GRB2,GSN,HCK,MEF2C,MTSS1,NCKAP1L,PAK2,PFDN5,PFN1,PREX1,PYCARD,RAC1,RHOA,S100A10,SPI1,SSNA1,TNF,TNFRSF1B,TPM3,TWF2,VASP,VIM,WASF2,WDR1,ZYX	36
Immunological Disease,Organismal Injury and Abnormalities	immediate hypersensitivity	Immediate hypersensitivity	4,70E-03	3,36E-01	 	-1,706	ACTB,CAPZB,CFL1,CHD4,CORO1A,CXCR4,DUSP1,EEF1A1,FABP5,FGR,FKBP1A,FLNA,GAPDH,GSN,H3-3A/H3-3B,HCK,HLA-DQA1,HLA-DRA,IFI30,ITGB7,JAK1,JPT1,MALT1,PPIA,PRDX1,PREX1,PSAP,S100A11,SPI1,SYK,TKT,TNF,TPI1,TPM3,VCP,ZYX	36
Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities	atopic disease	Atopic disease	5,12E-03	3,64E-01	 	 	ACTB,CAPZB,CFL1,CHD4,CXCR4,DUSP1,EEF1A1,FABP5,FGR,FKBP1A,FLNA,GAPDH,GSN,H3-3A/H3-3B,HCK,HLA-DQA1,HLA-DRA,IFI30,ITGB7,JAK1,JPT1,PPIA,PRDX1,PREX1,PSAP,S100A11,SPI1,SYK,TKT,TNF,TPI1,TPM3,VCP,ZYX	34
Infectious Diseases,Organismal Injury and Abnormalities	infection	Infection by RNA virus	5,45E-03	3,85E-01	Decreased	-5,197	ACTB,ACTR2,ACTR3,ADK,ANXA2,AP1S2,ARPC1B,ARPC3,ARPC5,ATP5F1A,ATP5F1B,ATP6V0D1,BLOC1S1,CARD16,CD19,CFL1,CLTA,CXCR3,CXCR4,DECR1,DUSP1,EEA1,EEF1A1,FDFT1,FDPS,FKBP1A,FLNA,GABARAPL2,GAPDH,GOLPH3,GRB2,H3-3A/H3-3B,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQB1,HLA-DRA,HSPA4,ITGB2,ITGB7,JAK1,LAPTM5,MS4A1,MT2A,NDUFS6,PARP1,PFN1,PKM,PLAC8,PLEK,PNRC1,POLR2L,PPIA,PSMA2,PSMA5,PSMB8,PSMD4,PTPRC,PYCARD,RAB1B,RAP1B,RHOA,SAMHD1,SAMM50,SAT1,SFT2D1,SPTAN1,SUB1,SUMO2,SYK,TAGLN2,TLE5,TNF,TNFRSF1B,TPT1,TRAPPC1,TSPO,TXNIP,UBE2L3,UGCG,VCP,WASF2,YBX1,YWHAE,ZYX	85
Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities,Reproductive System Disease	pituitary gland adenoma	Pituitary gland adenoma	5,62E-03	3,85E-01	 	 	ANXA2,CXCR4,GNAI2,H1-2,HMGA1,HMOX1,OGT,RAC2,RALY	9
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology	quantity	Quantity of TREG cells	5,62E-03	3,85E-01	 	-1,426	CD19,FABP5,FKBP1A,ITGB2,MALT1,PARP1,PIKFYVE,PTPN22,TLN1	9
Cell-To-Cell Signaling and Interaction	binding	Binding of lymphoma cell lines	5,62E-03	3,85E-01	Decreased	-2,352	ANXA2,CXCR3,HCK,ITGAX,ITGB2,PARVG,PTPN6,RHOA,TNF	9
Organismal Injury and Abnormalities,Renal and Urological Disease	injury	Injury of kidney	5,62E-03	3,85E-01	 	0,113	CXCR4,FKBP1A,GRN,PARP1,PKM,RAC1,TLN1,TNF,TXNIP	9
Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Tissue Development	accumulation	Accumulation of antigen presenting cells	5,62E-03	3,85E-01	 	-1,420	CD99,GRN,HCK,HMOX1,ITGAX,PFN1,PIKFYVE,TNF,TNFRSF1B	9
Cell-To-Cell Signaling and Interaction,Inflammatory Response	immune response	Immune response of leukocytes	5,76E-03	3,90E-01	Decreased	-3,628	CD19,CD47,CD68,CD79A,CNN2,FCMR,FGR,GLRX,GRN,GSN,HCK,HLA-DQB1,HMOX1,HSH2D,ITGAX,ITGB2,MALT1,MAP4K1,MYO1G,NCKAP1L,PARP1,PSMB8,PTPRC,PYCARD,SPI1,SYK,TCIRG1,TNF,TNFRSF1B,UCP2,VASP	31
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	cell movement	Cell movement of phagocytes	5,77E-03	3,90E-01	Decreased	-3,763	ANXA2,CD47,CD99,CNN2,CORO1A,CXCR3,CXCR4,DUSP1,FGR,FLNA,GNAI2,GRN,GSN,HCK,HLA-DQB1,HMOX1,ILK,ITGAX,ITGB2,JAK1,LITAF,LSP1,MALT1,NCKAP1L,PARP1,PFN1,PIKFYVE,PKM,PNOC,PPIA,PREX1,PSMB8,PTPN1,PTPN6,RAC1,RAC2,RAP1B,RASGRP2,RHOA,S100A10,SERPINB1,SPI1,SYK,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,VASP,YBX1,ZDHHC12	50
Neurological Disease,Organismal Injury and Abnormalities	movement disorder	Movement Disorders	5,88E-03	3,95E-01	 	1,894	ACTB,ADD3,ANXA2,AP1S2,ARF5,ARHGDIB,ARL6IP5,ATP2A3,ATP2B1,ATP5F1A,ATP5F1B,ATP5F1C,ATP5F1E,ATP5MF,ATP5MK,ATP5PB,ATP5PF,CAPNS1,CAPZB,CD68,COX5A,COX5B,CXCR3,DBNL,DECR1,EEF1A1,FDFT1,FDPS,FKBP1A,FTL,GAPDH,GPI,GRN,H3-3A/H3-3B,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,HSBP1,IDS,ITGAX,LY6E,MALT1,MEF2C,MT2A,MYL12A,NDUFA7,NDUFAB1,NDUFB2,NDUFS6,NDUFV2,NEAT1,NME1,OGT,PARK7,PARP1,PDLIM1,PFN1,PKM,PLEK,PPIA,PSAP,PSMB8,PSMF1,RASGRP2,RHOG,S100A10,SAT1,SCP2,SEPTIN6,SPTAN1,SRM,SUB1,TCF4,TESC,TNF,TPI1,TPM3,TPT1,TSC22D3,TSPO,UCP2,UGCG,UQCR11,UQCRH,VCP,VIM	87
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	adhesion	Adhesion of neutrophils	5,91E-03	3,95E-01	Decreased	-2,516	CD99,CORO1A,FLNA,GLRX,ITGAX,ITGB2,LCP1,PREX1,PTPN22,PTPN6,RASGRP2,SLC44A2,TLN1,TNF	14
Infectious Diseases,Organismal Injury and Abnormalities	sepsis	Sepsis	6,18E-03	4,10E-01	 	-0,466	ACTB,ACTR2,CAP1,CFL1,CSK,GRB2,HCK,HLA-DQB1,ITGB2,MT2A,MYL12A,PARP1,PLEK,POMP,PTPN1,PYCARD,RAP1B,RHOA,SAT1,SERPINB1,SPI1,TERF2IP,TNF,TNFRSF1B,TPM3,TSPO,VASP,YBX1,YWHAH	29
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	chemotaxis	Chemotaxis of phagocytes	6,38E-03	4,20E-01	Decreased	-2,358	CD47,CORO1A,CXCR3,CXCR4,DUSP1,FGR,GNAI2,GRN,GSN,HCK,ITGB2,LITAF,LSP1,NCKAP1L,PFN1,PIKFYVE,PNOC,PPIA,PREX1,PTPN6,RAC1,RAC2,RHOA,SERPINB1,SPI1,SYK,TMSB10/TMSB4X,TNF	28
Cellular Movement	migration	Migration of prostate cancer cell lines	6,40E-03	4,20E-01	 	-0,401	ANXA2,CD82,CD99,CTSH,CXCR4,GRN,HHEX,HMOX1,NCOA3,PAK2,RAC1,S100A11,SMARCC1,TNF,VIM	15
Endocrine System Disorders,Gastrointestinal Disease,Metabolic Disease,Organismal Injury and Abnormalities	diabetic complication	Diabetic complication	6,74E-03	4,40E-01	 	 	CD19,CD52,CD53,CD79A,CHI3L2,CORO1A,CRIP1,CTSH,CXCR3,CXCR4,DBI,DHRS9,DUSP1,FCMR,FCRL5,FGD2,FKBP1A,GLUL,HOPX,IKZF3,LCP1,LIMD2,LSP1,MEF2C,MS4A1,MT2A,MYO1G,NCKAP1L,NCOA4,OAS1,PLAC8,PNOC,PYCARD,RAC2,SIGLEC6,SREK1,TCF4,TMSB10/TMSB4X,TNF,TSC22D3,VIM,ZEB2	42
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cell movement	Cell movement of mononuclear leukocytes	6,85E-03	4,45E-01	Decreased	-2,412	ACTB,ANXA2,CD19,CD47,CD99,COMMD8,CORO1A,CUX1,CXCR3,CXCR4,DBNL,DUSP1,FABP5,GNAI2,HCK,HMOX1,IGF2BP3,ILK,ITGAX,ITGB2,ITGB7,JAK1,LCP1,MALT1,MAP4K1,MYO1G,NCKAP1L,PFN1,PIKFYVE,PPIA,PSMB8,PYCARD,RAC1,RAC2,RAP1B,RASGRP1,RHOA,SUMO1,TCIRG1,TLN1,TNF,TNFRSF1B,TRAPPC1,UCP2,VASP,WIPF1,ZDHHC12	47
Cellular Movement	cell movement	Cell movement of prostate cancer cell lines	7,04E-03	4,54E-01	 	-0,732	ANXA2,CD82,CD99,CTSH,CXCR4,GRN,HHEX,HMOX1,LCP1,NCOA3,PAK2,RAC1,S100A11,SMARCC1,TLN1,TNF,VIM	17
Cell Death and Survival	apoptosis	Apoptosis	7,16E-03	4,54E-01	Increased	3,294	ANXA2,ANXA4,ARHGDIB,ARL6IP5,BLOC1S2,BTG1,CAPNS1,CD19,CD47,CD53,CD82,CD99,CDK2AP1,CFL1,CIB1,CKS2,CNN2,CORO1A,COX5A,CRIP1,CSK,CTSH,CUX1,CXCR3,CXCR4,CYBA,CYTOR,DDAH2,DDX17,DECR1,DENR,DUSP1,DYNLL1,EEA1,EEF1A1,EEF1B2,EHD3,EIF4A1,EIF6,EMP3,FCMR,FGR,FKBP1A,FLNA,GAPDH,GLRX,GNAI2,GNG5,GOLPH3,GPI,GRN,GSN,H1-2,HCK,HCST,HLA-DQB1,HMGA1,HMOX1,HSH2D,HSPA4,IGF2BP3,IKZF3,ILK,ITGB2,JAK1,LAMTOR5,LAPTM5,LSP1,MAD1L1,MALT1,MAP4K1,MEF2A,MEF2C,MIEN1,MRPL52,MS4A1,MT2A,MTCH2,MTMR14,MTSS1,NAA38,NCKAP1L,NCOA3,NCOA4,NDUFV2,NME1,NME2,NOP53,OAS1,OGT,PAK2,PARK7,PARP1,PCLAF,PEA15,PFN1,PKM,PLAC8,PPIA,PPP1CA,PRDX1,PRDX5,PSAP,PSMA5,PSMB8,PSMD4,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RHOA,RHOG,RNF141,S100A11,SAMHD1,SAT1,SERPINB1,SF3B6,SH3BGRL3,SLC25A5,SMARCC1,SMARCE1,SNRPD1,SPI1,SRA1,SRPK2,SUB1,SUMO1,SUMO2,SYK,TAF10,TAGLN2,TCF4,TCIRG1,TERF2IP,TESC,TKT,TLE1,TLE5,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,TPT1,TRAPPC1,TSC22D3,TSPO,TXNIP,UCP2,UGCG,VASP,VCP,VDAC1,VIM,YBX1,YWHAE,ZBTB32,ZEB2,ZFAND6	162
Cell Morphology,Cellular Function and Maintenance	transmembrane potential	Transmembrane potential of mitochondria	7,20E-03	4,54E-01	 	-0,312	CD47,CLIC1,DYNLL1,GSN,HSPA4,MRPL52,MTCH2,NDUFAB1,OGT,PARK7,PARP1,PKM,PTPN6,PYCARD,RAC1,RAC2,TNF,TSPO,UCP2,VCP,VDAC1,VIM,YWHAE	23
Cellular Movement	migration	Migration of vascular cells	7,22E-03	4,54E-01	 	-1,547	ANXA2,CD47,CD82,CNN2,CYTOR,GLUL,HHEX,HMOX1,PKM,PPIA,PTPN1,PTPN6,RAC1,RHOA,TAGLN2,TMSB10/TMSB4X,TNF,WASF2	18
Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	neuromuscular disease	Neuromuscular disease	7,22E-03	4,54E-01	 	 	ACTB,ANXA2,AP1S2,ARHGDIB,ARL6IP5,ATP2B1,ATP5F1A,ATP5F1B,ATP5F1C,ATP5F1E,ATP5MF,ATP5MK,ATP5PB,ATP5PF,CAPNS1,CAPZB,CD19,CD47,CD52,CD68,COX5A,COX5B,COX8A,CXCR3,DBNL,EEF1A1,FDFT1,FDPS,FKBP1A,FTL,GAPDH,GOLPH3,GPI,H3-3A/H3-3B,HLA-DMB,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,HSBP1,IDS,LAT2,LY6E,MALT1,MRPS34,MS4A1,MT2A,MYL12A,NCOA3,NDUFA7,NDUFAB1,NDUFB2,NDUFS6,NDUFV2,NEAT1,NME1,OAS1,PARK7,PARP1,PDHB,PDLIM1,PFN1,PKM,PLEK,PPIA,PSAP,PSMA2,PSMB8,PTPRC,RASGRP2,RHOG,S100A10,SAT1,SEPTIN6,SPTAN1,SRM,SUB1,TESC,TNF,TPI1,TPM3,TPT1,TSC22D3,TSPO,UCP2,UGCG,UQCR11,UQCRH,VCP,VIM	90
Infectious Diseases,Organismal Injury and Abnormalities	infection	Infection by coronavirus	7,30E-03	4,54E-01	Decreased	-2,390	ACTB,ACTR2,ACTR3,AP1S2,BLOC1S1,CFL1,DECR1,DUSP1,EEA1,EEF1A1,FLNA,GAPDH,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQB1,HLA-DRA,JAK1,PFN1,PKM,PLAC8,PLEK,PPIA,PSMB8,SAT1,SYK,TAGLN2,TNF,TNFRSF1B,TPT1,TSPO,TXNIP,VCP,YWHAE	34
Embryonic Development,Hematological System Development and Function,Humoral Immune Response,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development	formation	Formation of germinal center	7,35E-03	4,54E-01	 	-1,633	CD19,GRB2,LCP1,MALT1,MEF2C,POU2F2,PTPN1,TCF4,TNF,WIPF1	10
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	migration	Migration of monocytes	7,35E-03	4,54E-01	Decreased	-2,216	ANXA2,CD47,CD99,ITGAX,ITGB2,JAK1,NCKAP1L,RAC2,RHOA,TNF	10
Cell Death and Survival	cell viability	Cell viability of lymphatic system cells	7,35E-03	4,54E-01	Decreased	-3,880	CD19,CD47,CD79A,CHD4,FCMR,HCK,HSH2D,LAT2,MALT1,MEF2C,PTPN6,PTPRC,PYCARD,RAC1,RAC2,SYK,TNF,TNFRSF1B,TSC22D3,WIPF1,ZEB2	21
Cellular Movement	homing	Homing of leukemia cell lines	8,21E-03	4,93E-01	 	-0,988	ANXA2,CD82,CSK,CXCR4,MS4A1,PPIA,TNF	7
Infectious Diseases,Organismal Injury and Abnormalities	infectivity	Infectivity of virus	8,21E-03	4,93E-01	 	0,640	ANXA2,CXCR4,HCK,PPIA,SAMHD1,SUMO1,TNF	7
Cardiovascular Disease,Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities	Wegener granulomatosis	Wegener granulomatosis	8,21E-03	4,93E-01	 	 	CD52,FDPS,JAK1,MS4A1,OSTF1,TNF,UGCG	7
Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	motor dysfunction	Motor dysfunction	8,21E-03	4,93E-01	 	0,555	ADD3,FDPS,GRN,OGT,PKM,PSMF1,SUB1	7
Cellular Movement	dissemination	Dissemination of cells	8,21E-03	4,93E-01	 	-1,508	ANXA2,BTG1,CD47,CXCR4,PREX1,PYCARD,RHOA	7
Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities	oral cancer	Oral cancer	8,53E-03	5,02E-01	 	 	ADD3,ATP5MF,ATP5PF,CDK2AP1,CHD4,CTSH,CYTOR,DUSP1,FABP5,FDFT1,FGD2,FUT8,GPI,GRN,H3-3A/H3-3B,HLA-DQA1,HVCN1,ITGAX,LCP1,LSP1,LY6E,MALT1,MEF2A,MEF2C,MTSS1,NCKAP1L,NCOA3,NEAT1,OAZ1,PARP1,PKM,POLR2L,PPP1CA,PREX1,PSMB8,PTPRC,RAP1B,SAT1,SERF2,SLC44A2,SMARCC1,SRA1,TLN1,TNF,UNC93B1,WASF2,ZDHHC21,ZEB2	48
Cell-mediated Immune Response,Lymphoid Tissue Structure and Development	frequency	Frequency of T lymphocytes	8,77E-03	5,02E-01	 	-0,722	HLA-DQB1,NDUFB2,PARK7,PARP1,PTPN22,PTPN6,RASGRP1,SERPINB1,TNF,UNC93B1,ZEB2	11
Organismal Functions,Organismal Injury and Abnormalities,Tissue Morphology	healing	Healing of wound	8,77E-03	5,02E-01	 	 	CNN2,GRN,GSN,ILK,ITGB2,PARP1,RAC1,RAC2,TNF,TNFRSF1B,VIM	11
Cellular Movement	transmigration	Transmigration of myeloid cells	8,77E-03	5,02E-01	Decreased	-2,428	CD47,CD99,CNN2,GNAI2,ITGB2,LSP1,PREX1,PTPN6,RASGRP2,RHOA,TNF	11
Organismal Injury and Abnormalities	visceromegaly	Visceromegaly	8,84E-03	5,02E-01	 	 	ATP2A3,CAPNS1,CD19,CD47,CIB1,CUX1,DUSP1,EHD3,FDFT1,FKBP1A,GNAI2,GRB2,GRN,GSN,HCK,HLA-DQA1,HMGA1,HMOX1,HOPX,IKZF3,ILK,ITGB2,JAK1,LAT2,LITAF,LY6E,MALT1,MEF2A,MEF2C,MTPN,NDUFS6,PARK7,PARP1,PFN1,PLD4,PPIA,PPP1CA,PRDX1,PTPN22,PTPN6,PTPRC,RAC1,RASGRP1,RHOA,S100A10,SCP2,SPI1,SPTAN1,TLN1,TNF,TNFRSF1B,TPI1,UNC93B1,VDAC1,WIPF1,ZEB2	56
Inflammatory Response,Organismal Injury and Abnormalities	inflammation	Inflammation of organ	9,18E-03	5,02E-01	Increased	2,402	ACTB,ADK,ANXA4,ARHGDIB,BCAS4,CAPZB,CD19,CD47,CD53,CD68,CD79A,CD99,CFL1,CHD4,CORO1A,COTL1,CSK,CXCR3,CXCR4,DDX17,DHRS9,DUSP1,EEF1A1,EHD3,FABP5,FDFT1,FDPS,FGR,FKBP1A,FLNA,GAPDH,GNAI2,GRN,GSN,H3-3A/H3-3B,HCK,HCST,HLA-DMB,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,IFI30,IKZF3,ITGAX,ITGB2,ITGB7,JAK1,JPT1,LAPTM5,MALT1,MAP4K1,MAZ,MS4A1,NEDD8,OAS1,OGT,PARK7,PARP1,PDLIM1,PIKFYVE,PKM,PPIA,PRDX1,PREX1,PSAP,PSMB2,PSMB8,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAC1,RFTN1,RHOA,S100A10,S100A11,SCP2,SERPINB1,SIGLEC10,SPI1,SYK,TCF4,TKT,TNF,TNFRSF1B,TPI1,TPM3,TSPO,UNC93B1,VCP,VIM,VSIR,WIPF1,YBX1,ZBTB32,ZYX	98
Organismal Development	abnormal morphology	Abnormal morphology of body cavity	9,29E-03	5,02E-01	 	 	ARHGDIB,ARID3A,ATP2A3,CAPNS1,CD19,CD47,CIB1,CUX1,CXCR4,DBNL,DUSP1,EHD3,FDFT1,FKBP1A,FLNA,FUT8,GNAI2,GNG5,GRB2,GRN,GSN,H1-2,HCK,HCST,HHEX,HLA-DQA1,HLA-DQB1,HMGA1,HMOX1,HOPX,IDS,IKZF3,ILK,ITGB2,ITGB7,JAK1,LITAF,LY6E,MALT1,MEF2A,MEF2C,MFSD1,MTMR14,MTPN,MTSS1,NDUFS6,PARK7,PARP1,PFN1,PLD4,PPIA,PPP1CA,PRDX1,PREX1,PSAP,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAC1,RASGRP1,RHOA,S100A10,SCP2,SPI1,SPTAN1,SYK,SYTL1,TCIRG1,TLN1,TNF,TNFRSF1B,TPI1,TSC22D3,TXNIP,UNC93B1,VDAC1,WASF2,WIPF1,YBX1,YWHAE,ZEB2	83
Dermatological Diseases and Conditions,Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	atopic dermatitis	Atopic dermatitis	9,41E-03	5,02E-01	 	 	CAPZB,CFL1,CXCR4,DUSP1,EEF1A1,FABP5,FGR,FKBP1A,FLNA,GSN,H3-3A/H3-3B,HCK,HLA-DQA1,HLA-DRA,IFI30,ITGB7,JAK1,JPT1,PPIA,PSAP,S100A11,SPI1,SYK,TNF,TPI1,TPM3,VCP,ZYX	28
Gene Expression	transcription	Transcription	9,54E-03	5,02E-01	Decreased	-4,164	ACTG1,ACTR2,ACTR3,ANXA2,ANXA4,ARID3A,BTG1,CD19,CD82,CDK2AP1,CHD4,CKS2,CNN2,CTSH,CUX1,CXCR4,DDX17,ELOB,FGR,FLNA,FUT8,GRN,GSN,GTF2A2,GTF3C6,H1-2,HHEX,HMGA1,HOPX,HSBP1,IKZF3,ILK,ITGAX,JAK1,LAMTOR5,LBH,LITAF,MAD1L1,MALT1,MAZ,MEF2A,MEF2C,MTCH2,NCOA3,NCOA4,NEDD8,NME1,NME2,NOP53,OGT,PAK2,PARK7,PARP1,PARP15,PDLIM1,PEA15,PFDN5,PFN1,PLAC8,POLR2E,POLR2G,POLR2L,POU2F2,PSMB2,PTPN22,PTPN6,PTPRC,RAC1,RASGRP1,RHOA,RHOG,RNF141,S100A10,SLC44A2,SMARCC1,SMARCE1,SPI1,SRA1,SRPK2,SUB1,SUMO1,SUMO2,SUPT4H1,SYK,TAF10,TAGLN2,TCF4,TCIRG1,TERF2IP,TESC,TLE1,TLE5,TNF,TNFRSF1B,TSC22D3,TXNIP,UBE2L3,VIM,VSIR,YBX1,YWHAH,ZBTB32,ZEB2	103
Inflammatory Disease,Organismal Injury and Abnormalities	chronic inflammatory disorder	Chronic inflammatory disorder	9,68E-03	5,02E-01	 	-0,013	ADK,ANXA4,ARHGDIB,ATP2B1,CD19,CD52,CD53,CD68,CD79A,COTL1,CXCR3,CXCR4,CYBA,DHRS9,DUSP1,DYNLL1,FDFT1,FDPS,FGR,FKBP1A,GLUL,GOLPH3,GRN,GSN,H3-3A/H3-3B,HCK,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,IKZF3,ITGB2,ITGB7,JAK1,LAPTM5,LBH,LCP1,LY6E,MAZ,MRPS36,MS4A1,MYL12A,PARP1,PDLIM1,PKM,POLR2L,PPIA,PPP1R7,PRDX1,PRDX5,PSMB2,PSMB8,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAB1B,RHOA,RTF2,S100A10,SF3B6,SUMO1,SYK,TALDO1,TCF4,TCIRG1,TLE1,TNF,TNFRSF1B,TPI1,TSPO,VIM	76
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	homing	Homing of leukocytes	9,70E-03	5,02E-01	Decreased	-2,884	CD47,CORO1A,CUX1,CXCR3,CXCR4,DUSP1,FGR,GNAI2,GRN,GSN,HCK,ITGB2,ITGB7,JAK1,LCP1,LITAF,LSP1,NCKAP1L,PFN1,PIKFYVE,PNOC,PPIA,PREX1,PTPN6,RAC1,RAC2,RAP1B,RHOA,SERPINB1,SPI1,SUMO1,SYK,TMSB10/TMSB4X,TNF,WIPF1	35
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	chronic leukemia	Chronic leukemia	9,70E-03	5,02E-01	 	 	ARL6IP5,CD52,CFL1,CSK,CUX1,DUSP1,FCMR,FGR,FKBP1A,HCK,HLA-DQA1,HVCN1,IKZF3,ITGAX,ITGB2,MRPL51,MS4A1,MTMR14,PARP1,PPIA,PPM1M,PPP1CA,PTPN1,PTPN18,PTPN22,PTPN6,PTPRC,RFTN1,SLC25A5,SPI1,SYK,TERF2IP,TNF,TSPO,ZYX	35
Connective Tissue Disorders,Dermatological Diseases and Conditions,Inflammatory Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	scleroderma	Scleroderma	9,77E-03	5,02E-01	 	 	ACTB,ACTR3,ARPC3,ARPC5,CD19,CD79A,CFL1,CIB1,CKS2,CXCR4,DHRS9,FGR,FIBP,HCK,ILK,ITGB2,ITGB7,JAK1,MS4A1,PARP1,PKM,RAC1,RAC2,RHOA,SPI1,TPI1,VIM	27
Cellular Function and Maintenance,Small Molecule Biochemistry	homeostasis	Homeostasis of ion	9,89E-03	5,02E-01	 	 	ATP2A3,ATP2B1,ATP6V0D1,CYB561A3,FTL,HMOX1,MT2A,MTMR14,NCOA4,TCIRG1,TESC,TSC22D3	12
Cardiovascular Disease,Cardiovascular System Development and Function,Organ Morphology,Organismal Development,Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of heart ventricle	9,89E-03	5,02E-01	 	 	CAPNS1,CXCR4,FKBP1A,GNG5,HHEX,HMOX1,LY6E,MEF2A,MEF2C,TNF,TXNIP,YWHAE	12
Cellular Movement	homing	Homing of lymphoma cell lines	1,00E-02	5,02E-01	 	0,152	CXCR3,ITGB7,MS4A1,MTSS1,TNF	5
Cellular Assembly and Organization,Cellular Function and Maintenance,Organismal Development	secretion	Secretion of alpha granules	1,00E-02	5,02E-01	 	-1,387	FLNA,PTPN22,RAP1B,RHOA,RHOG	5
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	activation	Activation of leukocyte cell lines	1,00E-02	5,02E-01	 	-0,692	CFL1,LSP1,MS4A1,SPI1,TNF	5
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	chemotaxis	Chemotaxis of peripheral blood leukocytes	1,00E-02	5,02E-01	 	-1,387	CXCR3,CXCR4,LCP1,PPIA,TNF	5
Cellular Assembly and Organization,Cellular Compromise	disruption	Disruption of filaments	1,00E-02	5,02E-01	 	-1,982	GSN,SEPTIN7,TMSB10/TMSB4X,TNF,VIM	5
Cell Cycle	oncogene-induced senescence	Oncogene-induced senescence of cells	1,00E-02	5,02E-01	 	 	GABARAPL2,HMGA1,OGT,PARP1,SPI1	5
Cardiovascular System Development and Function,Embryonic Development,Organismal Development,Tissue Development	development	Development of outflow tract	1,00E-02	5,02E-01	 	 	CFL1,FLNA,HHEX,ILK,MEF2C	5
Cellular Assembly and Organization	stabilization	Stabilization of actin filaments	1,00E-02	5,02E-01	Decreased	-2,184	CFL1,FLNA,GSN,VASP,WIPF1	5
Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization,Tissue Development	adhesion	Adhesion of cell-associated matrix	1,00E-02	5,02E-01	 	 	ITGB2,ITGB7,PARVG,RHOA,ZYX	5
Cardiovascular Disease,Cardiovascular System Development and Function,Organ Morphology,Organismal Development,Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of right ventricle	1,00E-02	5,02E-01	 	 	CXCR4,FKBP1A,GNG5,HMOX1,MEF2A	5
Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities	metastatic papillary thyroid cancer	Metastatic papillary thyroid carcinoma	1,00E-02	5,02E-01	 	 	FGR,JAK1,LIMD2,PTPRC,S100A11	5
Cellular Movement	cell movement	Arrest in cell movement	1,00E-02	5,02E-01	 	 	GNAI2,ITGB2,ITGB7,TLN1,TNF	5
Cardiovascular System Development and Function,Tissue Morphology	permeability	Permeability of blood vessel	1,00E-02	5,02E-01	 	0,314	GSN,LSP1,PLAC8,TNF,UCP2	5
Cellular Assembly and Organization,Cellular Compromise	depolymerization	Depolymerization of actin filaments	1,00E-02	5,02E-01	 	-1,960	CAP1,CFL1,GSN,PLEK,WDR1	5
Cell Morphology,Nervous System Development and Function,Organismal Development,Tissue Morphology	morphology	Morphology of astrocytes	1,00E-02	5,02E-01	 	 	PEA15,PSAP,RHOA,SPI1,VIM	5
Developmental Disorder,Hereditary Disorder,Lipid Metabolism,Metabolic Disease,Organismal Injury and Abnormalities,Small Molecule Biochemistry	Niemann-Pick disease type C	Niemann-Pick disease type C	1,00E-02	5,02E-01	 	 	CD47,CD68,GRN,ITGAX,UGCG	5
Cellular Function and Maintenance,Molecular Transport,Small Molecule Biochemistry	homeostasis	Homeostasis of iron ion	1,00E-02	5,02E-01	 	 	ATP6V0D1,CYB561A3,FTL,HMOX1,NCOA4	5
Cell Death and Survival,Embryonic Development	cell viability	Cell viability of embryonic cells	1,00E-02	5,02E-01	 	1,114	HMGA1,NOP53,OGT,PARP1,TNF	5
Hematological Disease,Organismal Injury and Abnormalities	microcytosis	Microcytosis	1,00E-02	5,02E-01	 	1,342	HMOX1,PRDX1,RAC1,RAC2,TNF	5
Behavior	grooming	Grooming	1,00E-02	5,02E-01	 	1,732	GRN,HMOX1,PREX1,TCF4,TNF	5
Organismal Injury and Abnormalities,Renal and Urological Disease	damage	Damage of renal glomerulus	1,00E-02	5,02E-01	 	1,406	CXCR3,CXCR4,FKBP1A,GRN,TXNIP	5
Cardiovascular System Development and Function,Cellular Movement	cell movement	Cell movement of endothelial cells	1,01E-02	5,02E-01	Decreased	-2,280	ANXA2,ATP5F1A,ATP5F1B,CD82,CNN2,CXCR4,CYTOR,FLNA,GLUL,GPI,GRN,HHEX,MEF2C,MTSS1,PKM,PTPN1,PTPN6,RAC1,RAP1B,RHOA,SEPTIN7,TAGLN2,TMSB10/TMSB4X,TNF,VASP,VIM	26
Endocrine System Disorders,Gastrointestinal Disease,Metabolic Disease,Organismal Injury and Abnormalities,Renal and Urological Disease	diabetic nephropathy	Diabetic nephropathy	1,01E-02	5,02E-01	 	 	CD19,CD52,CD53,CD79A,CHI3L2,CORO1A,CRIP1,CTSH,CXCR3,CXCR4,DHRS9,DUSP1,FCMR,FCRL5,FGD2,FKBP1A,GLUL,HOPX,IKZF3,LCP1,LIMD2,LSP1,MEF2C,MS4A1,MT2A,MYO1G,NCKAP1L,NCOA4,OAS1,PLAC8,PNOC,PYCARD,RAC2,SIGLEC6,SREK1,TCF4,TMSB10/TMSB4X,TSC22D3,VIM,ZEB2	40
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of tumor cell lines	1,02E-02	5,02E-01	Decreased	-2,229	ADD3,ANXA2,CD47,CD82,CD99,CSK,CXCR3,CXCR4,FLNA,GLRX,GOLPH3,ILK,ITGAX,ITGB2,LY6E,MAD1L1,MS4A1,NME1,PAK2,PARP1,PARVG,PKM,PREX1,PSMD4,PTPN6,RAC1,RASGRP2,RHOA,SPTAN1,TLN1,TNF,YBX1,ZEB2,ZYX	34
Cellular Movement	cellular infiltration	Cellular infiltration by myeloid cells	1,05E-02	5,02E-01	 	-1,628	ANXA2,CD47,CORO1A,DUSP1,HCK,HMOX1,ILK,ITGB2,MALT1,PARP1,PIKFYVE,PKM,PPIA,PREX1,PSMB8,PTPN1,PTPN6,RAC2,S100A10,SPI1,TNF,TNFRSF1B,VASP,YBX1,ZDHHC12	25
Cellular Development,Cellular Growth and Proliferation	proliferation	Proliferation of prostate cancer cell lines	1,05E-02	5,02E-01	Decreased	-2,325	CD99,CXCR3,DYNLL1,EIF4A1,FABP5,FDFT1,FDPS,GRN,HMOX1,IDS,ILK,LCP1,NCOA3,NCOA4,OGT,PARP1,RAC1,RHOA,SAT1,SMARCC1,SRM,SUMO2,TCIRG1,TNF,YBX1	25
Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	function	Abnormal function of neutrophils	1,07E-02	5,02E-01	 	 	CD47,CD82,FGR,GNAI2,HCK,ITGB2,LCP1,PLAC8,RAC2,RASGRP2,SERPINB1,SYK,TNF	13
Cell Death and Survival,Hematological System Development and Function,Organismal Injury and Abnormalities	cell viability	Cell viability of B lymphocytes	1,07E-02	5,02E-01	Decreased	-2,880	CD19,CD47,CD79A,CHD4,FCMR,HCK,HSH2D,MALT1,MEF2C,SYK,TNF,TSC22D3,WIPF1	13
Molecular Transport	transport	Transport of metal	1,07E-02	5,02E-01	 	-1,095	ATP2A3,ATP2B1,ATP6V0D1,CORO1A,CYB561A3,FTL,HMOX1,MT2A,NCOA4,VDAC1,YWHAB,YWHAE,YWHAH	13
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology	morphology	Morphology of lymphoid tissue	1,07E-02	5,02E-01	 	 	ARHGDIB,ARL6IP5,CD19,CD47,CUX1,CXCR4,DBNL,GNAI2,H1-2,HCK,HCST,HLA-DQA1,HLA-DQB1,HMGA1,HMOX1,HSH2D,IDS,IKZF3,ITGB2,ITGB7,JAK1,LCP1,MAD1L1,MALT1,PARP1,PLD4,PRDX1,PSAP,PTPN22,PTPN6,PTPRC,PTPRCAP,PYCARD,RASGRP1,SPI1,SYK,TCIRG1,TNF,TNFRSF1B,TSC22D3,TXNIP,UNC93B1,WIPF1,ZEB2	44
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	cell movement	Cell movement of macrophages	1,08E-02	5,02E-01	Decreased	-2,390	CNN2,CXCR3,CXCR4,FLNA,GNAI2,GSN,HCK,HMOX1,ITGB2,LITAF,NCKAP1L,PARP1,PFN1,PSMB8,PTPN1,PTPN6,RAC1,RAC2,RHOA,S100A10,TNF,VASP,YBX1,ZDHHC12	24
Cancer,Organismal Injury and Abnormalities,Respiratory Disease	advanced lung cancer	Advanced lung cancer	1,08E-02	5,02E-01	 	0,194	ANXA2,CXCR4,EEF1A1,EIF4A1,FDFT1,FDPS,FGR,FKBP1A,FTL,IFI30,JAK1,MYL12A,NCOA3,NEDD8,PARP1,PDLIM1,PPIA,RAC1,RHOA,TMSB10/TMSB4X,TNF,TPT1,YWHAE,ZEB2	24
Organismal Injury and Abnormalities	sclerosis	Sclerosis	1,11E-02	5,02E-01	 	 	ACTB,ARPC3,CD19,CD79A,CFL1,CIB1,CKS2,CXCR4,DHRS9,FGR,FIBP,HCK,IDS,ILK,ITGB2,ITGB7,JAK1,MS4A1,PARP1,PKM,RAC2,RHOA,TPI1	23
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	progressive parkinsonism	Progressive parkinsonism	1,11E-02	5,02E-01	 	 	ANXA2,AP1S2,ARHGDIB,ARL6IP5,CAPZB,DBNL,EEF1A1,FTL,GRN,H3-3A/H3-3B,HLA-DQA1,HLA-DRA,MEF2C,NDUFV2,NEAT1,PARK7,PSAP,S100A10,TNF,TPT1,TSPO,VCP,VIM	23
Free Radical Scavenging	production	Production of superoxide	1,13E-02	5,02E-01	Decreased	-2,127	CYBA,DBI,FGR,HCK,HVCN1,ILK,ITGAX,ITGB2,PSMB8,RAC1,RAC2,SPI1,TNF,UCP2	14
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	cell movement	Cell movement of monocytes	1,13E-02	5,02E-01	 	-1,787	ANXA2,CD47,CD99,CXCR4,DUSP1,ITGAX,ITGB2,JAK1,NCKAP1L,PPIA,RAC2,RHOA,TNF,VASP	14
Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Hematological System Development and Function,Inflammatory Response	phagocytosis	Phagocytosis by macrophages	1,13E-02	5,02E-01	Decreased	-2,460	CD47,CNN2,FGR,GRN,GSN,HCK,HMOX1,HSH2D,ITGB2,NCKAP1L,PTPRC,SPI1,TNF,UCP2	14
Cell Morphology,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cell spreading	Cell spreading of leukocytes	1,13E-02	5,02E-01	Decreased	-2,377	CD19,CD47,CNN2,CORO1A,FGR,HCK,ITGB2,MAP4K1,RAC1,RAP1B,RHOA,SYK,TLN1,TNF	14
Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	chronic colitis	Chronic colitis	1,13E-02	5,02E-01	 	 	ARHGDIB,CD19,CD53,CD79A,DHRS9,HLA-DMB,HLA-DQA1,HLA-DQB1,IKZF3,LAPTM5,MS4A1,PSMB8,PTPRC,TNF	14
Cell Cycle	ploidy	Ploidy	1,13E-02	5,02E-01	 	1,528	CIB1,CKS2,H3-3A/H3-3B,JAK1,MAD1L1,NME1,PAK2,PARP1,PTPN6,RHOA,TCIRG1,TNF,UGCG,YWHAH	14
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cellular infiltration	Cellular infiltration by granulocytes	1,17E-02	5,02E-01	 	-1,330	ANXA2,CD47,CORO1A,DUSP1,HCK,HMOX1,ILK,ITGB2,MALT1,PARP1,PIKFYVE,PKM,PPIA,PREX1,RAC2,SPI1,TNF,TNFRSF1B,VASP,YBX1,ZDHHC12	21
Cancer,Organismal Injury and Abnormalities,Respiratory Disease	non-small cell lung cancer	Stage I-IV non-small cell lung cancer	1,18E-02	5,02E-01	 	 	ANXA2,EEF1A1,EIF4A1,EIF4E2,FGR,FKBP1A,FTL,IFI30,JAK1,MYL12A,PARP1,PPIA,TMSB10/TMSB4X,TNF,TPT1	15
Cancer,Organismal Injury and Abnormalities	papillary neoplasm	Papillary neoplasm	1,18E-02	5,02E-01	 	 	ACP5,ANXA2,CARD16,CD79A,CXCR4,EEF1B2,FABP5,FGR,FKBP1A,GAPDH,GLRX,HLA-DQA1,HMGA1,IGF2BP3,JAK1,LIMD2,LSM14A,LY6E,PARP1,PEA15,PKM,PTPRC,RAC1,RHOG,S100A11,SYK,TESC,TNFRSF1B,TPI1,TXNIP,VIM	31
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cell rolling	Cell rolling of granulocytes	1,18E-02	5,02E-01	Decreased	-2,138	FGR,GNAI2,HCK,ITGB2,PREX1,RAC2,TLN1,TNF	8
Cellular Movement	invasion	Invasion of colorectal cancer cell lines	1,18E-02	5,02E-01	 	1,086	CD82,CSK,CXCR4,MAP4K1,NME1,PDLIM1,S100A10,TMSB10/TMSB4X	8
Digestive System Development and Function	ingestion	Ingestion by mice	1,18E-02	5,02E-01	 	0,152	GRN,MTSS1,PNOC,PSAP,PTPN1,SCP2,TNF,TNFRSF1B	8
Cell Death and Survival,Embryonic Development	cell death	Cell death of embryonic cells	1,18E-02	5,02E-01	 	-0,116	CAPNS1,H3-3A/H3-3B,HMGA1,MTCH2,NOP53,RAC1,TNF,TPM3	8
Cell Morphology	abnormal morphology	Abnormal morphology of plasma membrane	1,18E-02	5,02E-01	 	 	CFL1,CORO1A,GLRX,HMOX1,HSPA4,PFN1,UGCG,VIM	8
Connective Tissue Disorders,Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	systemic juvenile idiopathic arthritis	Systemic juvenile idiopathic arthritis	1,18E-02	5,02E-01	 	 	ATP2B1,DYNLL1,JAK1,MRPS36,RAB1B,SF3B6,TALDO1,TNF	8
Cell Morphology	size	Size of tumor cell lines	1,18E-02	5,02E-01	 	 	CAP1,GOLPH3,HVCN1,ILK,NCOA3,PTPRC,SMARCE1,TNF	8
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cell movement	Cell movement of PBMCs	1,18E-02	5,02E-01	 	-1,611	ANXA2,CD47,CD99,CXCR3,CXCR4,LCP1,PPIA,TNF	8
Cell Morphology,Hematological System Development and Function,Inflammatory Response	morphology	Morphology of macrophages	1,18E-02	5,02E-01	 	 	FGR,GRN,HCK,PLD4,PSAP,RASGRP1,SPI1,TNF	8
Cellular Movement,Embryonic Development	migration	Migration of embryonic cells	1,18E-02	5,02E-01	 	-0,038	CAPNS1,CFL1,CXCR4,GRB2,RAC1,RHOA,TNF,ZEB2	8
Cell-To-Cell Signaling and Interaction	binding	Binding of colorectal cancer cell lines	1,18E-02	5,02E-01	 	-0,615	CD82,CSK,ILK,NME1,PKM,RAC1,S100A10,TNF	8
Cellular Function and Maintenance	engulfment	Engulfment of leukemia cell lines	1,18E-02	5,02E-01	Decreased	-2,646	CD47,HMOX1,PSMD4,RAC1,RHOG,SPI1,TNF,VIM	8
Organismal Injury and Abnormalities,Respiratory Disease	damage	Damage of lung	1,19E-02	5,02E-01	 	-0,464	ANXA2,CXCR3,DDAH2,FKBP1A,FUT8,GAPDH,HLA-DQA1,HMOX1,HSH2D,ITGB2,JAK1,LY6E,PKM,RAC1,RHOA,SERPINB1,SLC44A2,TNF,TSPO,VASP	20
Cancer,Organismal Injury and Abnormalities	cancer	Stage I-II cancer	1,19E-02	5,02E-01	 	 	ANXA2,CYBA,EEF1A1,EIF4A1,FDFT1,FDPS,FGR,FKBP1A,FTL,GPI,IFI30,MS4A1,MYL12A,NME2,PPIA,PSMB2,TMSB10/TMSB4X,TNF,TPT1,ZEB2	20
Cell-To-Cell Signaling and Interaction	binding	Binding of tumor cell lines	1,19E-02	5,02E-01	Decreased	-2,985	ADD3,ANXA2,CD47,CD68,CD82,CD99,CSK,CXCR3,CXCR4,FLNA,GLRX,GOLPH3,HCK,ILK,ITGAX,ITGB2,LY6E,MAD1L1,MS4A1,NME1,PAK2,PARP1,PARVG,PKM,PREX1,PSMD4,PTPN6,RAC1,RASGRP2,RHOA,S100A10,SPTAN1,TLN1,TNF,YBX1,ZEB2,ZYX	37
Cellular Compromise,Inflammatory Response	degranulation	Degranulation of phagocytes	1,20E-02	5,02E-01	 	-1,855	CORO1A,DUSP1,FGR,HCK,ITGB2,LAT2,PAK2,PTPN22,PTPN6,PTPRC,RAC2,RASGRP1,SYK,TNF,WIPF1,ZEB2	16
Cellular Movement	cell movement	Cell movement of leukemia cell lines	1,20E-02	5,02E-01	Decreased	-2,439	ANXA2,CD47,CD82,CD99,CSK,CXCR4,FLNA,HMGA1,ITGB7,MS4A1,PPIA,RAC1,RASGRP1,RHOA,SYK,TNF	16
Cell Death and Survival,Organismal Injury and Abnormalities	cell viability	Cell viability of mononuclear leukocytes	1,20E-02	5,02E-01	Decreased	-3,193	CD19,CD47,CD79A,CHD4,FCMR,HCK,HSH2D,MALT1,MEF2C,NME1,PTPRC,PYCARD,RAC1,SYK,TNF,TNFRSF1B,TSC22D3,WIPF1,ZEB2	19
Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	abnormal bone density	Abnormal bone density	1,21E-02	5,02E-01	Increased	2,324	ACP5,ARL6IP5,CD47,FDFT1,FDPS,GSN,HCK,HCST,IDS,ITGB2,JAK1,RAC1,RHOA,SPI1,TCIRG1,TNF,VCP	17
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	cellular infiltration	Infiltration by neutrophils	1,21E-02	5,02E-01	 	-1,526	ANXA2,CORO1A,DUSP1,HMOX1,ILK,ITGB2,MALT1,PARP1,PIKFYVE,PKM,PREX1,RAC2,TNF,TNFRSF1B,VASP,YBX1,ZDHHC12	17
Cellular Compromise,Inflammatory Response	degranulation	Degranulation of myeloid cells	1,21E-02	5,02E-01	 	-1,407	CORO1A,CSK,DUSP1,FGR,HCK,ITGB2,LAT2,PAK2,PTPN22,PTPN6,PTPRC,RAC2,RASGRP1,SYK,TNF,WIPF1,ZEB2	17
Cancer,Organismal Injury and Abnormalities,Tumor Morphology	invasion	Invasion of tumor	1,21E-02	5,02E-01	 	-1,305	ANXA2,CD53,CD82,CIB1,CXCR4,FKBP1A,FLNA,HMOX1,MIEN1,NME1,PARK7,RAC1,RASGRP1,RHOA,RHOG,SYK,VASP,VIM	18
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of lymphatic system cells	1,21E-02	5,02E-01	Decreased	-2,233	ANXA2,CD47,CD99,CIB1,CXCR3,CXCR4,GNAI2,ITGB2,JAK1,MAP4K1,MYO1G,PTPN6,RAC1,RAC2,RAP1B,RASGRP1,RHOA,TNF	18
Cellular Movement,Connective Tissue Development and Function	cell movement	Cell movement of fibroblast cell lines	1,21E-02	5,02E-01	Decreased	-3,162	ACTR2,ARPC2,CSK,FABP5,FLNA,GPI,GRB2,HCK,ILK,MIEN1,MTSS1,PTPN1,RAC1,RAC2,RHOA,RHOG,VCP,VIM	18
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	transmigration	Transmigration of leukocytes	1,21E-02	5,02E-01	Decreased	-3,400	CD47,CD53,CD99,CNN2,CXCR3,CXCR4,FABP5,GNAI2,ITGAX,ITGB2,LSP1,PREX1,PTPN6,RAC1,RAC2,RASGRP2,RHOA,TNF	18
Cellular Movement	invasion	Invasion of prostate cancer cell lines	1,21E-02	5,02E-01	 	-1,816	CD82,CTSH,CXCR3,CXCR4,FABP5,GRN,HHEX,HMOX1,LCP1,NCOA3,NCOA4,RAC1,RHOA,S100A11,SMARCC1,TCIRG1,TNF,VIM	18
Connective Tissue Disorders,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	inflammation	Inflammation of joint	1,22E-02	5,03E-01	 	-1,192	ARHGAP30,ARHGDIB,ATP2B1,CD68,CD79A,CSK,CXCR3,CXCR4,DUSP1,DYNLL1,FDFT1,FDPS,FGR,FKBP1A,FTL,GLUL,GNAI2,GOLPH3,GPI,GRN,GSN,H3-3A/H3-3B,HCK,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,ITGB2,ITGB7,JAK1,LBH,LCP1,LY6E,MAP4K1,MAZ,MRPS36,MS4A1,MYL12A,PARP1,POLR2L,PPIA,PPP1R7,PRDX1,PRDX5,PSMB8,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAB1B,RTF2,S100A10,SF3B6,SLC44A2,SUMO1,SYK,TALDO1,TCF4,TCIRG1,TNF,TNFRSF1B,TPI1,TSPO,VIM,WIPF1	69
Tissue Morphology	quantity	Quantity of cells	1,34E-02	5,52E-01	Decreased	-2,750	ADD3,ARHGDIB,ARID3A,ATP2B1,BLOC1S2,CAPNS1,CD19,CD47,CD79A,CD82,CDK2AP1,CIB1,CKS2,CLTA,CNN2,CORO1A,CSK,CXCR3,CXCR4,DBI,DUSP1,DYNLL1,EEA1,FABP5,FCMR,FKBP1A,FLNA,GNAI2,GRN,GSN,HCK,HCST,HLA-DQA1,HLA-DQB1,HMGA1,HMOX1,HVCN1,IKZF3,ILK,ITGB2,ITGB7,JAK1,LITAF,LSP1,MAD1L1,MALT1,MEF2C,MS4A1,MTMR14,MYO1G,NCKAP1L,NEDD8,OGT,PAK2,PARK7,PARP1,PCLAF,PFN1,PIKFYVE,PKM,PLAC8,PLD4,POU2F2,PPIA,PRDX1,PRDX5,PREX1,PSAP,PSMB8,PTPN22,PTPN6,PTPRC,PTPRCAP,PYCARD,RAC1,RAC2,RAP1B,RASGRP1,RFTN1,RHOA,RNF141,SCP2,SERPINB1,SIGLEC10,SLC44A2,SMARCE1,SPI1,SPTAN1,SUB1,SUMO1,SYK,SYTL1,TCF4,TCIRG1,TLN1,TNF,TNFRSF1B,TPM3,TPT1,TRAPPC1,TSC22D3,TSPO,TXNIP,UCP2,UGCG,UNC93B1,VASP,VIM,WIPF1,YBX1,ZEB2	111
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	disorder of basal ganglia	Disorder of basal ganglia	1,35E-02	5,54E-01	 	 	ACTB,ANXA2,AP1S2,ARHGDIB,ARL6IP5,ATP2B1,ATP5F1A,ATP5F1B,ATP5F1C,ATP5F1E,ATP5MF,ATP5MK,ATP5PB,ATP5PF,CAPNS1,CAPZB,CD68,COX5A,COX5B,CXCR3,DBNL,EEF1A1,FDFT1,FTL,GAPDH,GPI,GRN,H3-3A/H3-3B,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,HSBP1,ITGAX,JAK1,LY6E,MALT1,MEF2C,MT2A,MYL12A,NDUFA7,NDUFAB1,NDUFB2,NDUFS6,NDUFV2,NEAT1,NME1,PARK7,PARP1,PDLIM1,PFN1,PKM,PLEK,PPIA,PSAP,PSMB8,RASGRP2,RHOG,S100A10,SAMHD1,SAT1,SEPTIN6,SRM,SUB1,TESC,TNF,TPI1,TPM3,TPT1,TSC22D3,TSPO,UCP2,UGCG,UQCR11,UQCRH,VCP,VIM	77
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	activation	Activation of leukocytes	1,42E-02	5,78E-01	 	-0,551	ANXA2,CD19,CD47,CD79A,CLEC2D,CORO1A,CSK,CTSH,CXCR3,DUSP1,FKBP1A,FUT8,GRN,HCK,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,HSH2D,HSPA4,HVCN1,IGF2BP3,ITGB2,LAPTM5,LAT2,MALT1,MEF2C,MS4A1,PAK2,PARK7,PARP1,PPIA,PRDX1,PREX1,PSAP,PSMB8,PTPN22,PTPN6,PTPRC,PYCARD,RASGRP1,RHOA,SIGLEC10,SYK,TCIRG1,TLN1,TNF,TNFRSF1B,TPT1,TRAPPC1,TXNIP,UNC93B1,VSIR	56
Cell Death and Survival,Organismal Injury and Abnormalities	cell death	Cell death of tumor cell lines	1,43E-02	5,81E-01	Increased	2,427	ANXA2,ATP2B1,ATP5F1A,BLOC1S2,BTG1,CAPNS1,CD47,CD82,CD99,CIB1,CKS2,CNN2,COX5A,CUX1,CXCR3,CXCR4,CYBA,DENR,DUSP1,DYNLL1,EEA1,EEF1A1,EEF1B2,EIF4A1,EMP3,FCMR,FDFT1,FGR,FKBP1A,GAPDH,GLRX,GPI,GRN,GSN,HCK,HCST,HLA-DQB1,HMGA1,HMOX1,HSH2D,HSPA4,IGF2BP3,ILK,JAK1,LAPTM5,LSP1,MAD1L1,MAP4K1,MAZ,MEF2A,MEF2C,MRPL52,MS4A1,MT2A,MTSS1,NAA38,NCOA3,NCOA4,NME1,NME2,OAZ1,OGT,PAK2,PARK7,PARP1,PEA15,PKM,PPIA,PPP1CA,PRDX1,PSMA5,PSMD4,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAC1,RHOA,RNF141,S100A11,SAMHD1,SAT1,SLC25A5,SMARCC1,SMARCE1,SNRPD1,SPI1,SRPK2,SUMO1,SYK,TAGLN2,TCF4,TERF2IP,TESC,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,TPT1,TSC22D3,UBE2L3,UCP2,UGCG,VCP,VDAC1,YBX1,YWHAE,YWHAH,ZEB2	110
Cellular Assembly and Organization	assembly	Assembly of organelle	1,43E-02	5,81E-01	Decreased	-3,155	ACTB,ACTG1,ACTR2,ACTR3,ANXA2,ARPC2,BRK1,CFL1,CHMP2A,CHMP4A,CORO1A,DYNLL1,FLNA,GDI2,GLUL,GNAI2,GNG5,GOLPH3,GPI,GRB2,GSN,HCK,LITAF,MTSS1,NCKAP1L,NDUFAB1,PAK2,PFDN5,PFN1,PIKFYVE,PREX1,PYCARD,RAB1B,RAC1,RHOA,S100A10,SEPTIN7,SNX3,SSNA1,TCIRG1,TMED5,TNF,TPM3,TWF2,UCP2,VASP,VCP,VDAC1,VIM,VPS25,WASF2,ZYX	52
Cellular Development,Cellular Growth and Proliferation	colony formation	Colony formation of breast cancer cell lines	1,46E-02	5,81E-01	 	-1,440	ANXA2,CD82,CKS2,EIF4A1,GRN,ILK,LY6E,NCOA3,PKM	9
Cellular Movement	cell movement	Cell movement of stem cells	1,46E-02	5,81E-01	 	-0,863	CFL1,CXCR4,MTCH2,PFN1,PTPN6,PTPRC,TCIRG1,TLN1,TNF	9
Molecular Transport,Nucleic Acid Metabolism,Small Molecule Biochemistry	quantity	Quantity of cyclic nucleotides	1,46E-02	5,81E-01	 	-0,756	ANXA4,CD47,CXCR4,GNAI2,PTPN22,PTPN6,PTPRC,RAC1,TNF	9
Hematological System Development and Function,Humoral Immune Response,Lymphoid Tissue Structure and Development,Tissue Morphology	quantity	Quantity of B-1a lymphocytes	1,46E-02	5,81E-01	 	-0,781	ARID3A,ATP2B1,CD19,CD79A,FCMR,PTPN6,RAC2,SIGLEC10,SPI1	9
Cellular Movement,Hematological System Development and Function,Humoral Immune Response,Immune Cell Trafficking	migration	Migration of B lymphocytes	1,46E-02	5,81E-01	 	-1,812	COMMD8,CXCR3,CXCR4,GNAI2,LCP1,MYO1G,RAP1B,TNF,TNFRSF1B	9
Cellular Movement	chemotaxis	Chemotaxis of blood cells	1,47E-02	5,81E-01	Decreased	-2,386	CD47,CORO1A,CUX1,CXCR3,CXCR4,DUSP1,FGR,GNAI2,GRN,GSN,HCK,ITGB2,LCP1,LITAF,LSP1,NCKAP1L,PFN1,PIKFYVE,PNOC,PPIA,PREX1,PTPN6,PTPRC,RAC1,RAC2,RHOA,SERPINB1,SPI1,SUMO1,SYK,TMSB10/TMSB4X,TNF,WIPF1	33
Cell Death and Survival,Organismal Injury and Abnormalities	cell viability	Cell viability of leukocytes	1,47E-02	5,81E-01	Decreased	-3,095	CD19,CD47,CD79A,CHD4,CXCR4,FCMR,HCK,HSH2D,ITGB2,JAK1,LAT2,MALT1,MEF2C,NME1,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RHOA,SYK,TNF,TNFRSF1B,TSC22D3,WIPF1,ZEB2	26
Cancer,Organismal Injury and Abnormalities	papillary adenocarcinoma	Papillary adenocarcinoma	1,47E-02	5,81E-01	 	 	ACP5,ANXA2,CARD16,CD79A,CXCR4,EEF1B2,FGR,FKBP1A,GAPDH,HLA-DQA1,HMGA1,IGF2BP3,JAK1,LIMD2,LSM14A,LY6E,PARP1,PKM,PTPRC,RAC1,S100A11,SYK,TESC,TPI1,TXNIP,VIM	26
Neurological Disease,Organismal Injury and Abnormalities	progressive encephalopathy	Progressive encephalopathy	1,51E-02	5,90E-01	 	 	ACTB,ANXA2,AP1S2,ARHGDIB,ARL6IP5,ATP5F1A,ATP5PB,CALM1 (includes others),CAPZB,CD68,CFL1,CHI3L2,CIB1,CXCR4,DBI,DBNL,DECR1,EEF1A1,EIF4A1,FDFT1,FDPS,FTL,GAPDH,GLRX,GRN,GSN,H3-3A/H3-3B,HLA-DQA1,HLA-DQB1,HLA-DRA,HMGA1,HMOX1,JPT1,LY6E,MEF2C,NDUFV2,NEAT1,OGT,PARK7,PARP15,PFN1,PPIA,PRDX1,PREX1,PSAP,RHOA,S100A10,SCP2,SRPK2,TNF,TPT1,TSPO,VCP,VDAC1,VIM	55
Cancer,Organismal Injury and Abnormalities	extracranial solid tumor	Advanced extracranial solid tumor	1,51E-02	5,90E-01	 	0,574	ANXA2,CARD16,CD47,CXCR3,CXCR4,EEF1A1,EIF4A1,FDFT1,FDPS,FGR,FKBP1A,FLNA,FTL,GLRX,GLUL,HMGA1,HMOX1,IFI30,JAK1,LIMD2,MS4A1,MYL12A,NCOA3,NEDD8,PARP1,PDLIM1,PPIA,PSMB2,PTPRC,RAC1,RHOA,S100A11,TMSB10/TMSB4X,TNF,TPT1,TXNIP,YWHAE,ZEB2	38
Cell-To-Cell Signaling and Interaction,Cellular Movement	recruitment	Recruitment of cells	1,55E-02	5,98E-01	Decreased	-2,586	CD19,CD47,CD53,CNN2,CXCR3,CXCR4,FABP5,FGR,FUT8,GLRX,GSN,HCK,HMOX1,ITGB2,ITGB7,LSP1,PARP1,PREX1,PYCARD,RAC1,RAP1B,RASGRP2,RHOA,RHOG,SYK,TNF,TNFRSF1B,TPT1,UCP2,VASP,VIM,ZDHHC12	32
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	recruitment	Recruitment of phagocytes	1,60E-02	5,98E-01	Decreased	-2,263	CD19,CD47,CD53,CNN2,CXCR4,FGR,FUT8,GLRX,GSN,HCK,ITGB2,ITGB7,LSP1,PARP1,PREX1,PYCARD,RAC1,RAP1B,RASGRP2,RHOA,TNF,TNFRSF1B,UCP2,ZDHHC12	24
Cellular Assembly and Organization,Organismal Development,Tissue Development	formation	Formation of filaments	1,63E-02	5,98E-01	Decreased	-2,984	ACTB,ACTG1,ARPC2,BRK1,CFL1,CORO1A,DYNLL1,GNAI2,GNG5,GPI,GRB2,GSN,HCK,MTSS1,NCKAP1L,PAK2,PFDN5,PFN1,PREX1,PYCARD,RAC1,RHOA,S100A10,SSNA1,TNF,TPM3,TWF2,VASP,VIM,WASF2,ZYX	31
Cell-To-Cell Signaling and Interaction,Cellular Movement	recruitment	Recruitment of blood cells	1,63E-02	5,98E-01	Decreased	-2,647	CD19,CD47,CD53,CNN2,CXCR3,CXCR4,FABP5,FGR,FUT8,GLRX,GSN,HCK,HMOX1,ITGB2,ITGB7,LSP1,PARP1,PREX1,PYCARD,RAC1,RAP1B,RASGRP2,RHOA,RHOG,SYK,TNF,TNFRSF1B,TPT1,UCP2,VASP,ZDHHC12	31
Cell-To-Cell Signaling and Interaction	response	Response of myeloid leukocytes	1,67E-02	5,98E-01	Decreased	-2,439	CD47,FGR,GLRX,GRN,HCK,ITGAX,ITGB2,PARK7,SYK,TNF	10
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	brain damage	Brain damage	1,67E-02	5,98E-01	 	-0,174	ADD3,CD47,FDPS,GSN,HMOX1,PARK7,PARP1,PYCARD,TSPO,UCP2	10
Cellular Movement	migration	Migration of leukemia cell lines	1,67E-02	5,98E-01	Decreased	-2,397	CD47,CD99,CXCR4,FLNA,MS4A1,RAC1,RASGRP1,RHOA,SYK,TNF	10
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	transmigration	Transmigration of granulocytes	1,67E-02	5,98E-01	Decreased	-2,370	CD47,CD99,CNN2,GNAI2,ITGB2,LSP1,PREX1,PTPN6,RASGRP2,TNF	10
Gene Expression	expression	Expression of RNA	1,67E-02	5,98E-01	Decreased	-3,181	ACTG1,ACTR2,ACTR3,ANXA2,ANXA4,ARID3A,BTG1,CD19,CD47,CD82,CDK2AP1,CHD4,CKS2,CNN2,CTSH,CUX1,CXCR3,CXCR4,DDX17,EIF4E2,ELOB,FGR,FLNA,FUT8,GAPDH,GRN,GSN,GTF2A2,GTF3C6,H1-2,HHEX,HMGA1,HOPX,HSBP1,IGF2BP3,IKZF3,ILK,ITGAX,JAK1,LAMTOR5,LBH,LITAF,LSM14A,MAD1L1,MALT1,MAZ,MEF2A,MEF2C,MRPL51,MTCH2,NCOA3,NCOA4,NEDD8,NME1,NME2,NOP53,OGT,PAK2,PARK7,PARP1,PARP15,PDLIM1,PEA15,PFDN5,PFN1,PLAC8,PNOC,POLR2E,POLR2G,POLR2L,POU2F2,PPP1CA,PTPN22,PTPN6,PTPRC,RAC1,RASGRP1,RHOA,RHOG,RNF141,S100A10,SLC44A2,SMARCC1,SMARCE1,SPI1,SRA1,SRPK2,SUB1,SUMO1,SUMO2,SUPT4H1,SYK,TAF10,TCF4,TCIRG1,TERF2IP,TESC,TLE1,TLE5,TNF,TNFRSF1B,TSC22D3,TXNIP,UBE2L3,VIM,VSIR,YBX1,YWHAH,ZBTB32,ZEB2	110
Molecular Transport	transport	Transport of molecule	1,71E-02	5,98E-01	 	-1,349	ANXA2,AP1S2,ARF5,ARL6IP5,ATP2A3,ATP2B1,ATP5F1B,ATP6V0D1,CLIC1,CORO1A,CYB561A3,DESI1,FABP5,FLNA,FTL,GLUL,GNAI2,GOLPH3,GRN,GSN,HHEX,HMGA1,HMOX1,HVCN1,ILK,LAPTM5,LY6E,MEF2A,MEF2C,MS4A1,MT2A,NCOA4,NME2,PARP1,PEA15,PKM,POU2F2,PPIA,PSAP,PTPN1,PTPN22,PTPRC,PYCARD,RABEP1,RAC1,RAC2,RHOA,SAMM50,SCP2,SLC38A1,SLC44A2,SNX3,SUMO1,SYK,SYTL1,TCIRG1,THOC7,TIMM13,TNF,TNFRSF1B,TPT1,TSPO,TXNIP,UCP2,UNC93B1,VDAC1,YBX1,YWHAB,YWHAE,YWHAH	70
Cancer,Neurological Disease,Organismal Injury and Abnormalities	glioblastoma cancer	Glioblastoma	1,72E-02	5,98E-01	 	 	CD47,CD99,CHMP2A,CKS2,CLEC2D,CSRP1,CXCR4,FGR,FLNA,H1-2,H3-3A/H3-3B,HLA-DQA1,HMGA1,IDS,IFI30,JAK1,LY6E,MAZ,NAA50,NEAT1,PARK7,PARP1,PCLAF,PKM,RAC1,RHOG,SMARCC1,TNF,TNFRSF1B,ZEB2	30
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	cellular infiltration	Cellular infiltration by phagocytes	1,72E-02	5,98E-01	 	-1,720	ANXA2,CORO1A,DUSP1,HMOX1,ILK,ITGB2,MALT1,PARP1,PIKFYVE,PKM,PPIA,PREX1,PSMB8,PTPN1,PTPN6,RAC2,S100A10,TNF,TNFRSF1B,VASP,YBX1,ZDHHC12	22
Cell Death and Survival,Organismal Injury and Abnormalities	apoptosis	Apoptosis of tumor cell lines	1,75E-02	5,98E-01	Increased	2,175	ANXA2,CAPNS1,CD47,CD82,CD99,CIB1,CKS2,CNN2,COX5A,CUX1,CXCR3,CXCR4,DENR,DUSP1,DYNLL1,EEA1,EEF1A1,EEF1B2,EIF4A1,EMP3,FCMR,FGR,FKBP1A,GAPDH,GLRX,GRN,GSN,HCK,HCST,HLA-DQB1,HMGA1,HMOX1,HSH2D,HSPA4,IGF2BP3,ILK,JAK1,LAPTM5,LSP1,MAD1L1,MAP4K1,MEF2A,MEF2C,MRPL52,MS4A1,MT2A,MTSS1,NCOA3,NCOA4,NME1,NME2,OGT,PAK2,PARK7,PARP1,PEA15,PKM,PPIA,PPP1CA,PRDX1,PSMA5,PSMD4,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAC1,RHOA,RNF141,S100A11,SAMHD1,SAT1,SLC25A5,SMARCC1,SMARCE1,SNRPD1,SPI1,SRPK2,SYK,TAGLN2,TCF4,TERF2IP,TESC,TLN1,TMSB10/TMSB4X,TNF,TNFRSF1B,TPT1,TSC22D3,UGCG,VCP,VDAC1,YBX1,YWHAE,ZEB2	96
Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization	cell-cell contact	Cell-cell contact	1,77E-02	5,98E-01	Decreased	-2,731	ACTG1,ACTR2,ACTR3,CAPZB,CD47,CD53,CD99,CORO1A,CSK,CXCR3,CXCR4,DBNL,GOLPH3,GPI,GRN,H3-3A/H3-3B,HOPX,HSPA4,ITGB2,LY6E,MEF2C,MTMR14,NME1,OGT,PAK2,PFN1,PTPRC,RAC1,RHOA,SELENOW,SPTAN1,SYK,TALDO1,TLN1,TNF,UCP2,VDAC1,VIM,ZEB2,ZYX	40
Cellular Movement	chemotaxis	Chemotaxis	1,77E-02	5,98E-01	Decreased	-2,485	ANXA2,CD47,CORO1A,CSK,CUX1,CXCR3,CXCR4,DUSP1,FGR,GLRX,GNAI2,GRB2,GRN,GSN,HCK,ILK,ITGB2,LCP1,LITAF,LSP1,MTSS1,NCKAP1L,PFN1,PIKFYVE,PNOC,PPIA,PREX1,PTPN6,PTPRC,RAC1,RAC2,RHOA,RHOG,SERPINB1,SPI1,SUMO1,SYK,TMSB10/TMSB4X,TNF,WIPF1	40
Cell Death and Survival	cell viability	Cell viability of breast cancer cell lines	1,78E-02	5,98E-01	 	-1,925	ANXA2,DUSP1,EIF4A1,FGR,HHEX,HMGA1,IGF2BP3,ILK,MRPL52,NEAT1,PARP1,PKM,PREX1,PSMB8,PYCARD,RHOA,SNRPD1,SYK,TNF,UGCG,YBX1	21
Cell-To-Cell Signaling and Interaction,Inflammatory Response	response	Response of phagocytes	1,78E-02	5,98E-01	Decreased	-2,949	CD47,CD68,CNN2,FGR,GLRX,GRN,GSN,HCK,HMOX1,HSH2D,ITGAX,ITGB2,MAP4K1,NCKAP1L,PSMB8,PTPRC,SPI1,SYK,TNF,UCP2,ZEB2	21
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders,Skeletal and Muscular Disorders	Parkinson disease	Parkinson's disease	1,78E-02	5,98E-01	 	 	ANXA2,AP1S2,ARHGDIB,ARL6IP5,CAPZB,DBNL,EEF1A1,FTL,H3-3A/H3-3B,HLA-DQA1,HLA-DRA,NDUFV2,NEAT1,PARK7,PSAP,S100A10,TNF,TPT1,TSPO,VCP,VIM	21
Embryonic Development,Organismal Development	development	Development of genitourinary system	1,78E-02	5,98E-01	 	-0,598	ANXA2,ANXA4,ARHGDIB,CIB1,CXCR4,DUSP1,EHD3,GRB2,GRN,GSN,H3-3A/H3-3B,HMGA1,HSPA4,IDS,ILK,LBH,MEF2C,MTMR14,MTSS1,NCOA3,NCOA4,NDUFS6,NME1,PARP1,PSAP,PTPN1,PTPN6,RAC1,RHOA,SAT1,SRA1,TAF10,TKT,TNF,TSC22D3	35
Cell Morphology,Cellular Assembly and Organization,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Nervous System Development and Function,Organismal Development,Tissue Development	neuritogenesis	Neuritogenesis	1,81E-02	5,98E-01	 	-1,951	CAPNS1,CD47,CFL1,CIB1,CRIP1,DBNL,FLNA,ILK,MEF2C,MTSS1,OGT,PAK2,PFN1,PSMF1,RAC1,RAP1B,RHOA,RHOG,SEPTIN7,SNX3,SSNA1,TNF,TNFRSF1B,TWF2,UGCG,VASP,VIM,YWHAH,ZEB2	29
Cardiovascular System Development and Function,Tissue Morphology	permeability	Permeability of vascular system	1,81E-02	5,98E-01	 	0,594	GSN,ITGB2,LSP1,PLAC8,PTPN6,RAC1,RAP1B,TNF,TNFRSF1B,UCP2,VASP	11
Embryonic Development,Organ Morphology,Organismal Development,Reproductive System Development and Function	mass	Mass of testis	1,81E-02	5,98E-01	 	 	CIB1,DUSP1,HSPA4,IDS,MTMR14,PSAP,PTPN1,SRA1,TKT,TNF,TSC22D3	11
Cellular Function and Maintenance,Small Molecule Biochemistry	homeostasis	Homeostasis of metal ion	1,81E-02	5,98E-01	 	 	ATP2A3,ATP2B1,ATP6V0D1,CYB561A3,FTL,HMOX1,MT2A,MTMR14,NCOA4,TCIRG1,TESC	11
Organismal Injury and Abnormalities,Reproductive System Disease	benign pelvic disease	Benign pelvic disease	1,82E-02	5,98E-01	 	 	ACTB,ANXA2,AP2S1,ATP5F1A,CD68,CHMP2A,CTSH,CUX1,CXCR3,CXCR4,CYBA,DUSP1,DYNLL1,FKBP1A,FLNA,GPI,GRB2,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DRA,HMGA1,HOPX,ITGAX,JAK1,LSP1,MEF2A,MFSD1,MYL6,NDUFV2,PLPP5,PTPN22,RAC1,RAP1B,SAMD3,SAT1,SERPINB1,SPTAN1,TMSB10/TMSB4X,TNF,TNFRSF1B,UGCG,UQCRH,VCP,VIM,YBX1,YWHAH,ZYX	48
Cellular Development	epithelial-mesenchymal transition	Epithelial-mesenchymal transition of breast cancer cell lines	1,83E-02	5,98E-01	 	-1,664	MRPL52,PTPN18,RHOA,TLN1,TNF,ZEB2	6
Tissue Development	formation	Formation of gland	1,83E-02	5,98E-01	 	 	GSN,LBH,LY6E,NCOA3,NME1,TNF	6
Cellular Compromise,Hypersensitivity Response,Inflammatory Response	degranulation	Degranulation of bone marrow-derived mast cells	1,83E-02	5,98E-01	 	-1,109	FGR,PAK2,PTPN6,SYK,WIPF1,ZEB2	6
Infectious Diseases,Organismal Injury and Abnormalities	infectivity	Infectivity of HIV-1	1,83E-02	5,98E-01	 	1,342	CXCR4,HCK,PPIA,SAMHD1,SUMO1,TNF	6
Cellular Assembly and Organization,Cellular Function and Maintenance	secretion	Secretion of granules	1,83E-02	5,98E-01	 	-1,467	ATP2A3,FLNA,PTPN22,RAP1B,RHOA,RHOG	6
Cellular Function and Maintenance,Connective Tissue Development and Function,Skeletal and Muscular System Development and Function,Tissue Development	function	Function of osteoclasts	1,83E-02	5,98E-01	 	 	CD47,CD68,GSN,HCST,PTPRC,TCIRG1	6
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Hematopoiesis	adhesion	Adhesion of hematopoietic progenitor cells	1,83E-02	5,98E-01	Decreased	-2,216	CIB1,CXCR3,ITGB2,RAC2,RAP1B,RHOA	6
Cancer,Organismal Injury and Abnormalities,Reproductive System Disease	prostatic intraepithelial neoplasia	Prostatic intraepithelial tumor	1,83E-02	5,98E-01	 	 	ANXA2,ARHGDIB,CUX1,FLNA,LY6E,SERPINB1	6
Cell Death and Survival	killing	Killing of T lymphocytes	1,83E-02	5,98E-01	 	-0,663	CD47,ELOB,PFN1,PTPRCAP,SYK,TNF	6
Neurological Disease,Organismal Injury and Abnormalities	spatial memory impairment	Spatial memory impairment	1,83E-02	5,98E-01	 	 	ARL6IP5,GRN,IDS,SUB1,TCF4,TNF	6
Cardiovascular Disease,Cardiovascular System Development and Function,Organ Morphology,Organismal Development,Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of ventricular wall	1,83E-02	5,98E-01	 	 	CXCR4,FKBP1A,HHEX,LY6E,MEF2C,YWHAE	6
Cellular Movement	haptotaxis	Haptotaxis of cells	1,83E-02	5,98E-01	 	-1,257	ACTR2,ARPC2,ILK,PTPN1,RAC1,RHOA	6
Cellular Assembly and Organization,Cellular Function and Maintenance	formation	Formation of actin cytoskeleton	1,83E-02	5,98E-01	 	-1,858	ACTB,DBNL,FLNA,MS4A1,RAC1,WIPF1	6
Cell-To-Cell Signaling and Interaction,Tissue Development	binding	Binding of extracellular matrix	1,83E-02	5,98E-01	 	 	CD82,ITGB2,ITGB7,PARVG,RHOA,ZYX	6
Free Radical Scavenging,Molecular Transport	release	Release of superoxide	1,83E-02	5,98E-01	 	-1,524	ANXA2,FGR,HCK,ITGB2,RAC1,TNF	6
Cell Morphology,Renal and Urological System Development and Function	shape change	Shape change of kidney cell lines	1,83E-02	5,98E-01	 	-1,067	ANXA2,FLNA,GRB2,RAC1,RHOA,VIM	6
Cellular Development,Cellular Growth and Proliferation,Nervous System Development and Function	myelination	Myelination of cells	1,83E-02	5,98E-01	Decreased	-2,194	ILK,OGT,PSAP,RAC1,TNF,TNFRSF1B	6
Connective Tissue Development and Function,Skeletal and Muscular System Development and Function	bone mineral density	Bone mineral density of limb bone	1,83E-02	5,98E-01	 	0,882	FDPS,ITGB2,PTPN6,RAC2,TNF,TSC22D3	6
Cardiovascular Disease,Cardiovascular System Development and Function,Organ Morphology,Organismal Development,Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of dilated heart ventricle	1,83E-02	5,98E-01	 	 	CAPNS1,FKBP1A,HMOX1,MEF2A,TNF,YWHAE	6
Cell Death and Survival	apoptosis	Apoptosis of stem cells	1,83E-02	5,98E-01	 	-0,798	HMGA1,MTCH2,NOP53,PCLAF,PFN1,TNF	6
Cell-To-Cell Signaling and Interaction,Nervous System Development and Function	activation	Activation of neuroglia	1,83E-02	5,98E-01	 	0,418	ANXA2,CD47,GRN,PARK7,TNF,VIM	6
Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization	cell-cell adhesion	Cell-cell adhesion	1,84E-02	5,98E-01	 	-1,435	CD47,CD99,CXCR3,GOLPH3,GPI,H3-3A/H3-3B,ITGB2,LY6E,MTMR14,NME1,OGT,PTPRC,RAC1,SELENOW,SYK,TALDO1,TNF,VDAC1,ZEB2,ZYX	20
Cellular Compromise,Inflammatory Response	degranulation	Degranulation of leukocytes	1,84E-02	5,98E-01	 	-0,830	CORO1A,CSK,DUSP1,FGR,HCK,ITGB2,LAT2,NCKAP1L,PAK2,PTPN22,PTPN6,PTPRC,RAC2,RASGRP1,SPI1,SYK,TNF,VSIR,WIPF1,ZEB2	20
Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Hematological System Development and Function,Inflammatory Response	phagocytosis	Phagocytosis of red blood cells	1,84E-02	5,98E-01	Decreased	-3,489	ACTR2,ACTR3,ARPC2,ARPC3,ARPC4,BRK1,FGR,GNAI2,HCK,ITGB2,JAK1,NCKAP1L,PLEK,RAC1,RAC2,SYK,TLN1,TNF,UBE2L3,WASF2	20
Organismal Injury and Abnormalities	blood clot	Blood clot	1,84E-02	5,98E-01	 	-1,196	ANXA2,ATP2A3,CSK,FLNA,HMOX1,ITGB2,MS4A1,PPIA,PSMB2,PTPN1,PTPN22,RAP1B,RHOA,RHOG,S100A10,SYK,TNF,TNFRSF1B,TWF2,VIM	20
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	Alzheimer disease or frontotemporal dementia	Alzheimer disease or frontotemporal dementia	1,88E-02	5,98E-01	 	 	ACTB,ATP5F1A,ATP5PB,CAPZB,CD68,CFL1,CHI3L2,CIB1,CXCR4,FDFT1,FDPS,GAPDH,GLRX,GRN,HLA-DQA1,HLA-DQB1,HMGA1,HMOX1,LY6E,MEF2C,NEAT1,OGT,PARK7,PARP15,PRDX1,PREX1,PSAP,SCP2,SRPK2,TNF,TSPO,VCP,VDAC1,VIM	34
Cellular Development,Cellular Growth and Proliferation,Nervous System Development and Function,Organismal Development,Tissue Development	development	Development of neurons	1,88E-02	5,98E-01	Decreased	-2,580	CAPNS1,CD47,CFL1,CIB1,CRIP1,CXCR4,DBNL,FLNA,GPI,ILK,ITGB2,MEF2A,MEF2C,MTSS1,OGT,PAK2,PFN1,PSMF1,RAC1,RAP1B,RHOA,RHOG,SEPTIN7,SNX3,SSNA1,TNF,TNFRSF1B,TWF2,UCP2,UGCG,VASP,VIM,YWHAH,ZEB2	34
Cancer,Organismal Injury and Abnormalities	head and neck adenocarcinoma	Head and neck adenocarcinoma	1,89E-02	5,98E-01	 	 	ANXA2,ATP5PF,CD79A,CXCR4,FGR,GAPDH,HLA-DQA1,HMGA1,JAK1,LIMD2,LY6E,NEAT1,PTPRC,RAC1,S100A11,SYK,TESC,TPI1,VIM	19
Cancer,Organismal Injury and Abnormalities	invasive adenocarcinoma	Invasive adenocarcinoma	1,89E-02	5,98E-01	 	 	ACP5,CUX1,EIF4A1,FGR,HLA-DQA1,JAK1,LIMD2,LY6E,MEF2C,OAS1,PAK2,PARP1,PREX1,PSAP,PTPN1,PTPRC,S100A11,TERF2IP,VIM	19
Cellular Development	epithelial-mesenchymal transition	Epithelial-mesenchymal transition	1,89E-02	5,98E-01	Decreased	-2,677	CKS2,DDX17,FLNA,GPI,HHEX,IGF2BP3,ILK,MEF2A,MRPL52,PDLIM1,PTPN18,PTPN6,RAC1,RHOA,SYK,TLN1,TNF,VIM,ZEB2	19
Cellular Movement,Hematological System Development and Function	cell movement	Cell movement of hematopoietic progenitor cells	1,91E-02	5,98E-01	 	-1,189	CXCR3,CXCR4,GNAI2,ITGB2,LCP1,MTCH2,PTPN6,PTPRC,RHOA,SPI1,TCIRG1,TNF	12
Organismal Injury and Abnormalities,Organismal Survival	neonatal death	Neonatal death	1,91E-02	5,98E-01	Increased	2,913	BLOC1S2,CXCR4,EIF4E2,JAK1,MEF2C,POU2F2,PSAP,SPI1,SYK,TCF4,TNF,YBX1	12
Cell Death and Survival,Hematological System Development and Function,Organismal Injury and Abnormalities	cell viability	Cell viability of lymphocytes	1,93E-02	5,98E-01	Decreased	-3,483	CD19,CD47,CD79A,CHD4,FCMR,HCK,HSH2D,MALT1,MEF2C,PTPRC,PYCARD,RAC1,SYK,TNF,TNFRSF1B,TSC22D3,WIPF1,ZEB2	18
Cardiovascular Disease,Hematological Disease,Organismal Injury and Abnormalities	thrombus	Thrombus	1,93E-02	5,98E-01	 	-0,874	ANXA2,ATP2A3,CSK,FLNA,HMOX1,ITGB2,MS4A1,PPIA,PSMB2,PTPN22,RAP1B,RHOA,RHOG,S100A10,SYK,TNF,TNFRSF1B,TWF2	18
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking	adhesion	Adhesion of mononuclear leukocytes	1,93E-02	5,98E-01	Decreased	-2,221	CD47,CD99,CXCR3,CXCR4,GNAI2,ITGAX,ITGB2,JAK1,LCP1,MAP4K1,MYO1G,PTPN6,RAC1,RAC2,RAP1B,RASGRP1,RHOA,TNF	18
Hematological System Development and Function	hemostasis	Hemostasis	1,93E-02	5,98E-01	 	-1,633	ANXA2,ATP2A3,CLIC1,FGR,GNAI2,GPI,GSN,HCK,PLEK,PPIA,RAP1B,RASGRP2,RHOA,SYK,TNF,VASP,VIM,WIPF1	18
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	frontotemporal lobar degeneration or amyotrophic lateral sclerosis	Frontotemporal lobar degeneration or amyotrophic lateral sclerosis	1,93E-02	5,98E-01	 	 	ACTB,CALM1 (includes others),DBI,EEF1A1,EIF4A1,GRN,GSN,JPT1,MEF2C,NEAT1,PARK7,PFN1,PPIA,PSAP,RHOA,TSPO,VCP,VIM	18
Dermatological Diseases and Conditions,Organismal Injury and Abnormalities	abnormality of skin morphology	Abnormality of skin morphology	1,93E-02	5,98E-01	 	-1,342	ACTB,ACTR3,ARPC3,ARPC5,CD19,CD52,CD79A,CFL1,CIB1,CKS2,CXCR4,DHRS9,DYNLL1,EEF1A1,FDPS,FGR,FIBP,FKBP1A,GRN,GSN,HCK,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,IFI30,ILK,ITGB2,ITGB7,JAK1,LAPTM5,LCP1,MS4A1,PARP1,PFN1,PKM,RAC1,RAC2,RHOA,RNPEPL1,SPI1,TERF2IP,TKT,TNF,TPI1,VIM	47
Organismal Injury and Abnormalities,Respiratory Disease	chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	1,97E-02	5,98E-01	 	1,119	ATP5F1E,ATP5MK,COX5B,COX8A,DBNL,FABP5,FLNA,FUT8,HCK,HLA-DQA1,HMOX1,MT2A,NDUFAB1,PTPN1,PYCARD,TNF,TSPO	17
Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities	papillary thyroid cancer	Papillary thyroid carcinoma	1,97E-02	5,98E-01	 	 	ANXA2,CD79A,CXCR4,FGR,GAPDH,HLA-DQA1,HMGA1,JAK1,LIMD2,LY6E,PTPRC,RAC1,S100A11,SYK,TESC,TPI1,VIM	17
Dermatological Diseases and Conditions,Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities	lichen planus	Lichen planus	1,97E-02	5,98E-01	 	 	CD52,CFL1,DYNLL1,EEF1A1,FKBP1A,GRN,GSN,HLA-DPA1,HLA-DPB1,HLA-DQB1,HLA-DRA,IFI30,ILK,LAPTM5,LCP1,PFN1,RNPEPL1	17
Organismal Injury and Abnormalities,Respiratory Disease	lung injury	Lung injury	1,97E-02	5,98E-01	 	-0,251	ANXA2,CXCR3,DDAH2,FKBP1A,FUT8,GAPDH,HLA-DQA1,HMOX1,HSH2D,ITGB2,JAK1,LY6E,PKM,RAC1,SLC44A2,TNF,TSPO	17
Cancer,Organismal Injury and Abnormalities,Reproductive System Disease	metastasis	Metastasis of breast cancer cell lines	1,97E-02	5,98E-01	 	-1,976	CXCR4,GPI,IGF2BP3,ILK,NCOA3,NME1,PDLIM1,PTPN18,RHOA,SYK,TLN1,TNF,VIM	13
Cellular Movement	cell movement	Cell movement of hepatoma cell lines	1,97E-02	5,98E-01	 	-1,118	ARID3A,CTSH,DDX17,HMOX1,IGF2BP3,NCOA3,NME1,PKM,PTPN6,RAC1,RAP1B,TAGLN2,VDAC1	13
Connective Tissue Disorders,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	experimentally-induced arthritis	Experimentally-induced arthritis	1,97E-02	5,98E-01	Decreased	-2,423	CXCR3,DUSP1,FGR,GPI,HCK,HMOX1,LBH,PARP1,PTPN22,PYCARD,TCIRG1,TNF,TNFRSF1B	13
Neurological Disease,Organismal Injury and Abnormalities	damage	Damage of nervous system	1,97E-02	5,98E-01	 	-0,743	ADD3,CD47,FDPS,FKBP1A,GSN,HMOX1,PARK7,PARP1,PYCARD,TNF,TNFRSF1B,TSPO,UCP2	13
Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	B-cell chronic lymphoproliferative disorder	B-cell chronic lymphoproliferative disorder	1,99E-02	5,98E-01	 	 	ARL6IP5,CD52,CFL1,DUSP1,FCMR,FGR,HLA-DQA1,HVCN1,IKZF3,ITGAX,ITGB2,MRPL51,MS4A1,MTMR14,PARP1,PPIA,PPM1M,PPP1CA,PTPN1,PTPN18,PTPN22,PTPRC,RFTN1,SYK,TERF2IP,TNF,ZYX	27
Gastrointestinal Disease,Inflammatory Disease,Organismal Injury and Abnormalities	inflammatory bowel disease	Inflammatory Bowel Disease	1,99E-02	5,98E-01	 	 	ARHGDIB,CD19,CD53,CD79A,CYBA,DHRS9,FDFT1,FDPS,FKBP1A,HLA-DMB,HLA-DQA1,HLA-DQB1,IKZF3,ITGB7,JAK1,LAPTM5,LY6E,MAZ,MS4A1,PKM,PSMB8,PTPRC,PYCARD,RHOA,TLE1,TNF,TSPO	27
Cellular Development,Tissue Development	differentiation	Differentiation of bone marrow cells	1,99E-02	5,98E-01	Decreased	-2,029	ACTR2,CIB1,EIF6,GRB2,HMGA1,MEF2C,PTPN6,RAC1,SPI1,TCF4,TESC,TNF,TRAPPC1,TSC22D3,WASF2,ZEB2	16
Organismal Development,Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of thoracic cavity	2,00E-02	5,98E-01	 	 	ARHGDIB,ARID3A,ATP2A3,CAPNS1,CIB1,CXCR4,DBNL,DUSP1,FKBP1A,FLNA,FUT8,GNAI2,GNG5,GRB2,GSN,H1-2,HCK,HHEX,HLA-DQA1,HMOX1,HOPX,ILK,JAK1,LITAF,LY6E,MALT1,MEF2A,MEF2C,MTMR14,MTPN,NDUFS6,PARK7,PARP1,PFN1,PPIA,PPP1CA,PTPN22,RAC1,RASGRP1,RHOA,S100A10,SPI1,SPTAN1,SYK,TLN1,TNF,TNFRSF1B,TPI1,TSC22D3,TXNIP,VDAC1,WASF2,WIPF1,YWHAE	54
Cardiovascular System Development and Function,Tissue Morphology	morphology	Morphology of blood vessel	2,00E-02	5,98E-01	 	 	CXCR4,EHD3,FLNA,HHEX,HMOX1,MEF2C,PARP1,RAC1,SYK,TNF,TNFRSF1B,UCP2,VIM,WASF2	14
Cellular Movement	movement	Movement of progenitor cells	2,00E-02	5,98E-01	 	-1,611	CFL1,CXCR3,CXCR4,GNAI2,GSN,ITGB2,LCP1,MTCH2,PTPN6,PTPRC,RHOA,SPI1,TCIRG1,TNF	14
Cellular Movement	invasion	Invasion of cells	2,03E-02	5,98E-01	Decreased	-4,739	ANXA2,ARF5,ARID3A,CAP1,CAPNS1,CD53,CD82,CD99,CIB1,CKS2,CSK,CTSH,CXCR3,CXCR4,CYTOR,DBNL,DUSP1,EFHD2,EIF4A1,FABP5,FKBP1A,FLNA,FUT8,GAPDH,GLUL,GNAI2,GOLPH3,GPI,GRB2,GRN,GSN,HHEX,HMGA1,HMOX1,HSBP1,IGF2BP3,ILK,ITGAX,ITGB2,LCP1,MALT1,MAP4K1,MIEN1,MRPL52,NCOA3,NCOA4,NDUFB2,NEAT1,NME1,NME2,OGT,PAK2,PARK7,PDLIM1,PEA15,PFN1,PIKFYVE,PKM,PREX1,PTPN1,PTPN6,PYCARD,RAC1,RAP1B,RHOA,RHOG,RNF141,S100A10,S100A11,SLC38A1,SMARCC1,SPI1,SRA1,SYK,TAGLN2,TCF4,TCIRG1,TESC,TLN1,TMSB10/TMSB4X,TNF,VASP,VCP,VDAC1,VIM,WASF2,YBX1,ZEB2	88
Cell Death and Survival,Organismal Injury and Abnormalities	cell death	Cell death of leukemia cell lines	2,10E-02	5,98E-01	 	0,551	BLOC1S2,BTG1,CD47,CD82,CD99,CXCR4,DUSP1,FCMR,FGR,GAPDH,GSN,HCK,HMGA1,HMOX1,MAP4K1,OGT,PAK2,PARP1,PKM,PPIA,PPP1CA,PTPN6,PTPRC,PYCARD,RAC1,SAT1,TNF,TNFRSF1B,TPT1,TSC22D3,UGCG,YBX1	32
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	chemotaxis	Chemotaxis of leukocytes	2,10E-02	5,98E-01	Decreased	-2,386	CD47,CORO1A,CUX1,CXCR3,CXCR4,DUSP1,FGR,GNAI2,GRN,GSN,HCK,ITGB2,LCP1,LITAF,LSP1,NCKAP1L,PFN1,PIKFYVE,PNOC,PPIA,PREX1,PTPN6,RAC1,RAC2,RHOA,SERPINB1,SPI1,SUMO1,SYK,TMSB10/TMSB4X,TNF,WIPF1	32
Cardiovascular System Development and Function,Organ Morphology,Organismal Development	morphology	Morphology of heart	2,18E-02	5,98E-01	 	 	ARID3A,ATP2A3,CAPNS1,CAPZB,CIB1,CXCR4,DUSP1,FKBP1A,FLNA,GNAI2,GNG5,GRB2,GSN,H1-2,HCK,HHEX,HLA-DQA1,HMOX1,HOPX,ILK,LITAF,LY6E,MEF2A,MEF2C,MTMR14,MTPN,NDUFS6,PARK7,PARP1,PFN1,PPIA,PPP1CA,RAC1,RHOA,S100A10,SPTAN1,TKT,TLN1,TNF,TNFRSF1B,TPI1,TXNIP,VDAC1,WASF2,YWHAE	45
Cell-To-Cell Signaling and Interaction,Cellular Movement	recruitment	Recruitment of myeloid cells	2,19E-02	5,98E-01	 	-1,964	CD19,CD47,CD53,CNN2,CXCR4,FGR,FUT8,GLRX,GSN,HCK,ITGB2,ITGB7,LSP1,PARP1,PREX1,PYCARD,RAC1,RAP1B,RASGRP2,RHOA,TNF,TNFRSF1B,TPT1,UCP2,ZDHHC12	25
Cellular Movement	invasion	Invasion of tumor cell lines	2,21E-02	5,98E-01	Decreased	-4,583	ANXA2,ARF5,ARID3A,CAP1,CAPNS1,CD82,CD99,CIB1,CKS2,CSK,CTSH,CXCR3,CXCR4,CYTOR,DBNL,DUSP1,EFHD2,EIF4A1,FABP5,FUT8,GAPDH,GLUL,GNAI2,GOLPH3,GPI,GRN,GSN,HHEX,HMGA1,HMOX1,HSBP1,IGF2BP3,ILK,ITGB2,LCP1,MALT1,MAP4K1,MRPL52,NCOA3,NCOA4,NDUFB2,NEAT1,NME1,NME2,PAK2,PARK7,PDLIM1,PEA15,PKM,PREX1,PTPN1,PTPN6,RAC1,RAP1B,RHOA,RNF141,S100A10,S100A11,SLC38A1,SMARCC1,SRA1,SYK,TAGLN2,TCF4,TCIRG1,TESC,TLN1,TMSB10/TMSB4X,TNF,VCP,VDAC1,VIM,WASF2,YBX1,ZEB2	75
Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	non-traumatic arthropathy	Non-traumatic arthropathy	2,25E-02	5,98E-01	 	-0,519	ARHGAP30,ARHGDIB,ATP2B1,CD68,CD79A,CXCR3,CXCR4,DUSP1,DYNLL1,FDFT1,FDPS,FKBP1A,GLUL,GOLPH3,GRN,GSN,H3-3A/H3-3B,HCK,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,ITGB2,JAK1,LBH,LCP1,LY6E,MAZ,MRPS36,MS4A1,MYL12A,PARP1,POLR2L,PPIA,PPP1R7,PRDX1,PRDX5,PSMB8,PTPN1,PTPN22,PTPRC,RAB1B,RTF2,S100A10,SF3B6,SLC44A2,SUMO1,SYK,TALDO1,TCF4,TCIRG1,TNF,TNFRSF1B,TPI1,TSPO,VIM	59
Organismal Development,Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of mediastinum	2,39E-02	5,98E-01	 	 	ARHGDIB,ARID3A,ATP2A3,CAPNS1,CIB1,CXCR4,DUSP1,FKBP1A,FLNA,GNAI2,GNG5,GRB2,GSN,H1-2,HCK,HHEX,HLA-DQA1,HMOX1,HOPX,ILK,JAK1,LITAF,LY6E,MALT1,MEF2A,MEF2C,MTMR14,MTPN,NDUFS6,PARK7,PARP1,PFN1,PPIA,PPP1CA,PTPN22,RAC1,RASGRP1,RHOA,S100A10,SPI1,SPTAN1,TLN1,TNF,TNFRSF1B,TPI1,TSC22D3,TXNIP,VDAC1,WASF2,WIPF1,YWHAE	51
Cardiovascular System Development and Function	morphology	Morphology of cardiovascular system	2,39E-02	5,98E-01	 	 	ARID3A,ATP2A3,CAPNS1,CAPZB,CIB1,CXCR4,DUSP1,EHD3,FKBP1A,FLNA,GNAI2,GNG5,GRB2,GSN,H1-2,HCK,HHEX,HLA-DQA1,HMOX1,HOPX,ILK,LITAF,LY6E,MEF2A,MEF2C,MTMR14,MTPN,NDUFS6,PARK7,PARP1,PFN1,PPIA,PPP1CA,PSAP,RAC1,RHOA,RHOG,S100A10,SPTAN1,SYK,TKT,TLN1,TNF,TNFRSF1B,TPI1,TXNIP,UCP2,VDAC1,VIM,WASF2,YWHAE	51
Cardiovascular Disease,Organismal Injury and Abnormalities	atherosclerosis	Atherosclerosis	2,40E-02	5,98E-01	Decreased	-2,489	ATP2B1,CD47,CD68,FABP5,FKBP1A,GNAI2,HMOX1,IDS,ITGAX,ITGB2,MEF2A,MS4A1,NCOA3,PARP1,PFN1,PKM,PPIA,RHOA,SCP2,SPI1,TKT,TNF,VASP	23
Hematological System Development and Function,Tissue Morphology	quantity	Quantity of blood cells	2,43E-02	5,98E-01	 	-1,817	ADD3,ARHGDIB,ARID3A,ATP2B1,BLOC1S2,CAPNS1,CD19,CD47,CD79A,CD82,CIB1,CLTA,CNN2,CORO1A,CSK,CXCR3,CXCR4,DBI,DUSP1,FABP5,FCMR,FKBP1A,FLNA,GNAI2,GRN,GSN,HCK,HCST,HLA-DQA1,HLA-DQB1,HMOX1,HVCN1,IKZF3,ITGB2,ITGB7,JAK1,LITAF,LSP1,MALT1,MS4A1,MYO1G,NCKAP1L,NEDD8,PAK2,PARK7,PARP1,PCLAF,PIKFYVE,PKM,PLAC8,PLD4,POU2F2,PPIA,PRDX1,PREX1,PSAP,PSMB8,PTPN22,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RAP1B,RASGRP1,RHOA,SERPINB1,SIGLEC10,SPI1,SYK,TCF4,TCIRG1,TLN1,TNF,TNFRSF1B,TPM3,TRAPPC1,TSC22D3,TSPO,TXNIP,UNC93B1,VASP,WIPF1,YBX1,ZEB2	85
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	cell rolling	Cell rolling of neutrophils	2,43E-02	5,98E-01	Decreased	-2,138	FGR,GNAI2,HCK,PREX1,RAC2,TLN1,TNF	7
Cellular Development	maturation	Maturation of progenitor cells	2,43E-02	5,98E-01	 	0,114	CAPZB,CXCR4,HMOX1,PTPN6,PTPRC,RASGRP1,TLE5	7
Neurological Disease,Organismal Injury and Abnormalities	memory deficits	Memory deficits	2,43E-02	5,98E-01	 	 	ARL6IP5,FABP5,GRN,IDS,SUB1,TCF4,TNF	7
Post-Translational Modification	autophosphorylation	Autophosphorylation of protein	2,43E-02	5,98E-01	 	 	FGR,HCK,MAP4K1,PAK2,PIKFYVE,PTPRC,SYK	7
Cell-To-Cell Signaling and Interaction	response	Response of bacteria	2,43E-02	5,98E-01	 	-1,331	FCMR,MYO1G,NCKAP1L,RAC1,SYK,TNF,YBX1	7
Organismal Functions	hypoactivity	Hypoactivity of mice	2,43E-02	5,98E-01	 	 	ARL6IP5,DECR1,HMOX1,IDS,PARK7,PSAP,TNF	7
Cellular Movement	scattering	Scattering of cells	2,43E-02	5,98E-01	 	-0,708	ANXA2,CFL1,CSK,MTCH2,RAC1,RHOA,TMSB10/TMSB4X	7
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	hairy cell leukemia	Hairy cell leukemia	2,43E-02	5,98E-01	 	 	ARL6IP5,CFL1,FGR,ITGAX,MRPL51,MS4A1,RFTN1	7
Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Inflammatory Response	phagocytosis	Phagocytosis of leukemia cell lines	2,43E-02	5,98E-01	Decreased	-2,449	CD47,HMOX1,PSMD4,RHOG,SPI1,TNF,VIM	7
Cardiovascular System Development and Function,Tissue Morphology	permeability	Permeability of vasculature	2,43E-02	5,98E-01	 	0,128	GSN,LSP1,PLAC8,RAC1,TNF,UCP2,VASP	7
Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization	cell-cell adhesion	Cell-cell adhesion of tumor cell lines	2,43E-02	5,98E-01	 	-0,485	CXCR3,GOLPH3,LY6E,NME1,TNF,ZEB2,ZYX	7
Free Radical Scavenging,Molecular Transport	release	Release of reactive oxygen species	2,43E-02	5,98E-01	 	-1,135	ANXA2,FGR,GRN,HCK,ITGB2,RAC1,TNF	7
Hematological System Development and Function,Humoral Immune Response,Immune Cell Trafficking,Inflammatory Response,Tissue Development	accumulation	Accumulation of B lymphocytes	2,43E-02	5,98E-01	 	-1,166	CD19,CD99,ITGB2,PTPN1,TLN1,TNF,TSC22D3	7
Cellular Assembly and Organization,Cellular Compromise	depolymerization	Depolymerization of filaments	2,43E-02	5,98E-01	 	-1,709	CAP1,CFL1,CIB1,GSN,ILK,PLEK,WDR1	7
Nutritional Disease,Organismal Injury and Abnormalities	body mass index	Body mass index	2,43E-02	5,98E-01	 	 	CXCR4,HHEX,NCOA3,PTPN1,TNF,TNFRSF1B,UCP2	7
Organismal Functions	percentage body fat	Percentage body fat	2,43E-02	5,98E-01	 	0,447	CXCR4,PTPN1,SAT1,TERF2IP,TNF,TSC22D3,UBL5	7
Cellular Movement	emigration	Emigration of cells	2,43E-02	5,98E-01	 	-0,780	CNN2,CXCR4,GSN,ITGB2,LSP1,RHOA,TNF	7
Cell-To-Cell Signaling and Interaction	binding	Binding of carcinoma cell lines	2,43E-02	5,98E-01	 	0,277	CD82,ILK,PKM,RAC1,YBX1,ZEB2,ZYX	7
Cell Death and Survival	activation-induced cell death	Activation-induced cell death	2,43E-02	5,98E-01	Decreased	-2,586	MAP4K1,PARP1,RAC1,RAC2,TNF,TNFRSF1B,TSC22D3	7
Cellular Function and Maintenance,Tissue Development	function	Function of bone cells	2,43E-02	5,98E-01	 	 	CD47,CD68,GSN,HCST,PTPRC,TCIRG1,TNF	7
Dermatological Diseases and Conditions,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	dermatitis	Dermatitis	2,43E-02	5,98E-01	 	1,982	BCAS4,CAPZB,CD47,CFL1,CSK,CXCR4,DUSP1,EEF1A1,FABP5,FGR,FKBP1A,FLNA,GSN,H3-3A/H3-3B,HCK,HLA-DQA1,HLA-DQB1,HLA-DRA,IFI30,ITGB2,ITGB7,JAK1,JPT1,MALT1,MS4A1,OAS1,PPIA,PSAP,PSMB2,PTPN6,PTPRC,S100A11,SPI1,SYK,TNF,TPI1,TPM3,VCP,ZYX	39
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cellular infiltration	Cellular infiltration by leukocytes	2,49E-02	5,98E-01	 	-0,556	ANXA2,CD19,CD47,CORO1A,CUX1,CXCR3,DBNL,DUSP1,FABP5,HCK,HMOX1,IGF2BP3,ILK,ITGB2,MALT1,PARP1,PIKFYVE,PKM,PPIA,PREX1,PSMB8,PTPN1,PTPN6,RAC2,S100A10,SPI1,TCIRG1,TNF,TNFRSF1B,TRAPPC1,UCP2,VASP,YBX1,ZDHHC12	34
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	acute lymphoblastic leukemia	Acute lymphoblastic leukemia	2,49E-02	5,98E-01	 	 	ACP5,ACTG1,ADD3,BTG1,CD19,CD52,CD79A,CHD4,CSK,CXCR4,FKBP1A,GOLPH3,GPI,HCK,HHEX,HLA-DQA1,ITGB2,JAK1,LY6E,MS4A1,MYO1G,NAA50,NCOA3,PARP1,PPIA,PSMB2,PTPN1,PTPRC,RHOA,RNPEPL1,SLC44A2,SNRNP25,SYK,ZEB2	34
Organismal Injury and Abnormalities,Organismal Survival	organismal death	Organismal death	2,51E-02	5,98E-01	Increased	7,358	ACTB,ACTG1,ADK,ANXA2,ARF5,ARHGDIB,ARID3A,ATP2B1,ATP5MF,BLOC1S1,BLOC1S2,CAP1,CAPNS1,CAPZB,CD19,CD47,CD68,CD82,CDK2AP1,CFL1,CHD4,CHMP2A,CKS2,CLTA,CRIP1,CSK,CSRP1,CUX1,CXCR3,CXCR4,CYTOR,DBI,DDX17,DUSP1,EFHD2,EHD3,EIF4A1,EIF4E2,EIF6,FABP5,FDFT1,FKBP1A,FLNA,FTL,FUT8,GNAI2,GNG5,GRB2,GRN,GSN,H1-2,H3-3A/H3-3B,HCK,HCST,HHEX,HMGA1,HMOX1,HOPX,HSBP1,IDS,IFI30,IGF2BP3,IKZF3,ILK,ITGAX,ITGB2,JAK1,LAT2,LCP1,LY6E,MAD1L1,MALT1,MEF2A,MEF2C,MTSS1,MYL6,NAA50,NCOA3,NDUFAB1,NEAT1,NEDD8,NOP53,PAK2,PARP1,PCLAF,PDLIM1,PEA15,PFN1,PIKFYVE,PKM,PLD4,POU2F2,PPIA,PRDX1,PSAP,PSMD4,PTPN1,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RHOA,S100A10,S100A11,SEPTIN6,SEPTIN7,SMARCC1,SPI1,SPTAN1,SREK1,SUB1,SUMO2,SUPT4H1,SYK,TAF10,TAGLN2,TCF4,TCIRG1,TKT,TLE5,TLN1,TNF,TNFRSF1B,TPM3,TPT1,TXNIP,UBE2L3,UCP2,UGCG,UNC93B1,VASP,VCP,VDAC1,VIM,WASF2,WDR1,WIPF1,YBX1,YWHAE,ZDHHC12,ZEB2	142
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	cell movement	Cell movement of peripheral blood monocytes	2,52E-02	5,98E-01	Decreased	-2,000	ANXA2,CD99,PPIA,TNF	4
Inflammatory Response,Organismal Injury and Abnormalities	chronic inflammation	Chronic inflammation	2,52E-02	5,98E-01	 	 	HMOX1,ITGB7,TNF,VSIR	4
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	mobilization	Mobilization of mononuclear leukocytes	2,52E-02	5,98E-01	 	-1,000	CXCR3,CXCR4,ITGB2,TNF	4
Cell Signaling,Small Molecule Biochemistry	quantity	Quantity of nitric oxide	2,52E-02	5,98E-01	 	0,747	HSPA4,TNF,TNFRSF1B,UCP2	4
Cellular Assembly and Organization,Cellular Function and Maintenance,Protein Trafficking	sequestration	Sequestration of G-actin	2,52E-02	5,98E-01	 	 	GSN,PFN1,TMSB10/TMSB4X,TWF2	4
Connective Tissue Disorders,Hematological Disease,Organismal Injury and Abnormalities	poikilocytosis	Poikilocytosis	2,52E-02	5,98E-01	 	1,980	PRDX1,RAC1,RAC2,RHOA	4
Cell Morphology,Cellular Assembly and Organization,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation	formation	Formation of membrane processes	2,52E-02	5,98E-01	 	 	FKBP1A,RAC1,RHOA,RHOG	4
Cell Morphology,Cellular Assembly and Organization	morphology	Morphology of endosomes	2,52E-02	5,98E-01	 	 	ANXA2,PIKFYVE,SNX3,VCP	4
Cell-To-Cell Signaling and Interaction	detachment	Detachment of myeloid cells	2,52E-02	5,98E-01	 	-0,762	NCKAP1L,PTPN6,PTPRC,RHOA	4
Organismal Injury and Abnormalities	morbidity	Morbidity	2,52E-02	5,98E-01	 	 	DUSP1,PYCARD,TNF,TNFRSF1B	4
Cellular Assembly and Organization,Cellular Function and Maintenance	organization	Organization of plasma membrane projections	2,52E-02	5,98E-01	 	 	CAPZB,CFL1,ILK,PLEK	4
Post-Translational Modification	lipidation	Lipidation of protein	2,52E-02	5,98E-01	 	 	GLUL,UGCG,ZDHHC12,ZDHHC21	4
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	unclassifiable B-cell lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma	Unclassifiable B-cell lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma	2,52E-02	5,98E-01	 	 	CD79A,MS4A1,POU2F2,PTPRC	4
Connective Tissue Development and Function,Organismal Development,Tissue Development	development	Development of adipose tissue	2,52E-02	5,98E-01	 	 	NCOA3,PARP1,SPI1,TNF	4
Cancer,Cellular Movement,Connective Tissue Disorders,Organismal Injury and Abnormalities	invasion	Invasion of connective tissue cells	2,52E-02	5,98E-01	 	-1,067	CXCR4,GRB2,RAC1,TNF	4
Cellular Development	differentiation	Differentiation of vasculature	2,52E-02	5,98E-01	 	 	CXCR4,MEF2C,PKM,SPI1	4
Cardiovascular Disease,Hematological Disease,Organismal Injury and Abnormalities	microcytic anemia	Microcytic anemia	2,52E-02	5,98E-01	 	1,000	HMOX1,RAC1,RAC2,TNF	4
Cellular Movement	migration	Migration of lymphoma cell lines	2,52E-02	5,98E-01	 	-0,068	HVCN1,MS4A1,NME1,RAC2	4
Cardiovascular System Development and Function,Organ Development,Organ Morphology,Skeletal and Muscular System Development and Function	contractility	Contractility of ventricular myocardium	2,52E-02	5,98E-01	 	-1,067	FKBP1A,MEF2C,TNF,TXNIP	4
Cardiovascular System Development and Function,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Organismal Development,Tissue Development	development	Development of vascular endothelial cells	2,52E-02	5,98E-01	 	 	ANXA2,MEF2C,TNF,WASF2	4
Cell Morphology,Cellular Assembly and Organization,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Nervous System Development and Function,Organismal Development,Tissue Development	myelination	Myelination of axons	2,52E-02	5,98E-01	 	-1,981	ILK,OGT,RAC1,TNFRSF1B	4
Organismal Injury and Abnormalities,Renal and Urological Disease	injury	Injury of renal glomerulus	2,52E-02	5,98E-01	 	1,982	CXCR4,FKBP1A,GRN,TXNIP	4
Cardiovascular System Development and Function,Cell-To-Cell Signaling and Interaction	attachment	Attachment of endothelial cells	2,52E-02	5,98E-01	 	-1,131	ITGB2,PKM,RHOA,TNF	4
Carbohydrate Metabolism,Lipid Metabolism,Small Molecule Biochemistry	synthesis	Synthesis of phosphatidylcholine	2,52E-02	5,98E-01	 	 	DBI,FABP5,SLC44A2,TNF	4
Cell Morphology,Cell-To-Cell Signaling and Interaction,Nervous System Development and Function	plasticity	Plasticity of synapse	2,52E-02	5,98E-01	 	 	MEF2C,RAC1,SLC38A1,TNF	4
Cellular Movement	transendothelial migration	Transendothelial migration of leukemia cell lines	2,52E-02	5,98E-01	 	-1,982	CD99,RAC1,RHOA,TNF	4
Cancer,Cellular Movement,Organismal Injury and Abnormalities,Reproductive System Disease,Tumor Morphology	invasion	Invasion of mammary tumor cells	2,52E-02	5,98E-01	 	 	CXCR4,FLNA,RHOA,SYK	4
Cellular Assembly and Organization,DNA Replication, Recombination, and Repair	quantity	Quantity of chromosomes	2,52E-02	5,98E-01	 	 	H3-3A/H3-3B,MAD1L1,SPI1,YBX1	4
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	chemotaxis	Chemotaxis of PBMCs	2,52E-02	5,98E-01	 	-1,000	CXCR4,LCP1,PPIA,TNF	4
Cellular Development,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development	maturation	Maturation of thymocytes	2,52E-02	5,98E-01	 	-0,152	CXCR4,PTPN6,PTPRC,RASGRP1	4
Cell-To-Cell Signaling and Interaction	calcium response	Calcium response of cells	2,52E-02	5,98E-01	 	 	CD19,PTPRC,SIGLEC10,SUMO1	4
Cellular Movement	chemokinesis	Chemokinesis	2,52E-02	5,98E-01	 	-1,989	GRB2,RAC1,RAC2,TNF	4
Cell Death and Survival,Embryonic Development	cell viability	Cell viability of embryonic stem cells	2,52E-02	5,98E-01	 	 	HMGA1,NOP53,OGT,PARP1	4
Cellular Development,Cellular Growth and Proliferation	proliferation	Proliferation of thyroid tumor cell lines	2,52E-02	5,98E-01	 	-0,594	CXCR4,IGF2BP3,RAC1,TXNIP	4
Cellular Compromise	acidification	Acidification of cells	2,52E-02	5,98E-01	 	 	HVCN1,PARP1,PKM,TCIRG1	4
Organismal Injury and Abnormalities,Renal and Urological Disease	polyuria	Polyuria	2,52E-02	5,98E-01	Increased	2,000	GRN,ILK,MTSS1,PSAP	4
Cellular Movement	cell rolling	Arrest in cell rolling	2,52E-02	5,98E-01	 	 	GNAI2,ITGB2,ITGB7,TLN1	4
Cellular Function and Maintenance	homeostasis	Homeostasis of red blood cells	2,52E-02	5,98E-01	 	 	GPI,HMOX1,NCKAP1L,PRDX1	4
Nervous System Development and Function,Organ Morphology,Tissue Morphology	quantity	Quantity of brain cells	2,52E-02	5,98E-01	 	-1,964	CXCR4,PSAP,RAC1,SPTAN1	4
Cardiovascular System Development and Function,Cellular Development,Tissue Development	differentiation	Differentiation of endothelial cells	2,52E-02	5,98E-01	 	-0,152	BTG1,CXCR4,HHEX,PKM	4
Nervous System Development and Function	development	Development of nerves	2,52E-02	5,98E-01	 	 	CHD4,ILK,MEF2C,TCIRG1	4
Cellular Movement	diapedesis	Diapedesis	2,52E-02	5,98E-01	 	 	CNN2,ITGB2,LSP1,RHOA	4
Hematological Disease,Organismal Injury and Abnormalities	anisocytosis	Anisocytosis	2,52E-02	5,98E-01	 	1,980	HMOX1,PRDX1,RAC1,RAC2	4
Nervous System Development and Function	remyelination	Remyelination	2,52E-02	5,98E-01	 	-0,689	CXCR4,OGT,TNF,TNFRSF1B	4
Connective Tissue Development and Function,Skeletal and Muscular System Development and Function,Tissue Morphology	quantity	Quantity of osteoblasts	2,52E-02	5,98E-01	 	0,000	CAPNS1,CD47,TNF,TSC22D3	4
Cellular Assembly and Organization	generation	Generation of actin filaments	2,52E-02	5,98E-01	 	 	RAC1,RAC2,RHOA,VASP	4
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	acute leukemia	Acute leukemia	2,57E-02	5,98E-01	 	-0,943	ACP5,ACTB,ACTG1,ADD3,ANXA2,ARID3A,ATP5F1A,BTG1,CD19,CD47,CD52,CD68,CD79A,CD82,CD99,CHD4,CORO1A,CSK,CUX1,CXCR4,EEF1A1,EIF4A1,FGR,FKBP1A,FLNA,GDI2,GOLPH3,GPI,GRN,HCK,HHEX,HLA-DQA1,HLA-DQB1,HLA-DRA,HMGA1,HSPA4,IGF2BP3,ITGAX,ITGB2,JAK1,LSM14A,LY6E,MAD1L1,MAP4K1,MEF2C,MS4A1,MTCH2,MYO1G,NAA50,NCOA3,NDUFA11,NDUFA7,NDUFAB1,NDUFB2,NDUFV2,PARP1,PPHLN1,PPIA,PPP1R7,PSMB2,PSMB8,PTPN1,PTPN6,PTPRC,RAC1,RAC2,RHOA,RNPEPL1,SLC25A5,SLC44A2,SNRNP25,SPI1,SREK1,SYK,TCF4,TLN1,TMSB10/TMSB4X,TNF,TPI1,TSPO,UBE2L3,YBX1,YWHAE,ZEB2	84
Cellular Assembly and Organization,Cellular Function and Maintenance,Organismal Development,Tissue Development	formation	Formation of actin filaments	2,60E-02	5,98E-01	Decreased	-2,358	ACTB,ACTG1,ARPC2,BRK1,CFL1,CORO1A,GNAI2,GNG5,GPI,GRB2,GSN,HCK,MTSS1,NCKAP1L,PAK2,PFDN5,PFN1,PREX1,PYCARD,RAC1,RHOA,S100A10,TNF,TPM3,TWF2,VASP,WASF2,ZYX	28
Infectious Diseases,Organismal Injury and Abnormalities	infection	Infection of mammalia	2,60E-02	5,98E-01	Increased	3,346	CD47,CD82,CXCR4,DDX17,DUSP1,FCMR,FGR,GNAI2,GRB2,GRN,HCK,HLA-DQB1,HMOX1,IFI30,ITGAX,ITGB2,ITGB7,LCP1,PLAC8,PYCARD,RAC2,RHOA,SAMHD1,SERPINB1,TNF,TNFRSF1B,UCP2,UNC93B1	28
Cardiovascular Disease,Connective Tissue Disorders,Dermatological Diseases and Conditions,Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	systemic sclerosis	Systemic sclerosis	2,62E-02	5,98E-01	 	 	ACTB,ARPC3,CD19,CD79A,CFL1,CIB1,CKS2,CXCR4,DHRS9,FGR,FIBP,HCK,ILK,ITGB2,ITGB7,JAK1,MS4A1,PARP1,PKM,RAC2,TPI1	21
Cancer,Organismal Injury and Abnormalities	malignant tumor	Refractory malignant tumor	2,62E-02	5,98E-01	 	 	CD19,CD52,CSK,CXCR4,EEF1A1,FDFT1,FDPS,FGR,FKBP1A,HCK,HLA-DRA,HMOX1,JAK1,MS4A1,PARP1,PPIA,PSMB2,PSMB8,PTPRC,TNF,TSPO	21
Gastrointestinal Disease,Inflammatory Disease,Organismal Injury and Abnormalities	gastroenteritis	Gastroenteritis	2,64E-02	5,98E-01	 	1,670	ARHGDIB,CD19,CD47,CD53,CD79A,CORO1A,DHRS9,FKBP1A,GNAI2,HLA-DMB,HLA-DQA1,HLA-DQB1,HMOX1,IKZF3,ITGB7,JAK1,LAPTM5,MAZ,MS4A1,PARK7,PARP1,PKM,PSMB8,PTPN22,PTPRC,PYCARD,RAC1,RHOA,TNF,TNFRSF1B,TSPO,UNC93B1,WIPF1	33
Cell-To-Cell Signaling and Interaction,Inflammatory Response	immune response	Immune response of phagocytes	2,73E-02	5,98E-01	Decreased	-2,951	CD47,CD68,CNN2,FGR,GLRX,GRN,GSN,HCK,HMOX1,HSH2D,ITGAX,ITGB2,MAP4K1,NCKAP1L,PSMB8,PTPRC,SPI1,SYK,TNF,UCP2	20
Digestive System Development and Function,Hepatic System Development and Function,Organ Morphology,Organismal Development	morphology	Morphology of liver	2,73E-02	5,98E-01	 	 	CUX1,DECR1,DUSP1,EIF6,FABP5,FDFT1,GRN,HHEX,IDS,MFSD1,PARP1,PRDX5,PREX1,PSAP,SCP2,SPI1,TKT,TNF,TNFRSF1B,YBX1	20
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	degenerative brain disorder	Degenerative brain disorder	2,73E-02	5,98E-01	 	 	ACTB,CALM1 (includes others),DBI,EEF1A1,EIF4A1,FTL,GRN,GSN,JPT1,MEF2C,NEAT1,PARK7,PFN1,PPIA,PSAP,RHOA,TNF,TSPO,VCP,VIM	20
Nervous System Development and Function	morphology	Morphology of nervous system	2,73E-02	5,98E-01	 	 	BLOC1S2,BTG1,CD47,CFL1,CORO1A,CXCR4,DUSP1,EIF4E2,FLNA,GRN,HHEX,HSPA4,IDS,OGT,PARK7,PEA15,PFN1,PSAP,PSMF1,PTPN1,PTPRC,PYCARD,RAC1,RAP1B,RHOA,SLC44A2,SMARCC1,SPI1,TCF4,TKT,TNF,TNFRSF1B,TPM3,UCP2,UGCG,VIM,YWHAE	37
Cancer,Organismal Injury and Abnormalities	undifferentiated malignant neoplasm	Undifferentiated malignant neoplasm	2,74E-02	5,98E-01	 	 	CD19,CD47,CD68,CD79A,CXCR4,DHRS9,EIF4A1,FKBP1A,FUT8,GAPDH,GPI,HMGA1,IFI30,IGF2BP3,ITGAX,JAK1,PARK7,PARP1,PKM,PSMB2,RHOA,SPTAN1,SYK,TNFRSF1B,TPI1,VIM,ZEB2	27
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	chronic form of lymphocytic leukemia	Chronic form of lymphocytic leukemia	2,74E-02	5,98E-01	 	 	ARL6IP5,CD52,CFL1,DUSP1,FCMR,FGR,HLA-DQA1,HVCN1,IKZF3,ITGAX,ITGB2,MRPL51,MS4A1,MTMR14,PARP1,PPIA,PPM1M,PPP1CA,PTPN1,PTPN18,PTPN22,PTPRC,RFTN1,SYK,TERF2IP,TNF,ZYX	27
Cellular Movement,Immune Cell Trafficking	cell movement	Cell movement of lymphatic system cells	2,76E-02	5,98E-01	 	-1,960	ACTB,CD19,CD47,CD99,CIB1,COMMD8,CORO1A,CUX1,CXCR3,CXCR4,DBNL,FABP5,GNAI2,HMOX1,IGF2BP3,ITGB2,ITGB7,JAK1,LCP1,MALT1,MAP4K1,MYO1G,PFN1,PIKFYVE,PPIA,PYCARD,RAC1,RAC2,RAP1B,RASGRP1,RHOA,SUMO1,SYK,TLN1,TNF,TNFRSF1B,TRAPPC1,UCP2,VASP,WIPF1,ZDHHC12	41
Cell-To-Cell Signaling and Interaction	response	Response of leukemia cell lines	2,83E-02	5,98E-01	Decreased	-2,449	CD47,HMOX1,MS4A1,PSMD4,RHOG,SPI1,TNF,VIM	8
Hematological Disease,Organismal Injury and Abnormalities	polycythemia	Polycythemia	2,83E-02	5,98E-01	 	1,501	CUX1,HMGA1,JAK1,PRDX1,PTPN6,RAC1,RAC2,RHOA	8
Cancer,Organismal Injury and Abnormalities,Respiratory Disease	non-small cell lung carcinoma	Stage I metastatic non-small cell lung carcinoma	2,83E-02	5,98E-01	 	 	EEF1A1,EIF4A1,FTL,IFI30,MYL12A,PPIA,TMSB10/TMSB4X,TPT1	8
Cellular Development,Cellular Growth and Proliferation	proliferation	Proliferation of neuroblastoma cell lines	2,83E-02	5,98E-01	 	-0,287	CXCR4,HMGA1,ILK,JAK1,PCLAF,RHOA,SMARCE1,TNF	8
Connective Tissue Disorders,Hematological Disease,Organismal Injury and Abnormalities	thalassemia	Thalassemia	2,83E-02	5,98E-01	 	 	CD52,FDFT1,FDPS,FKBP1A,JAK1,PPIA,SPI1,TNF	8
Cellular Movement	trafficking	Trafficking of cells	2,83E-02	5,98E-01	 	-0,796	CXCR4,GNAI2,ITGB2,RAC1,RAP1B,TNF,TNFRSF1B,VASP	8
Organismal Functions	movement	Movement of rodents	2,83E-02	5,98E-01	 	 	ARL6IP5,DECR1,HMOX1,IDS,PARK7,PSAP,TLN1,TNF	8
Cell Signaling,Cellular Assembly and Organization,Post-Translational Modification,Protein Synthesis	nucleation	Nucleation of actin	2,83E-02	5,98E-01	 	 	ACTR3,ARPC1B,ARPC3,ARPC5,CORO1A,FGR,GSN,HCK	8
Cell Cycle	S phase	S phase of tumor cell lines	2,83E-02	5,98E-01	 	1,664	EMP3,HMOX1,MTCH2,PCLAF,PTPN6,SPI1,TNF,TSC22D3	8
Cellular Development,Cellular Growth and Proliferation,Connective Tissue Development and Function	development	Development of fibroblast cell lines	2,83E-02	5,98E-01	 	-0,447	GNAI2,GOLPH3,GRN,PTPN1,PTPN6,RAC1,RHOA,VDAC1	8
Cell Signaling,Molecular Transport,Nucleic Acid Metabolism,Small Molecule Biochemistry	concentration	Concentration of cyclic AMP	2,83E-02	5,98E-01	 	-0,349	ANXA4,CD47,CXCR4,GNAI2,PTPN6,PTPRC,RAC1,TNF	8
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	cerebral degeneration	Cerebral degeneration	2,83E-02	5,98E-01	 	 	ACTB,CALM1 (includes others),DBI,EEF1A1,EIF4A1,GRN,GSN,JPT1,MEF2C,NEAT1,PARK7,PFN1,PPIA,PSAP,RHOA,TNF,TSPO,VCP,VIM	19
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	B-cell leukemia	B-cell leukemia	2,93E-02	5,98E-01	 	 	ACP5,ADD3,BTG1,CD19,CD52,CD79A,CHD4,CSK,CXCR4,DUSP1,FCMR,FKBP1A,GOLPH3,GPI,HCK,HHEX,HLA-DQA1,HVCN1,IKZF3,ITGB2,JAK1,MS4A1,MTMR14,MYO1G,PARP1,PPIA,PPM1M,PPP1CA,PSMB2,PTPN1,PTPN18,PTPN22,PTPRC,RNPEPL1,SNRNP25,SYK,TERF2IP,TNF,ZEB2,ZYX	40
Cellular Development,Hematological System Development and Function,Lymphoid Tissue Structure and Development	maturation	Maturation of leukocytes	2,94E-02	5,98E-01	 	-1,821	CD19,CD47,CSK,CXCR4,HLA-DRA,HMOX1,ITGB2,LCP1,MAD1L1,POU2F2,PTPN6,PTPRC,RASGRP1,RHOA,TLE5,TNF,TNFRSF1B,ZEB2	18
Cancer,Organismal Injury and Abnormalities	tumor	Early stage tumor	2,94E-02	5,98E-01	 	 	ANXA2,CD19,CD79A,EEF1A1,EIF4A1,FDFT1,FDPS,FKBP1A,FTL,IFI30,MS4A1,MYL12A,NME2,PARP1,PPIA,PSMB2,TMSB10/TMSB4X,TPT1	18
Cellular Function and Maintenance	internalization	Internalization by tumor cell lines	3,04E-02	5,98E-01	Decreased	-3,508	ATP6V0D1,ATP6V1F,CD47,EFHD2,HMOX1,ILK,LY6E,NME1,NME2,OGT,PSMD4,RAC1,RHOA,RHOG,SPI1,TNF,VIM	17
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	3,04E-02	5,98E-01	 	 	ACTB,CALM1 (includes others),DBI,EEF1A1,EIF4A1,GRN,GSN,JPT1,NEAT1,PARK7,PFN1,PPIA,PSAP,RHOA,TSPO,VCP,VIM	17
Cardiovascular System Development and Function	morphology	Morphology of vasculature	3,04E-02	5,98E-01	 	 	CXCR4,EHD3,FLNA,HHEX,HMOX1,MEF2C,PARP1,PPIA,PSAP,RAC1,RHOG,SYK,TNF,TNFRSF1B,UCP2,VIM,WASF2	17
Cellular Development,Tissue Development	differentiation	Differentiation of epithelial tissue	3,04E-02	5,98E-01	Decreased	-2,408	BTG1,CXCR4,FABP5,HHEX,MEF2C,NCOA3,NME2,PKM,PYCARD,RAC1,RHOA,TAF10,TAGLN2,TNF,TXNIP,UGCG,ZEB2	17
Infectious Diseases,Organismal Injury and Abnormalities	infection	Infection by Retroviridae	3,04E-02	5,98E-01	Decreased	-4,542	ACTR3,ADK,ANXA2,ATP5F1B,CARD16,CD19,CLTA,CXCR4,FDFT1,FDPS,FKBP1A,GABARAPL2,GOLPH3,GRB2,H3-3A/H3-3B,HSPA4,ITGB7,JAK1,LAPTM5,MS4A1,MT2A,NDUFS6,PARP1,PNRC1,POLR2L,PSMA2,PSMA5,PSMD4,PTPRC,RAB1B,RAP1B,SAMHD1,SAMM50,SFT2D1,SPTAN1,SUB1,SUMO2,TAGLN2,TLE5,TNF,TNFRSF1B,TPT1,TRAPPC1,TSPO,UBE2L3,YBX1,ZYX	47
Amino Acid Metabolism,Post-Translational Modification,Small Molecule Biochemistry	phosphorylation	Phosphorylation of L-tyrosine	3,09E-02	5,98E-01	 	-1,951	CSK,FGR,HCK,ITGB2,JAK1,PAK2,PTPN6,PTPRC,SYK	9
Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Duchenne muscular dystrophy	Duchenne muscular dystrophy	3,09E-02	5,98E-01	 	 	CAP1,CFL1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,IFI30,PSAP,S100A11	9
Cell Morphology,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	cell spreading	Cell spreading of phagocytes	3,09E-02	5,98E-01	Decreased	-2,157	CNN2,CORO1A,FGR,HCK,ITGB2,RHOA,SYK,TLN1,TNF	9
Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization	quantity	Quantity of actin stress fibers	3,09E-02	5,98E-01	 	-1,129	CFL1,CSK,FLNA,GLUL,NME1,PIKFYVE,RAC1,RHOA,SPTAN1	9
Cellular Function and Maintenance	internalization	Internalization of bacteria	3,09E-02	5,98E-01	 	-1,813	CSK,FCMR,ILK,MYO1G,NCKAP1L,RAC1,SYK,TNF,WASF2	9
Cellular Development,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development	megakaryopoiesis	Megakaryopoiesis	3,09E-02	5,98E-01	 	-0,378	ACTR2,CIB1,EIF6,HMGA1,MEF2C,RAC1,TESC,WASF2,ZEB2	9
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	transmigration	Transmigration of neutrophils	3,09E-02	5,98E-01	Decreased	-2,197	CD47,CD99,CNN2,ITGB2,LSP1,PREX1,PTPN6,RASGRP2,TNF	9
Cell-To-Cell Signaling and Interaction	signaling	Signaling of cells	3,09E-02	5,98E-01	 	-0,720	CD19,GOLPH3,ITGB2,PTPN6,PTPRC,SIGLEC10,SUMO1,TNF,VASP	9
Cardiovascular System Development and Function	neovascularization	Neovascularization	3,09E-02	5,98E-01	 	-1,342	ANXA2,CD47,CD82,CXCR3,CXCR4,ITGB2,RAC1,S100A10,TNF	9
Cell Morphology,Cellular Assembly and Organization	morphology	Morphology of actin cytoskeleton	3,09E-02	5,98E-01	 	 	FLNA,MTSS1,PDLIM1,PIKFYVE,RAC1,RAC2,RHOA,RHOG,WIPF1	9
Cardiovascular Disease,Cardiovascular System Development and Function,Organ Morphology,Organismal Development,Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of heart	3,09E-02	5,98E-01	 	 	ARID3A,ATP2A3,CAPNS1,CIB1,CXCR4,DUSP1,FKBP1A,FLNA,GNAI2,GNG5,GRB2,GSN,H1-2,HCK,HHEX,HLA-DQA1,HMOX1,HOPX,ILK,LITAF,LY6E,MEF2A,MEF2C,MTMR14,MTPN,NDUFS6,PARK7,PARP1,PFN1,PPIA,PPP1CA,RAC1,RHOA,S100A10,SPTAN1,TLN1,TNF,TNFRSF1B,TPI1,TXNIP,VDAC1,WASF2,YWHAE	43
Immunological Disease,Organismal Injury and Abnormalities	allergy	Allergy	3,11E-02	5,98E-01	 	-1,081	ACTB,CAPZB,CFL1,CHD4,CORO1A,CXCR4,DUSP1,EEF1A1,FABP5,FDFT1,FGR,FKBP1A,FLNA,GAPDH,GSN,H3-3A/H3-3B,HCK,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,IFI30,ITGB7,JAK1,JPT1,MALT1,PPIA,PRDX1,PREX1,PSAP,S100A11,SPI1,SYK,TKT,TNF,TPI1,TPM3,VCP,ZYX	39
Infectious Diseases,Organismal Injury and Abnormalities	COVID-19	COVID-19	3,13E-02	5,98E-01	 	 	ACTB,AP1S2,BLOC1S1,CFL1,DECR1,DUSP1,EEF1A1,FLNA,GAPDH,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQB1,HLA-DRA,JAK1,PFN1,PKM,PLAC8,PLEK,PPIA,PSMB8,SAT1,SYK,TAGLN2,TNF,TNFRSF1B,TPT1,TSPO,TXNIP,YWHAE	30
Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	colitis	Colitis	3,13E-02	5,98E-01	 	1,180	ARHGDIB,CD19,CD47,CD53,CD79A,DHRS9,FKBP1A,GNAI2,HLA-DMB,HLA-DQA1,HLA-DQB1,IKZF3,ITGB7,JAK1,LAPTM5,MAZ,MS4A1,PARK7,PARP1,PKM,PSMB8,PTPN22,PTPRC,PYCARD,RAC1,RHOA,TNF,TSPO,UNC93B1,WIPF1	30
Nervous System Development and Function,Tissue Morphology	quantity	Quantity of neurons	3,13E-02	5,98E-01	 	-0,766	CLTA,CXCR4,DUSP1,GNAI2,GRN,PSAP,PTPN6,RAC1,RHOA,SLC44A2,SMARCE1,SPTAN1,SUB1,TNF,UCP2,VIM	16
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	migration	Migration of antigen presenting cells	3,13E-02	5,98E-01	Decreased	-2,227	CNN2,CXCR3,CXCR4,FLNA,HCK,HLA-DQB1,HMOX1,NCKAP1L,PARP1,PTPN6,RAC1,RAC2,RHOA,S100A10,SPI1,TNF	16
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	recruitment	Recruitment of neutrophils	3,13E-02	5,98E-01	Decreased	-2,717	CD19,CD47,CD53,FGR,GLRX,GSN,HCK,ITGB2,LSP1,PREX1,PYCARD,RAC1,RAP1B,RASGRP2,TNF,ZDHHC12	16
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking	adhesion	Adhesion of lymphocytes	3,13E-02	5,98E-01	 	-1,878	CD47,CD99,CXCR3,CXCR4,GNAI2,ITGB2,JAK1,MAP4K1,MYO1G,PTPN6,RAC1,RAC2,RAP1B,RASGRP1,RHOA,TNF	16
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cellular infiltration	Cellular infiltration by mononuclear leukocytes	3,13E-02	5,98E-01	Increased	2,057	CD19,CXCR3,DBNL,HCK,HMOX1,IGF2BP3,ILK,MALT1,PIKFYVE,PSMB8,TCIRG1,TNF,TRAPPC1,UCP2,VASP,ZDHHC12	16
Cell-To-Cell Signaling and Interaction	communication	Communication of cells	3,14E-02	5,98E-01	 	-0,158	ANXA4,CALM1 (includes others),CAP1,CD19,CIB1,CLEC2D,CLIC1,CSK,CXCR3,CXCR4,GDI2,GNAI2,GOLPH3,HCK,HHEX,HMOX1,ILK,ITGB2,JAK1,LAT2,LY6E,MAP4K1,NOP53,OGT,PEA15,PIKFYVE,PNOC,PREX1,PTPN1,PTPN6,PTPRC,RAC1,RAC2,RASGRP1,RASGRP2,S100A11,SIGLEC10,SRPK2,SUB1,SUMO1,SYK,TLE1,TNF,TNFRSF1B,TWF2,UGCG,VASP,VIM,YWHAE,ZFAND6	50
Organismal Injury and Abnormalities,Reproductive System Disease	endometriosis	Endometriosis	3,21E-02	5,98E-01	 	 	ACTB,CD68,CTSH,CXCR3,CXCR4,DUSP1,DYNLL1,GPI,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DRA,JAK1,MEF2A,PTPN22,RAC1,RAP1B,SAT1,SERPINB1,TMSB10/TMSB4X,TNF,TNFRSF1B,VIM,YWHAH	24
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology	morphology	Morphology of lymph follicle	3,21E-02	5,98E-01	 	 	ARHGDIB,CD47,CXCR4,HCK,HLA-DQB1,IKZF3,ITGB7,LCP1,PTPN22,PTPRC,SPI1,TCIRG1,TNF,TNFRSF1B,WIPF1	15
Cell Morphology	shape change	Shape change of leukocytes	3,21E-02	5,98E-01	Decreased	-2,382	CD19,CD47,CNN2,CORO1A,FGR,HCK,ITGB2,MAP4K1,RAC1,RAP1B,RHOA,SYK,TLN1,TNF,WIPF1	15
Cell Morphology,Tissue Morphology	morphology	Morphology of connective tissue cells	3,21E-02	5,98E-01	 	 	CD68,DUSP1,EIF6,MEF2C,PARP1,PPP1R18,PTPN1,PTPN6,PTPRC,PYCARD,RAC1,RAC2,RHOA,SUMO1,TNF	15
Molecular Transport	transport	Transport of ion	3,21E-02	5,98E-01	 	-0,555	ATP2A3,ATP2B1,ATP5F1B,CLIC1,CORO1A,HVCN1,SLC44A2,SYK,TCIRG1,TSPO,UCP2,VDAC1,YWHAB,YWHAE,YWHAH	15
Cardiovascular Disease,Cardiovascular System Development and Function,Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of cardiovascular system	3,23E-02	5,98E-01	 	 	ARID3A,ATP2A3,CAPNS1,CIB1,CXCR4,DUSP1,EHD3,FKBP1A,FLNA,GNAI2,GNG5,GRB2,GSN,H1-2,HCK,HHEX,HLA-DQA1,HMOX1,HOPX,ILK,LITAF,LY6E,MEF2A,MEF2C,MTMR14,MTPN,NDUFS6,PARK7,PARP1,PFN1,PPIA,PPP1CA,PSAP,RAC1,RHOA,S100A10,SPTAN1,SYK,TLN1,TNF,TNFRSF1B,TPI1,TXNIP,VDAC1,WASF2,YWHAE	46
Cardiovascular System Development and Function	morphogenesis	Morphogenesis of cardiovascular system	3,24E-02	5,98E-01	Decreased	-2,000	ANXA2,FKBP1A,FLNA,GRN,ILK,ITGAX,LY6E,MEF2C,SYK,TNF	10
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis,Organismal Development,Tissue Development	myelopoiesis	Myelopoiesis of bone marrow	3,24E-02	5,98E-01	 	0,000	ACTR2,CIB1,EIF6,FLNA,HMGA1,MEF2C,RAC1,TESC,WASF2,ZEB2	10
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis,Tissue Development	myelopoiesis	Myelopoiesis of hematopoietic progenitor cells	3,24E-02	5,98E-01	 	-0,378	ACTR2,CIB1,EIF6,HMGA1,MEF2C,RAC1,SPI1,TESC,WASF2,ZEB2	10
Cancer,Organismal Injury and Abnormalities	neoplasia	Neoplasia of fibroblast cell lines	3,24E-02	5,98E-01	 	-1,741	DYNLL1,EEF1A1,FGR,GNAI2,GPI,HCK,JAK1,RAC1,RHOA,TNF	10
Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization	quantity	Quantity of focal adhesions	3,24E-02	5,98E-01	 	-0,563	ACTB,CAPNS1,CSK,FLNA,HSBP1,ILK,RAC1,RHOA,SPTAN1,TLN1	10
Cellular Assembly and Organization	quantity	Quantity of actin filaments	3,24E-02	5,98E-01	 	-1,129	CFL1,CSK,FLNA,GLUL,ITGB2,NME1,PIKFYVE,RAC1,RHOA,SPTAN1	10
Cellular Movement,Connective Tissue Development and Function	migration	Migration of fibroblast cell lines	3,24E-02	5,98E-01	Decreased	-2,412	CSK,FABP5,HCK,ILK,MIEN1,RAC1,RAC2,RHOA,RHOG,VCP	10
Cellular Development,Cellular Growth and Proliferation	development	Development of breast cancer cell lines	3,24E-02	5,98E-01	 	-0,938	ANXA2,CD82,CKS2,EIF4A1,EMP3,GRN,ILK,LY6E,NCOA3,PKM	10
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	activation	Activation of T lymphocytes	3,25E-02	5,98E-01	 	-0,823	CD19,CD47,CORO1A,CSK,CXCR3,DUSP1,FKBP1A,FUT8,HLA-DPA1,HLA-DPB1,HLA-DQB1,HLA-DRA,HSH2D,HSPA4,IGF2BP3,ITGB2,LAPTM5,LAT2,MALT1,PAK2,PARP1,PTPN22,PTPN6,PTPRC,PYCARD,RASGRP1,SIGLEC10,TCIRG1,TLN1,TNF,TNFRSF1B,TRAPPC1,UNC93B1,VSIR	34
Cancer,Organismal Injury and Abnormalities,Reproductive System Disease	neoplasia	Neoplasia of breast cancer cell lines	3,28E-02	5,98E-01	 	-1,648	CD82,CXCR4,GPI,IGF2BP3,ILK,NCOA3,NME1,PDLIM1,PTPN18,RHOA,SYK,TLN1,TNF,VIM	14
Cardiovascular Disease,Developmental Disorder,Organismal Injury and Abnormalities	congenital heart disease	Congenital heart disease	3,28E-02	5,98E-01	 	1,980	CALM1 (includes others),CHD4,CXCR4,FKBP1A,FLNA,GNG5,GSN,HHEX,MEF2C,TKT,TNF,VASP,WASF2,YWHAE	14
Cell Signaling	MAPKKK cascade	MAPKKK cascade	3,28E-02	5,98E-01	Decreased	-2,203	DUSP1,GRB2,LAPTM5,LBH,MAP4K1,MEF2A,MEF2C,PPIA,PSAP,PTPN6,PTPRC,SYK,TNF,YWHAE	14
Cell-mediated Immune Response,Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	adhesion	Adhesion of T lymphocytes	3,28E-02	5,98E-01	 	-1,881	CD47,CD99,CXCR3,CXCR4,GNAI2,ITGB2,JAK1,MAP4K1,RAC1,RAC2,RAP1B,RASGRP1,RHOA,TNF	14
Cardiovascular Disease,Connective Tissue Disorders,Dermatological Diseases and Conditions,Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	diffuse systemic sclerosis	Diffuse systemic sclerosis	3,28E-02	5,98E-01	 	 	ACTB,ARPC3,CFL1,CIB1,CKS2,CXCR4,FGR,FIBP,HCK,ILK,ITGB2,JAK1,RAC2,TPI1	14
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	recruitment	Recruitment of leukocytes	3,31E-02	5,98E-01	Decreased	-2,647	CD19,CD47,CD53,CNN2,CXCR3,CXCR4,FABP5,FGR,FUT8,GLRX,GSN,HCK,HMOX1,ITGB2,ITGB7,LSP1,PARP1,PREX1,PYCARD,RAC1,RAP1B,RASGRP2,RHOA,SYK,TNF,TNFRSF1B,TPT1,UCP2,ZDHHC12	29
Cell Death and Survival,Cell Morphology,Nervous System Development and Function,Neurological Disease,Organismal Injury and Abnormalities,Tissue Morphology	loss	Loss of neurons	3,32E-02	5,98E-01	 	 	BLOC1S2,GRN,HSPA4,OGT,PARK7,PFN1,PSAP,PTPN1,PTPRC,TNF,UCP2	11
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	transmigration	Transmigration of phagocytes	3,32E-02	5,98E-01	Decreased	-2,256	CD47,CD99,CNN2,ITGAX,ITGB2,LSP1,PREX1,PTPN6,RASGRP2,RHOA,TNF	11
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	transmigration	Transmigration of mononuclear leukocytes	3,32E-02	5,98E-01	Decreased	-2,960	CD47,CD99,CXCR3,CXCR4,FABP5,ITGAX,ITGB2,RAC1,RAC2,RHOA,TNF	11
Cancer,Organismal Injury and Abnormalities	benign head and neck neoplasm	Benign head and neck neoplasm	3,32E-02	5,98E-01	 	 	ANXA2,CXCR4,FKBP1A,GNAI2,H1-2,HMGA1,HMOX1,OGT,PARK7,RAC2,RALY	11
Cellular Movement	migration	Migration of colorectal cancer cell lines	3,32E-02	5,98E-01	 	-0,835	CD47,CD82,CSK,IGF2BP3,MTSS1,PDLIM1,PKM,RAC1,RHOA,RNF141,TNF	11
Carbohydrate Metabolism,Molecular Transport,Small Molecule Biochemistry	uptake	Uptake of D-glucose	3,32E-02	5,98E-01	 	-0,879	CAP1,HMGA1,NCOA3,PEA15,PIKFYVE,PKM,PTPN1,RAC1,SEPTIN7,TNF,TXNIP	11
Cellular Assembly and Organization	quantity	Quantity of filaments	3,32E-02	5,98E-01	 	-0,664	CFL1,CSK,FLNA,GLUL,ITGB2,NME1,PIKFYVE,RAC1,RHOA,SPTAN1,VIM	11
Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	abnormality	Abnormality of limb	3,33E-02	5,98E-01	 	-0,600	CD47,CSK,FDFT1,FDPS,IDS,ITGB2,LITAF,PPIA,PTPN6,RHOA,SYK,TCIRG1,TNF	13
Cellular Development	maturation	Maturation of lymphatic system cells	3,33E-02	5,98E-01	 	-1,906	CD19,CSK,CXCR4,HLA-DRA,LCP1,MAD1L1,POU2F2,PTPN6,PTPRC,RASGRP1,TNF,TRAPPC1,ZEB2	13
Neurological Disease,Organismal Injury and Abnormalities	neurological signs	Neurological signs	3,34E-02	5,98E-01	 	0,555	ACTB,ARL6IP5,ATP2B1,ATP5F1A,ATP5F1B,ATP5F1C,ATP5F1E,ATP5MF,ATP5MK,ATP5PB,ATP5PF,CAPNS1,CD68,COX5A,COX5B,CXCR3,FABP5,FDFT1,GAPDH,GPI,GRN,HLA-DQA1,HLA-DQB1,HMOX1,HSBP1,IDS,LY6E,MALT1,MT2A,MYL12A,NDUFA7,NDUFAB1,NDUFB2,NDUFS6,NDUFV2,NME1,PARP1,PDLIM1,PFN1,PKM,PLEK,PPIA,PSMB8,RAC1,RASGRP2,RHOG,S100A10,SAT1,SEPTIN6,SRM,SUB1,TCF4,TESC,TNF,TPI1,TPM3,TSC22D3,TSPO,UCP2,UGCG,UQCR11,UQCRH	62
Cellular Development,Hematological System Development and Function,Lymphoid Tissue Structure and Development	maturation	Maturation of lymphocytes	3,34E-02	5,98E-01	 	-1,710	CD19,CSK,CXCR4,HLA-DRA,LCP1,MAD1L1,POU2F2,PTPN6,PTPRC,RASGRP1,TNF,ZEB2	12
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis,Organismal Development,Tissue Development	hematopoiesis	Hematopoiesis of bone marrow	3,34E-02	5,98E-01	 	0,102	ACTR2,CIB1,EIF6,FLNA,HMGA1,MEF2C,PTPN22,RAC1,TESC,TNF,WASF2,ZEB2	12
Cancer,Cellular Movement,Organismal Injury and Abnormalities,Tumor Morphology	invasion	Invasion of tumor cells	3,34E-02	5,98E-01	 	-0,673	CD53,CXCR4,FKBP1A,FLNA,HMOX1,MIEN1,PARK7,RAC1,RHOA,RHOG,SYK,VASP	12
Cardiovascular Disease,Cardiovascular System Development and Function,Organ Morphology,Organismal Development,Organismal Injury and Abnormalities	hypertrophy	Hypertrophy of heart	3,37E-02	5,98E-01	 	 	CIB1,DUSP1,FKBP1A,GNAI2,GRB2,GSN,HCK,HMOX1,HOPX,MEF2A,MEF2C,MTPN,PARK7,PARP1,PFN1,PPIA,RAC1,RHOA,S100A10,SPTAN1,TLN1,TNF,TNFRSF1B	23
Connective Tissue Disorders,Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	rheumatoid arthritis	Rheumatoid arthritis	3,47E-02	5,98E-01	 	 	ARHGDIB,ATP2B1,CD68,CD79A,CXCR4,DUSP1,DYNLL1,FDPS,FKBP1A,GLUL,GOLPH3,GRN,GSN,H3-3A/H3-3B,HCK,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,ITGB2,JAK1,LBH,LCP1,LY6E,MAZ,MRPS36,MS4A1,MYL12A,PARP1,POLR2L,PPIA,PPP1R7,PRDX1,PRDX5,PSMB8,PTPN1,PTPN22,PTPRC,RAB1B,RTF2,S100A10,SF3B6,SUMO1,SYK,TALDO1,TCF4,TCIRG1,TNF,TNFRSF1B,TPI1,TSPO,VIM	55
Gene Expression	transcription	Transcription of RNA	3,48E-02	5,98E-01	Decreased	-3,292	ACTR2,ACTR3,ANXA2,ANXA4,ARID3A,BTG1,CD19,CD82,CDK2AP1,CKS2,CUX1,CXCR4,DDX17,ELOB,FGR,FLNA,GRN,GTF2A2,GTF3C6,H1-2,HHEX,HMGA1,HOPX,HSBP1,IKZF3,ILK,JAK1,LBH,LITAF,MAD1L1,MALT1,MAZ,MEF2A,MEF2C,MTCH2,NCOA3,NCOA4,NEDD8,NME1,NME2,NOP53,OGT,PAK2,PARK7,PARP1,PARP15,PDLIM1,PEA15,PFDN5,PFN1,PLAC8,POLR2E,POLR2G,POLR2L,POU2F2,PTPN6,RAC1,RASGRP1,RHOA,RHOG,RNF141,S100A10,SLC44A2,SMARCC1,SMARCE1,SPI1,SRA1,SUB1,SUMO1,SUMO2,SUPT4H1,SYK,TAF10,TCF4,TERF2IP,TESC,TLE1,TLE5,TNF,TNFRSF1B,TSC22D3,TXNIP,UBE2L3,YBX1,YWHAH,ZBTB32,ZEB2	87
Metabolic Disease,Organismal Injury and Abnormalities	amyloidosis	Amyloidosis	3,50E-02	5,98E-01	 	 	ACTB,ATP5F1A,ATP5PB,CAPZB,CD47,CD68,CFL1,CHI3L2,CIB1,CXCR4,FDFT1,FDPS,GAPDH,GLRX,GRN,GSN,HLA-DQA1,HLA-DQB1,HMGA1,HMOX1,ITGAX,LY6E,MAZ,NEAT1,OGT,PARP15,PRDX1,PREX1,PSAP,PSMB2,SCP2,SRPK2,TNF,TSPO,VCP,VDAC1,VIM	37
Molecular Transport	quantity	Quantity of metal	3,54E-02	5,98E-01	 	-0,342	ANXA2,ATP2B1,CD19,CXCR3,CXCR4,FKBP1A,FTL,GNAI2,GRN,GSN,HMOX1,LAT2,PPIA,PTPN6,PTPRC,TNF,TRAPPC1,TSC22D3,TXNIP,UCP2,VDAC1,YWHAE	22
Metabolic Disease,Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	Alzheimer disease	Alzheimer disease	3,65E-02	5,98E-01	 	 	ACTB,ATP5F1A,ATP5PB,CAPZB,CD68,CFL1,CHI3L2,CIB1,CXCR4,FDFT1,FDPS,GAPDH,GLRX,GRN,HLA-DQA1,HLA-DQB1,HMGA1,HMOX1,LY6E,NEAT1,OGT,PARP15,PRDX1,PREX1,PSAP,SCP2,SRPK2,TNF,TSPO,VCP,VDAC1,VIM	32
Cellular Movement	cellular infiltration	Cellular infiltration	3,69E-02	5,98E-01	 	-0,801	ACTB,ANXA2,CD19,CD47,CHD4,CORO1A,CUX1,CXCR3,DBNL,DUSP1,FABP5,GAPDH,HCK,HMOX1,IGF2BP3,ILK,ITGB2,MALT1,PARP1,PIKFYVE,PKM,PPIA,PRDX1,PREX1,PSMB8,PTPN1,PTPN6,RAC2,S100A10,SPI1,TCIRG1,TKT,TNF,TNFRSF1B,TPI1,TRAPPC1,UCP2,VASP,YBX1,ZDHHC12	40
Cell Death and Survival,Organismal Injury and Abnormalities	apoptosis	Apoptosis of leukemia cell lines	3,70E-02	5,98E-01	 	0,631	CD47,CD82,CD99,CXCR4,DUSP1,FCMR,FGR,GSN,HCK,HMGA1,HMOX1,MAP4K1,OGT,PAK2,PARP1,PPIA,PPP1CA,PTPN6,PTPRC,PYCARD,RAC1,TNF,TNFRSF1B,TPT1,TSC22D3,UGCG,YBX1	27
Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	enteritis	Enteritis	3,87E-02	5,98E-01	 	1,765	ARHGDIB,CD19,CD47,CD53,CD79A,DHRS9,FKBP1A,GNAI2,HLA-DMB,HLA-DQA1,HLA-DQB1,IKZF3,ITGB7,JAK1,LAPTM5,MAZ,MS4A1,PARK7,PARP1,PKM,PSMB8,PTPN22,PTPRC,PYCARD,RAC1,RHOA,TNF,TNFRSF1B,TSPO,UNC93B1,WIPF1	31
Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Renal and Urological Disease	nephritis	Nephritis	3,91E-02	5,98E-01	 	1,646	CD19,CD79A,CXCR3,FGR,FKBP1A,GRN,HLA-DQB1,HMOX1,IKZF3,ITGAX,JAK1,MS4A1,PARP1,PDLIM1,PPIA,PSMB2,PTPN6,PTPRC,RHOA,S100A10,SIGLEC10,SYK,TCF4,TNF,WIPF1,YBX1	26
Molecular Transport	quantity	Quantity of metal ion	3,91E-02	5,98E-01	 	-0,250	ANXA2,ATP2B1,CD19,CXCR3,CXCR4,FKBP1A,GNAI2,GRN,GSN,LAT2,PPIA,PTPN6,PTPRC,TNF,TRAPPC1,TSC22D3,TXNIP,UCP2,VDAC1,YWHAE	20
Antimicrobial Response,Inflammatory Response	antimicrobial response	Antimicrobial response	3,91E-02	5,98E-01	Decreased	-2,200	COTL1,CXCR4,FGR,GAPDH,HCK,ITGAX,JAK1,LAMTOR5,LSM14A,MALT1,OAS1,PLAC8,PPIA,PTPN22,PTPRC,PYCARD,ROMO1,SAMHD1,SYK,TNF	20
Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry	quantity	Quantity of steroid	3,91E-02	5,98E-01	 	1,164	DBI,DUSP1,FABP5,FDFT1,HMGA1,HMOX1,HVCN1,JAK1,PARP1,PKM,PNOC,PSAP,PTPN1,RHOA,SCIMP,SCP2,TERF2IP,TNF,TSC22D3,TXNIP	20
Hematological System Development and Function,Hematopoiesis,Tissue Morphology	quantity	Quantity of hematopoietic progenitor cells	3,92E-02	5,98E-01	 	0,345	ADD3,ARHGDIB,ARID3A,ATP2B1,BLOC1S2,CAPNS1,CD47,CD79A,CIB1,CORO1A,CSK,CXCR4,FLNA,GNAI2,HLA-DQB1,IKZF3,ITGB2,JAK1,MS4A1,PAK2,PARK7,PCLAF,PRDX1,PTPN6,PTPRC,RAC1,RAC2,RAP1B,RASGRP1,SPI1,SYK,TCF4,TCIRG1,TNF,TRAPPC1,TSC22D3,VASP,WIPF1,ZEB2	39
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cell movement	Cell movement of lymphocytes	3,92E-02	5,98E-01	 	-1,981	ACTB,CD19,CD47,CD99,COMMD8,CORO1A,CUX1,CXCR3,CXCR4,DBNL,FABP5,GNAI2,HMOX1,IGF2BP3,ITGB2,ITGB7,JAK1,LCP1,MALT1,MAP4K1,MYO1G,PFN1,PIKFYVE,PPIA,PYCARD,RAC1,RAC2,RAP1B,RASGRP1,RHOA,SUMO1,TLN1,TNF,TNFRSF1B,TRAPPC1,UCP2,VASP,WIPF1,ZDHHC12	39
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development	cell proliferation	Cell proliferation of T lymphocytes	3,95E-02	5,98E-01	 	-1,117	ARHGDIB,CD19,CD47,CD79A,CD99,CORO1A,CXCR3,CXCR4,DBI,DUSP1,EHD3,ELOB,FIBP,FKBP1A,FTL,GNAI2,GPI,HLA-DMB,HLA-DPA1,HLA-DPB1,HMOX1,HSH2D,IKZF3,ITGAX,ITGB2,LAPTM5,LAT2,LCP1,MAD1L1,MALT1,MAP4K1,MRPL51,NCKAP1L,PARK7,PARP1,PEA15,PTPN22,PTPN6,PTPRC,PTPRCAP,PYCARD,RAC2,RASGRP1,RHOA,SPI1,SYK,TCIRG1,TLN1,TNF,TNFRSF1B,TSC22D3,TXNIP,VIM,VSIR,WIPF1,ZBTB32	56
Lymphoid Tissue Structure and Development,Tissue Morphology	quantity	Quantity of lymphatic system cells	3,97E-02	5,98E-01	Decreased	-2,436	ARHGDIB,ARID3A,ATP2B1,CD19,CD47,CD79A,CIB1,CLTA,CNN2,CORO1A,CSK,CXCR3,CXCR4,FABP5,FCMR,FKBP1A,FLNA,GNAI2,HCK,HCST,HLA-DQA1,HLA-DQB1,HVCN1,IKZF3,ITGB2,ITGB7,JAK1,LSP1,MALT1,MS4A1,MYO1G,PAK2,PARK7,PARP1,PCLAF,PIKFYVE,PKM,PLD4,POU2F2,PPIA,PRDX1,PSAP,PSMB8,PTPN22,PTPN6,PTPRC,PTPRCAP,PYCARD,RAC1,RAC2,RAP1B,RASGRP1,RFTN1,RHOA,SIGLEC10,SPI1,SYK,TCF4,TCIRG1,TLN1,TNF,TNFRSF1B,TRAPPC1,TSPO,TXNIP,VASP,WIPF1,ZEB2	68
Infectious Diseases,Organismal Injury and Abnormalities	HIV infection	HIV infection	3,98E-02	5,98E-01	Decreased	-4,501	ACTR3,ADK,ANXA2,ATP5F1B,CARD16,CD19,CLTA,CXCR4,FDFT1,FDPS,FKBP1A,GABARAPL2,GOLPH3,H3-3A/H3-3B,HSPA4,ITGB7,JAK1,LAPTM5,MS4A1,MT2A,NDUFS6,PARP1,PNRC1,POLR2L,PSMA2,PSMA5,PSMD4,PTPRC,RAB1B,RAP1B,SAMHD1,SAMM50,SFT2D1,SPTAN1,SUB1,SUMO2,TAGLN2,TLE5,TNF,TNFRSF1B,TPT1,TRAPPC1,TSPO,UBE2L3,YBX1,ZYX	46
Inflammatory Response,Organismal Injury and Abnormalities	inflammation	Inflammation of absolute anatomical region	4,00E-02	5,98E-01	 	1,083	ACTB,ADK,ANXA4,ARHGAP30,ARHGDIB,ATP2B1,CD19,CD47,CD53,CD68,CD79A,CD99,CHD4,CORO1A,COTL1,CSK,CXCR3,CXCR4,DDX17,DHRS9,DUSP1,DYNLL1,EHD3,FDFT1,FDPS,FGR,FKBP1A,FTL,GAPDH,GLUL,GNAI2,GOLPH3,GPI,GRN,GSN,H3-3A/H3-3B,HCK,HCST,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HMOX1,IFI30,IKZF3,ITGAX,ITGB2,ITGB7,JAK1,LAPTM5,LBH,LCP1,LITAF,LY6E,MALT1,MAP4K1,MAZ,MRPS36,MS4A1,MYL12A,NEDD8,OGT,PARK7,PARP1,PDLIM1,PIKFYVE,PKM,POLR2L,PPIA,PPP1R7,PRDX1,PRDX5,PREX1,PSMB2,PSMB8,PTPN1,PTPN22,PTPN6,PTPRC,PYCARD,RAB1B,RAC1,RFTN1,RHOA,RTF2,S100A10,SCP2,SERPINB1,SF3B6,SIGLEC10,SLC44A2,SPI1,SUMO1,SYK,TALDO1,TCF4,TCIRG1,TKT,TNF,TNFRSF1B,TPI1,TSPO,UNC93B1,VIM,VSIR,WIPF1,YBX1,ZBTB32	110
Cellular Movement,Hematological System Development and Function,Hematopoiesis	homing	Homing of hematopoietic progenitor cells	4,02E-02	5,98E-01	 	 	CXCR3,CXCR4,GNAI2,SPI1,TCIRG1	5
Cellular Movement,Hematopoiesis,Immune Cell Trafficking,Inflammatory Response	migration	Migration of megakaryocytes	4,02E-02	5,98E-01	 	-1,000	CIB1,CXCR4,LCP1,SYK,TNF	5
Cellular Growth and Proliferation,Connective Tissue Development and Function,Tissue Development	proliferation	Proliferation of bone cells	4,02E-02	5,98E-01	 	 	CAPNS1,DUSP1,RHOA,TCIRG1,TNF	5
Connective Tissue Development and Function,Skeletal and Muscular System Development and Function	bone mineral density	Bone mineral density of femur	4,02E-02	5,98E-01	 	 	FDPS,ITGB2,PTPN6,RAC2,TSC22D3	5
Cellular Movement	migration	Migration of kidney cancer cell lines	4,02E-02	5,98E-01	 	-0,972	BRK1,IGF2BP3,RAC1,YBX1,ZEB2	5
Gene Expression	transcription	Initiation of transcription of RNA	4,02E-02	5,98E-01	 	 	ELOB,GTF2A2,MAZ,NCOA4,TAF10	5
Cell Signaling,Cell-To-Cell Signaling and Interaction	cytokine and chemokine mediated signaling pathway	Cytokine and chemokine mediated signaling pathway	4,02E-02	5,98E-01	 	 	FKBP1A,HCK,JAK1,PTPN6,PTPRC	5
Cell-To-Cell Signaling and Interaction,Inflammatory Response	immune response	Immune response of leukocyte cell lines	4,02E-02	5,98E-01	 	0,555	FGR,PKM,PTPN6,RAC1,SYK	5
Cell Death and Survival	cell viability	Cell viability of bone marrow cells	4,02E-02	5,98E-01	Decreased	-2,219	LAT2,PTPN6,RAC1,RAC2,TNF	5
Cell Cycle,Cellular Development	senescence	Senescence of epithelial cells	4,02E-02	5,98E-01	 	-0,651	FUT8,ILK,PARP1,RASGRP1,TNF	5
DNA Replication, Recombination, and Repair,Nucleic Acid Metabolism,Small Molecule Biochemistry	incorporation	Incorporation of thymidine	4,02E-02	5,98E-01	 	0,728	CSK,PTPN6,TNF,TPT1,YWHAE	5
Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities	salivary gland carcinoma	Salivary gland carcinoma	4,02E-02	5,98E-01	 	 	ATP5PF,CHD4,FUT8,LSP1,NEAT1	5
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Organ Morphology,Organismal Development,Tissue Morphology	morphology	Morphology of mesenteric lymph node	4,02E-02	5,98E-01	 	 	ARHGDIB,MALT1,TCIRG1,TNF,TXNIP	5
Cardiovascular Disease,Organismal Injury and Abnormalities	foam cells	Foam cells	4,02E-02	5,98E-01	 	 	HMOX1,IDS,PARP1,PPIA,SPI1	5
Cardiovascular System Development and Function,Organ Development,Organ Morphology	contractility	Contractility of heart ventricle	4,02E-02	5,98E-01	 	-0,555	FKBP1A,MEF2C,RHOA,TNF,TXNIP	5
Endocrine System Disorders,Immunological Disease,Metabolic Disease,Organismal Injury and Abnormalities	Graves disease	Graves disease	4,02E-02	5,98E-01	 	 	CD68,HLA-DPB1,MS4A1,PTPN22,TNF	5
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	migration	Migration of bone marrow-derived macrophages	4,02E-02	5,98E-01	Decreased	-2,200	FLNA,HCK,NCKAP1L,RAC2,TNF	5
Cellular Movement	movement	Movement of bacteria	4,02E-02	5,98E-01	 	-1,131	ANXA2,PFN1,PYCARD,RAC1,RHOA	5
Cellular Movement	cell movement	Cell movement of melanoma cells	4,02E-02	5,98E-01	 	1,000	CD82,CXCR4,GSN,LSP1,VIM	5
Cardiovascular Disease,Immunological Disease,Organismal Injury and Abnormalities	Behcet disease	Behcet disease	4,02E-02	5,98E-01	 	 	HLA-DQA1,HLA-DRA,IFI30,MT2A,TNF	5
Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization	fusion	Fusion of tumor cell lines	4,02E-02	5,98E-01	 	-1,400	ACTR2,ACTR3,LY6E,RHOA,TNF	5
Cardiovascular Disease,Organismal Injury and Abnormalities	ventricular dilatation	Ventricular dilatation	4,02E-02	5,98E-01	 	 	CAPNS1,FKBP1A,HMOX1,MEF2A,TNF	5
Cellular Development	lifespan	Lifespan of blood cells	4,02E-02	5,98E-01	Decreased	-2,200	CD19,CD79A,NCKAP1L,RHOA,TWF2	5
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Nervous System Development and Function	activation	Activation of microglia	4,02E-02	5,98E-01	 	0,845	ANXA2,CD47,GRN,PARK7,TNF	5
Cell Death and Survival,Embryonic Development	cell death	Cell death of embryonic stem cells	4,02E-02	5,98E-01	 	-0,555	H3-3A/H3-3B,HMGA1,MTCH2,NOP53,TPM3	5
Cell Morphology,Connective Tissue Development and Function,Embryonic Development,Organismal Development,Skeletal and Muscular System Development and Function,Tissue Development,Tissue Morphology	morphology	Morphology of osteoclasts	4,02E-02	5,98E-01	 	 	CD68,PPP1R18,PTPRC,RAC1,TNF	5
Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Tissue Morphology	quantity	Quantity of megakaryocytes	4,02E-02	5,98E-01	 	1,960	CIB1,CSK,FLNA,PAK2,VASP	5
Cellular Movement,Hematological System Development and Function,Humoral Immune Response,Immune Cell Trafficking,Lymphoid Tissue Structure and Development	homing	Homing of B lymphocytes	4,02E-02	5,98E-01	 	-1,949	GNAI2,ITGB7,RAC2,RAP1B,WIPF1	5
Cellular Movement	chemotaxis	Chemotaxis of leukemia cell lines	4,02E-02	5,98E-01	 	 	ANXA2,CSK,CXCR4,PPIA,TNF	5
Inflammatory Response	frequency	Frequency of phagocytes	4,02E-02	5,98E-01	 	-1,154	NDUFB2,PTPN22,SPI1,TNF,ZEB2	5
Cancer,Hematological Disease,Organismal Injury and Abnormalities	myeloid hyperplasia	Myeloid hyperplasia	4,02E-02	5,98E-01	 	0,140	HMGA1,ITGB2,RAC2,TNF,VASP	5
Embryonic Development,Organ Development,Organismal Development,Reproductive System Development and Function,Tissue Development	formation	Formation of mammary gland	4,02E-02	5,98E-01	 	 	GSN,LBH,NCOA3,NME1,TNF	5
Inflammatory Disease,Inflammatory Response,Neurological Disease,Organismal Injury and Abnormalities	inflammation	Inflammation of meninges	4,02E-02	5,98E-01	 	-1,929	CD47,MS4A1,PYCARD,TNF,TNFRSF1B	5
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	cell movement	Cell movement of monocyte-derived dendritic cells	4,02E-02	5,98E-01	 	-0,958	CXCR3,CXCR4,HLA-DQB1,LSP1,TNF	5
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Hypersensitivity Response,Inflammatory Response	binding	Binding of mast cells	4,02E-02	5,98E-01	 	 	HCK,ITGB2,ITGB7,PAK2,RAC2	5
Developmental Disorder,Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities	autosomal dominant congenital eye anomaly	Autosomal dominant congenital eye anomaly	4,02E-02	5,98E-01	 	 	ACTB,ACTG1,FTL,TCF4,VIM	5
Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Renal and Urological Disease	autosomal dominant polycystic kidney disease	Autosomal dominant polycystic kidney disease	4,02E-02	5,98E-01	 	 	CUX1,FKBP1A,GSN,PRDX5,PTPRC	5
Carbohydrate Metabolism,Lipid Metabolism,Small Molecule Biochemistry	metabolism	Metabolism of phosphatidylcholine	4,02E-02	5,98E-01	 	 	DBI,FABP5,SLC44A2,SPI1,TNF	5
Cellular Assembly and Organization,Cellular Compromise	disruption	Disruption of cytoskeleton	4,02E-02	5,98E-01	 	0,640	ADD3,GSN,RAC1,RHOA,TNF	5
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	non-Alzheimer degenerative dementia	Non-Alzheimer degenerative dementia	4,02E-02	5,98E-01	 	 	GRN,MEF2C,PARK7,TNF,VCP	5
Connective Tissue Development and Function,Skeletal and Muscular System Development and Function,Tissue Development	growth	Growth of bone tissue	4,02E-02	5,98E-01	 	 	CAPNS1,DUSP1,RHOA,TCIRG1,TNF	5
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	migration	Migration of PBMCs	4,02E-02	5,98E-01	 	-0,686	CD47,CD99,CXCR3,CXCR4,LCP1	5
Infectious Diseases,Organismal Injury and Abnormalities	flu	Flu	4,02E-02	5,98E-01	 	 	DUSP1,NOP53,PTPRC,TNF,UGCG	5
Cellular Growth and Proliferation	cell focus formation	Cell focus formation	4,02E-02	5,98E-01	 	 	ANXA2,GOLPH3,HMGA1,RAC1,RHOA	5
Cell-To-Cell Signaling and Interaction,Molecular Transport,Small Molecule Biochemistry	concentration	Concentration of 5-hydroxytryptamine	4,02E-02	5,98E-01	 	-0,000	CDCA7L,HMOX1,PARK7,S100A10,TNF	5
Cell-To-Cell Signaling and Interaction,Cellular Compromise,Cellular Function and Maintenance,Hematological System Development and Function,Inflammatory Response	respiratory burst	Respiratory burst of neutrophils	4,02E-02	5,98E-01	 	-1,989	FGR,HCK,ITGB2,SYK,TNF	5
Nervous System Development and Function,Organismal Development,Tissue Development	myelination	Myelination of nervous tissue	4,02E-02	5,98E-01	Decreased	-2,194	ILK,OGT,RAC1,TNF,TNFRSF1B	5
Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Hematological System Development and Function,Inflammatory Response	phagocytosis	Phagocytosis by bone marrow-derived macrophages	4,02E-02	5,98E-01	 	-0,962	CD47,HCK,NCKAP1L,TNF,UCP2	5
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	B-cell neoplasm	B-cell neoplasm	4,09E-02	5,98E-01	 	0,343	ACP5,ADD3,ANXA2,ANXA4,ARL6IP5,BTG1,CD19,CD47,CD52,CD68,CD79A,CDV3,CFL1,CHD4,CSK,CXCR3,CXCR4,DUSP1,EEF1A1,EIF4A1,FCMR,FDFT1,FDPS,FGR,FKBP1A,FLNA,GNAI2,GOLPH3,GPI,GRB2,GSN,H1-2,HCK,HHEX,HLA-DQA1,HMOX1,HVCN1,IKZF3,ITGAX,ITGB2,JAK1,LAPTM5,LCP1,LY6E,MAD1L1,MALT1,MEF2A,MRPL51,MS4A1,MTCH2,MTMR14,MYO1G,NME1,PARP1,PCLAF,PLD4,PNRC1,POU2F2,PPIA,PPM1M,PPP1CA,PRDX1,PSMA2,PSMB2,PSMB8,PTPN1,PTPN18,PTPN22,PTPN6,PTPRC,RAC1,RALY,RFTN1,RHOA,RNPEPL1,S100A10,SAMHD1,SIGLEC10,SLC25A5,SNRNP25,SPI1,SRPK2,SYK,TERF2IP,TMEM183A,TNF,VDAC1,VIM,WASF2,YWHAE,ZEB2,ZYX	92
Cellular Development	maturation	Maturation of blood cells	4,10E-02	5,98E-01	 	-1,590	CAPZB,CD19,CD47,CSK,CXCR4,HLA-DRA,HMOX1,ITGB2,LCP1,MAD1L1,POU2F2,PTPN6,PTPRC,RASGRP1,RHOA,TLE5,TNF,TNFRSF1B,ZEB2	19
Connective Tissue Disorders,Hematological Disease,Organismal Injury and Abnormalities	hemoglobinopathy	Hemoglobinopathy	4,10E-02	5,98E-01	 	 	ACTB,ADK,CD52,FDFT1,FDPS,FKBP1A,HLA-DQA1,HMOX1,JAK1,PPIA,PSMD4,RAC1,RAP1B,SLC25A5,SPI1,SPTAN1,TNF,VCP,VDAC1	19
Cellular Development,Connective Tissue Development and Function,Tissue Development	differentiation	Differentiation of connective tissue cells	4,10E-02	5,98E-01	Decreased	-2,527	ADK,AP1S2,CAPNS1,CD47,CLIC1,DUSP1,DYNLL1,GRB2,GRN,GSN,H3-3A/H3-3B,HCST,HMGA1,HMOX1,ILK,LY6E,MEF2C,PARP1,PLAC8,PPP1CA,PSMB8,SELENOW,SPI1,SYK,TCIRG1,TNF,TSC22D3,VASP,VIM,YWHAH	30
Tissue Development	accumulation	Accumulation of cells	4,13E-02	5,98E-01	Decreased	-2,006	CD19,CD99,CXCR3,CXCR4,DUSP1,GNAI2,GRN,HCK,HMOX1,ITGAX,ITGB2,PFN1,PIKFYVE,PPM1G,PTPN1,RAC2,RASGRP1,SAMHD1,SPI1,TLN1,TNF,TNFRSF1B,TSC22D3,VSIR,WASF2	25
Cancer,Organismal Injury and Abnormalities,Reproductive System Disease	mammary tumor	Invasive mammary tumor	4,13E-02	5,98E-01	 	 	ACP5,CALM1 (includes others),CXCR3,CXCR4,FDFT1,FDPS,FKBP1A,FLNA,GABARAPL2,HLA-DQA1,JAK1,LY6E,MEF2C,NAA50,NCOA3,OAS1,PAK2,PARP1,PEA15,PKM,PREX1,PSAP,RHOA,TERF2IP,WDR1	25
Infectious Diseases,Organismal Injury and Abnormalities	neonatal late-onset sepsis	Neonatal late-onset sepsis	4,29E-02	5,98E-01	 	 	ACTB,ACTR2,CAP1,CFL1,GRB2,HCK,ITGB2,MT2A,MYL12A,PLEK,POMP,PTPN1,RHOA,SAT1,TPM3,VASP,YBX1,YWHAH	18
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	schizophrenia	Schizophrenia	4,29E-02	5,98E-01	 	 	CSRP1,DUSP1,GLRX,GLUL,GSN,LCP1,MT2A,NDUFV2,NEDD8,RASGRP1,SAMD3,TCF4,TNF,TSPO,TXNIP,VDAC1,YWHAE,YWHAH	18
Cell Signaling,Small Molecule Biochemistry	synthesis	Synthesis of nitric oxide	4,29E-02	5,98E-01	 	-1,068	CALM1 (includes others),CD47,CYBA,DDAH2,DUSP1,HCK,HMOX1,HSPA4,ILK,JAK1,PARK7,PARP1,PFN1,PRDX1,TNF,TNFRSF1B,UCP2,ZDHHC21	18
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	tumorigenesis	Tumorigenesis of lymphocytes	4,32E-02	5,98E-01	 	1,034	ACP5,ADD3,ANXA2,ANXA4,ARL6IP5,BTG1,CD19,CD47,CD52,CD68,CD79A,CDCA7L,CDV3,CFL1,CHD4,CSK,CTSH,CXCR3,CXCR4,DUSP1,EEF1A1,EIF4A1,FABP5,FCMR,FDFT1,FDPS,FGR,FKBP1A,FLNA,GNAI2,GOLPH3,GPI,GRB2,GSN,H1-2,HCK,HHEX,HLA-DPB1,HLA-DQA1,HLA-DRA,HMGA1,HMOX1,HVCN1,IFI30,IKZF3,ITGAX,ITGB2,JAK1,LAPTM5,LCP1,LY6E,MAD1L1,MALT1,MAP4K1,MEF2A,MRPL51,MS4A1,MTCH2,MTMR14,MYO1G,NCOA3,NME1,OAS1,PAK2,PARP1,PCLAF,PLAC8,PLD4,PNRC1,POU2F2,PPIA,PPM1M,PPP1CA,PRDX1,PSMA2,PSMB2,PSMB8,PTPN1,PTPN18,PTPN22,PTPN6,PTPRC,RAC1,RAC2,RALY,RFTN1,RHOA,RNPEPL1,S100A10,SAMHD1,SIGLEC10,SLC25A3,SLC25A5,SMARCC1,SNRNP25,SPI1,SRPK2,SYK,TERF2IP,TMEM183A,TMSB10/TMSB4X,TNF,TNFRSF1B,VCP,VDAC1,VIM,WASF2,WIPF1,YWHAE,ZEB2,ZYX	111
Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities	oral cavity carcinoma	Oral cavity carcinoma	4,34E-02	5,98E-01	 	 	ADD3,ATP5MF,ATP5PF,CDK2AP1,CHD4,CTSH,CYTOR,FDFT1,FGD2,FUT8,GPI,GRN,HLA-DQA1,HVCN1,ITGAX,LCP1,LSP1,LY6E,MEF2A,MEF2C,MTSS1,NCKAP1L,NCOA3,NEAT1,PARP1,PKM,POLR2L,PPP1CA,PREX1,PSMB8,PTPRC,SERF2,SLC44A2,SMARCC1,SRA1,TLN1,TNF,UNC93B1,WASF2,ZDHHC21,ZEB2	41
Cancer,Organismal Injury and Abnormalities	anaplastic carcinoma	Anaplastic carcinoma	4,36E-02	5,98E-01	 	 	CD47,CD68,CD79A,CXCR4,EIF4A1,FKBP1A,FUT8,GAPDH,GPI,HMGA1,IFI30,IGF2BP3,ITGAX,JAK1,PARK7,PARP1,PKM,RHOA,SPTAN1,SYK,TNFRSF1B,TPI1,VIM,ZEB2	24
Organismal Injury and Abnormalities	non-malignant disorder	Non-malignant disorder	4,42E-02	5,98E-01	 	-0,537	ACTB,ACTG1,ADK,ANXA2,ANXA4,AP2S1,ATP5F1A,ATP6V1F,CD52,CD68,CHMP2A,CTSH,CUX1,CXCR3,CXCR4,CYBA,DDX17,DUSP1,DYNLL1,FABP5,FDFT1,FDPS,FKBP1A,FLNA,FTL,GLRX,GLUL,GNAI2,GPI,GRB2,H1-2,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DRA,HMGA1,HMOX1,HOPX,IDS,ILK,ITGAX,JAK1,LSP1,LY6E,MEF2A,MFSD1,MS4A1,MTSS1,MYL6,NDUFV2,OAZ1,OGT,PARK7,PEA15,PLAC8,PLPP5,PPIA,PRDX1,PRDX5,PSMB8,PTPN22,PTPN6,PYCARD,RAC1,RAC2,RALY,RAP1B,RHOA,RHOG,S100A11,SAMD3,SAT1,SERPINB1,SPTAN1,SUMO1,SYK,TMSB10/TMSB4X,TNF,TNFRSF1B,TSPO,UGCG,UQCRH,VCP,VIM,YBX1,YWHAH,ZEB2,ZYX	88
Inflammatory Response,Neurological Disease,Organismal Injury and Abnormalities	inflammation	Inflammation of central nervous system	4,42E-02	5,98E-01	 	-0,427	CD19,CD47,CD68,CD99,CORO1A,DUSP1,EHD3,FDFT1,FDPS,FKBP1A,GRN,HCST,HLA-DQA1,HLA-DQB1,IFI30,ITGAX,MALT1,MAP4K1,MS4A1,PARP1,PSMB8,PTPN22,PTPRC,PYCARD,RFTN1,SERPINB1,SPI1,TNF,TNFRSF1B,UNC93B1,VIM,VSIR,ZBTB32	33
Nervous System Development and Function,Tissue Morphology	morphology	Morphology of nervous tissue	4,60E-02	5,98E-01	 	 	BLOC1S2,CD47,CFL1,CORO1A,CXCR4,DUSP1,FLNA,GRN,HSPA4,IDS,OGT,PARK7,PEA15,PFN1,PSAP,PSMF1,PTPN1,PTPRC,RAC1,RAP1B,RHOA,SPI1,TNF,TNFRSF1B,TPM3,UCP2,UGCG,VIM	28
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cell movement	Cell movement of antigen presenting cells	4,60E-02	5,98E-01	Decreased	-2,590	CNN2,CXCR3,CXCR4,FLNA,GNAI2,GSN,HCK,HLA-DQB1,HMOX1,ITGB2,LITAF,LSP1,MALT1,NCKAP1L,PARP1,PFN1,PSMB8,PTPN1,PTPN6,RAC1,RAC2,RHOA,S100A10,SPI1,TNF,VASP,YBX1,ZDHHC12	28
Protein Synthesis	quantity	Quantity of protein in blood	4,61E-02	5,98E-01	 	0,473	ARHGDIB,CD19,DUSP1,FABP5,FCMR,GNAI2,HMGA1,HMOX1,ITGB2,LAT2,MTSS1,NCOA3,PLD4,PPIA,PRDX5,PTPN1,PYCARD,SAT1,SCP2,TERF2IP,TNF,TNFRSF1B,TSC22D3	23
Hematological System Development and Function,Hematopoiesis,Organismal Development,Tissue Development	development	Development of bone marrow	4,68E-02	5,98E-01	 	-0,477	ACTR2,CD47,CIB1,EIF6,FLNA,HMGA1,MEF2C,PTPN22,PTPN6,PTPRC,RAC1,SPI1,TESC,TNF,WASF2,ZEB2	16
Cellular Growth and Proliferation	outgrowth	Outgrowth of cells	4,68E-02	5,98E-01	 	-0,130	CD47,GRN,JAK1,OGT,PARP1,PSAP,PTPN1,PTPN6,RAC1,RAP1B,RHOA,RHOG,SLC25A5,SNX3,TNF,VIM	16
Cell Morphology,Cellular Assembly and Organization,Cellular Function and Maintenance	reorganization	Reorganization of cytoskeleton	4,68E-02	5,98E-01	Decreased	-2,591	ARHGDIB,CD47,CD99,CFL1,CXCR3,FLNA,GRB2,HCK,ILK,LCP1,PLEK,PTPN1,RAC1,RHOA,SYK,VIM	16
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	migration	Migration of mononuclear leukocytes	4,68E-02	5,98E-01	Decreased	-2,775	ACTB,ANXA2,CD19,CD47,CD99,COMMD8,CORO1A,CUX1,CXCR3,CXCR4,DBNL,FABP5,GNAI2,IGF2BP3,ITGAX,ITGB2,ITGB7,JAK1,LCP1,MALT1,MAP4K1,MYO1G,NCKAP1L,PFN1,PIKFYVE,PYCARD,RAC1,RAC2,RAP1B,RASGRP1,RHOA,SUMO1,TLN1,TNF,TNFRSF1B,VASP	36
Cancer,Organismal Injury and Abnormalities	advanced malignant tumor	Advanced malignant tumor	4,69E-02	5,98E-01	Decreased	-3,006	ACP5,ACTB,ANXA2,ARID3A,BTG1,CARD16,CD47,CD52,CD82,CD99,CDCA7L,CHD4,CSK,CTSH,CUX1,CXCR3,CXCR4,CYBA,CYTOR,EEF1A1,EIF4A1,FDFT1,FDPS,FGR,FKBP1A,FLNA,FTL,FUT8,GLRX,GLUL,GOLPH3,GPI,HCK,HCST,HMGA1,HMOX1,HSPA4,IDS,IFI30,IGF2BP3,ILK,ITGB2,JAK1,LAPTM5,LIMD2,MALT1,MEF2A,MS4A1,MYL12A,NCOA3,NDUFB2,NEDD8,NME1,PARK7,PARP1,PDLIM1,PFN1,PKM,PPIA,PSAP,PSMB2,PTPN18,PTPRC,RAC1,RAC2,RHOA,S100A11,SMARCC1,SYK,TLN1,TMSB10/TMSB4X,TNF,TPT1,TSPO,TXNIP,VIM,YBX1,YWHAE,ZEB2	79
Cellular Assembly and Organization	organization	Organization of organelle	4,69E-02	5,98E-01	 	-1,195	ANXA2,CAPZB,CFL1,CHMP2A,CHMP4A,CIB1,CORO1A,CSK,FKBP1A,FLNA,GOLPH3,GRN,GSN,H1-2,H3-3A/H3-3B,ILK,IRAG2,LCP1,MTSS1,PARK7,PARP1,PIKFYVE,PLEK,RAB1B,RAC1,RAC2,RHOA,SMARCC1,TCIRG1,TNF,VIM,ZEB2	32
Inflammatory Response	degranulation	Degranulation	4,87E-02	5,98E-01	 	-1,184	CORO1A,CSK,DUSP1,FGR,GLRX,HCK,ITGB2,LAT2,NCKAP1L,PAK2,PKM,PTPN22,PTPN6,PTPRC,RAC2,RASGRP1,SPI1,SYK,TNF,VSIR,WIPF1,ZEB2	22
Cardiovascular System Development and Function,Organismal Development,Tissue Morphology	density	Density of blood vessel	4,87E-02	5,98E-01	 	1,172	CXCR4,GLRX,GSN,NCOA3,PTPN1,RAC1	6
Cell Morphology,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	cell spreading	Cell spreading of mononuclear leukocytes	4,87E-02	5,98E-01	 	-1,342	CD19,CD47,MAP4K1,RAC1,RAP1B,RHOA	6
Cell Cycle,Cellular Movement	cytokinesis	Cytokinesis of cervical cancer cell lines	4,87E-02	5,98E-01	 	-1,342	CAPZB,GNAI2,RAC1,RHOA,SEPTIN6,SEPTIN7	6
Cardiovascular System Development and Function,Cell Morphology,Organismal Development,Tissue Morphology	morphology	Morphology of endothelial cells	4,87E-02	5,98E-01	 	 	CXCR4,PPIA,PSAP,RAC1,RHOG,SYK	6
Cellular Assembly and Organization,Cellular Function and Maintenance	formation	Formation of multivesicular bodies	4,87E-02	5,98E-01	 	 	ANXA2,CHMP2A,CHMP4A,LITAF,SNX3,VPS25	6
Cell Death and Survival	apoptosis	Apoptosis of renal glomerulus	4,87E-02	5,98E-01	 	-0,923	DUSP1,EHD3,ILK,PKM,PTPN6,TNF	6
Cellular Function and Maintenance,Hematological System Development and Function,Tissue Development	function	Function of blood platelets	4,87E-02	5,98E-01	 	 	CD47,FLNA,RAC1,RASGRP2,RHOA,VASP	6
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of carcinoma cell lines	4,87E-02	5,98E-01	 	-0,152	ILK,PKM,RAC1,YBX1,ZEB2,ZYX	6
Cellular Function and Maintenance	regulation	Regulation of cells	4,87E-02	5,98E-01	Decreased	-2,000	CD47,FGR,PARP1,RAC1,TNF,TNFRSF1B	6
Cardiovascular System Development and Function,Organismal Development,Tissue Morphology	vasodilation	Vasodilation of artery	4,87E-02	5,98E-01	 	1,516	FKBP1A,HMOX1,ILK,PTPN1,RAC1,TNF	6
Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	familial degenerative brain disorder	Familial degenerative brain disorder	4,87E-02	5,98E-01	 	 	FTL,GRN,MEF2C,PARK7,PFN1,VCP	6
Cell Death and Survival,Cellular Development,Nervous System Development and Function,Tissue Development,Tissue Morphology	regeneration	Regeneration of neurons	4,87E-02	5,98E-01	 	0,128	CXCR4,FLNA,GRN,PTPN6,RHOA,VIM	6
Neurological Disease,Organismal Injury and Abnormalities	astrocytosis	Astrocytosis	4,87E-02	5,98E-01	 	0,440	ADK,GRN,OGT,PSAP,RAC1,TNF	6
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	recruitment	Recruitment of monocytes	4,87E-02	5,98E-01	Decreased	-2,416	CD47,FGR,HCK,PREX1,TNF,TNFRSF1B	6
Cell Morphology,Cellular Assembly and Organization,Cellular Function and Maintenance	formation	Formation of pseudopodia	4,87E-02	5,98E-01	 	 	CXCR4,FUT8,ILK,RAC1,RHOA,S100A11	6
Tissue Morphology	quantity	Quantity of bacteria	4,87E-02	5,98E-01	 	1,620	CD19,CXCR3,FCMR,HMOX1,PARP1,TNF	6
Cell Morphology,Hematological System Development and Function,Immunological Disease,Inflammatory Response,Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of macrophages	4,87E-02	5,98E-01	 	 	FGR,HCK,PLD4,PSAP,SPI1,TNF	6
Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Inflammatory Response	phagocytosis	Phagocytosis of bacteria	4,87E-02	5,98E-01	 	-1,741	FCMR,MYO1G,NCKAP1L,RAC1,SYK,TNF	6
Organismal Development	development	Development of exocrine gland	4,87E-02	5,98E-01	 	 	GSN,LBH,NCOA3,NME1,TNF,ZDHHC21	6
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	transendothelial migration	Transendothelial migration of leukocytes	4,87E-02	5,98E-01	Decreased	-2,216	CD47,CD99,CXCR3,RAC1,RAC2,TNF	6
Cell-To-Cell Signaling and Interaction,Inflammatory Response	respiratory burst	Respiratory burst of myeloid cells	4,87E-02	5,98E-01	 	-1,994	FGR,HCK,ITGB2,PTPRC,SYK,TNF	6
Cellular Development,Hematological System Development and Function,Hematopoiesis	maturation	Maturation of hematopoietic progenitor cells	4,87E-02	5,98E-01	 	-0,243	CAPZB,CXCR4,PTPN6,PTPRC,RASGRP1,TLE5	6
Cell Death and Survival,Embryonic Development	apoptosis	Apoptosis of embryonic cells	4,87E-02	5,98E-01	 	-0,654	CAPNS1,HMGA1,MTCH2,NOP53,RAC1,TNF	6
Cardiovascular System Development and Function,Organ Morphology,Organismal Development	morphology	Morphology of right ventricle	4,87E-02	5,98E-01	 	 	CXCR4,FKBP1A,GNG5,HHEX,HMOX1,MEF2A	6
Cancer,Organismal Injury and Abnormalities	transformation	Transformation of fibroblasts	4,87E-02	5,98E-01	 	-0,492	BRK1,CSK,GRB2,PAK2,PRDX1,RASGRP1	6
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Inflammatory Response	binding	Binding of monocytes	4,87E-02	5,98E-01	Decreased	-2,362	ITGAX,ITGB2,LCP1,RAC1,RHOA,TNF	6
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of colorectal cancer cell lines	4,87E-02	5,98E-01	 	-0,808	CSK,ILK,NME1,PKM,RAC1,TNF	6
Cell-To-Cell Signaling and Interaction,Hair and Skin Development and Function	binding	Binding of epithelial cell lines	4,87E-02	5,98E-01	Decreased	-2,392	ANXA2,GRB2,ITGB2,LY6E,OGT,PTPN1	6
Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry	quantity	Quantity of ceramide	4,87E-02	5,98E-01	 	-0,151	PKM,PSAP,RAC1,RHOA,TNF,UGCG	6
Cellular Assembly and Organization	assembly	Assembly of cell junction	4,88E-02	5,98E-01	 	-1,109	ACTB,ACTG1,DBNL,HOPX,ITGB2,MEF2C,OGT,PAK2,PFN1,RAP1B,RHOA,TLN1,TNF,UCP2,ZYX	15
Lipid Metabolism,Metabolic Disease,Organismal Injury and Abnormalities,Small Molecule Biochemistry	disorder of lipid metabolism	Disorder of lipid metabolism	4,88E-02	5,98E-01	 	1,000	CD47,CD68,DECR1,FDFT1,GRN,HLA-DQA1,ITGAX,LCP1,PPIA,PSAP,PTPN1,SCP2,TNF,TXNIP,UGCG	15
Lymphoid Tissue Structure and Development	frequency	Frequency of lymphocytes	4,88E-02	5,98E-01	 	-0,233	CD19,CXCR3,FUT8,HLA-DQB1,NDUFB2,PARK7,PARP1,PTPN22,PTPN6,RASGRP1,SERPINB1,SPI1,TNF,UNC93B1,ZEB2	15
Cellular Development,Cellular Growth and Proliferation,Hair and Skin Development and Function	proliferation	Proliferation of epithelial cell lines	4,88E-02	5,98E-01	 	-1,089	CDK2AP1,DECR1,GRB2,HSPA4,IGF2BP3,MEF2A,NDUFAB1,NME1,OGT,RHOA,SAT1,SUMO1,TNF,TSC22D3,VDAC1	15
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Organ Morphology,Tissue Morphology	morphology	Morphology of lymphoid organ	4,89E-02	5,98E-01	 	 	ARHGDIB,ARL6IP5,CD19,CD47,CUX1,DBNL,GNAI2,H1-2,HCK,HCST,HLA-DQA1,HLA-DQB1,HMGA1,HMOX1,HSH2D,IDS,IKZF3,ITGB2,JAK1,MAD1L1,MALT1,PARP1,PLD4,PRDX1,PSAP,PTPN22,PTPN6,PTPRC,PTPRCAP,RASGRP1,SPI1,TCIRG1,TNF,TNFRSF1B,TSC22D3,TXNIP,UNC93B1,WIPF1,ZEB2	39
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	dementia	Dementia	4,97E-02	5,98E-01	 	 	ACTB,ATP5F1A,ATP5PB,CAPZB,CD68,CFL1,CHI3L2,CIB1,CXCR4,FDFT1,FDPS,GAPDH,GLRX,GOLPH3,GRN,HLA-DQA1,HLA-DQB1,HMGA1,HMOX1,LY6E,MEF2C,NEAT1,OGT,PARK7,PARP15,PRDX1,PREX1,PSAP,SCP2,SRPK2,TNF,TSPO,VCP,VDAC1,VIM	35
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	tauopathy	Tauopathy	4,97E-02	5,98E-01	 	 	ACTB,ATP5F1A,ATP5PB,CAPZB,CD68,CFL1,CHI3L2,CIB1,CXCR4,FDFT1,FDPS,GAPDH,GLRX,GRN,HLA-DQA1,HLA-DQB1,HMGA1,HMOX1,ITGAX,LY6E,MEF2C,NEAT1,OGT,PARK7,PARP15,PRDX1,PREX1,PSAP,SCP2,SRPK2,TNF,TSPO,VCP,VDAC1,VIM	35
Cellular Movement	cell movement	Cell movement of tumor cell lines	4,98E-02	5,98E-01	Decreased	-4,789	ANXA2,AP1S2,ARHGDIB,ARID3A,ARPC1B,ARPC2,BRK1,BTG1,CAP1,CAPNS1,CD47,CD82,CD99,CDCA7L,CKS2,CLIC1,CSK,CTSH,CXCR3,CXCR4,CYBA,CYTOR,DDX17,EFHD2,FLNA,GAPDH,GLUL,GNAI2,GOLPH3,GPI,GRB2,GRN,HCK,HHEX,HMGA1,HMOX1,HSBP1,HVCN1,IGF2BP3,ILK,ITGB7,JAK1,LCP1,MAD1L1,MALT1,MRPL52,MS4A1,MTCH2,MTSS1,NCOA3,NDUFB2,NEAT1,NME1,NME2,OGT,PAK2,PARK7,PARVG,PDLIM1,PFN1,PKM,PPIA,PPP1CA,PREX1,PTPN1,PTPN6,RAC1,RAC2,RAP1B,RASGRP1,RHOA,RHOG,RNF141,S100A10,S100A11,SLC38A1,SMARCC1,SYK,TAGLN2,TESC,TLN1,TNF,TPM3,VASP,VCP,VDAC1,VIM,WASF2,YBX1,ZEB2,ZYX	91
